Cell HMS LINCS ID	Cell Name	Small Molecule HMS LINCS ID	Small Molecule Name	Primary Target	Pathway	GR50	GRmax	GR_AOC	Death_AUC	GR Hill Coefficient	GEC50	GR r2
50211-2	HCC1806	10390-103-1	Abemaciclib	CDK4/6	Cell cycle	0.59453	-0.4440	0.3921	0.1035	0.6190	3.5069	0.96621
50211-2	HCC1806	10071-101-1	Palbociclib	CDK4/6	Cell cycle	Inf	0.6924	0.1460	0.0085	1.6543	0.024125	0.93749
50211-2	HCC1806	10006-101-1	AZD7762	CHK1/2	Cell cycle	0.016629	-0.4822	0.8897	0.3907	1.6771	0.023183	0.99277
50211-2	HCC1806	10387-101-1	Volasertib	PLK	Cell cycle	0.0027998	-0.1323	0.7262	0.2950	5.0000	0.0029495	0.99776
50211-2	HCC1806	10287-101-2	Dinaciclib	pan CDK	Cell cycle	0.013395	-0.4585	0.6439	0.3114	3.4710	0.016174	0.99891
50211-2	HCC1806	10245-999-4	Cisplatin	Chemo	Chemotherapy	0.82764	-0.3648	0.3231	0.1009	1.1777	1.5296	0.98889
50211-2	HCC1806	10248-102-3	Doxorubicin	Chemo	Chemotherapy	0.015898	-0.3241	0.6281	0.1971	1.0948	0.021206	0.97525
50211-2	HCC1806	10102-101-4	Taxol	Chemo	Chemotherapy	0.0014225	-0.2113	0.8398	0.3493	2.1569	0.0016621	0.96243
50211-2	HCC1806	10278-102-2	Topotecan	Topo I	Chemotherapy	0.0052709	-0.5458	1.0747	0.3515	1.0834	0.0094879	0.95633
50211-2	HCC1806	10250-101-3	Etoposide	Topo II	Chemotherapy	0.096233	-0.5629	0.6490	0.2019	0.9767	0.2057	0.99535
50211-2	HCC1806	10020-101-1	Dasatinib	BCR/ABL	MAPK/nRTK	0.053677	-0.0992	0.6297	0.1625	1.4311	0.062326	0.98998
50211-2	HCC1806	10142-101-1	Trametinib	MEK	MAPK/nRTK	Inf	0.7036	0.1086	0.0280	4.8006	0.007609	0.89189
50211-2	HCC1806	10032-101-1	Saracatinib	SRC	MAPK/nRTK	1.73	0.2213	0.2336	0.0480	0.6559	1.8399	0.97728
50211-2	HCC1806	10179-101-1	ABT-737	Bcl2/XL	Misc	12.0843	0.7293	-0.0285	0.0138	5.0000	12.4641	0.7932
50211-2	HCC1806	10282-101-2	Vorinostat	HDAC	Misc	1.1276	0.0178	0.2397	0.0491	1.3263	1.2167	0.99564
50211-2	HCC1806	10161-101-1	Luminespib	HSP90	Misc	0.010903	-0.1751	0.5413	0.2054	2.8582	0.012009	0.99662
50211-2	HCC1806	10478-102-1	A-1210477	Mcl-1	Misc	Inf	0.9047	-0.0078	0.0015	4.2962	12.7646	0.58471
50211-2	HCC1806	10144-101-3	Olaparib	PARP	Misc	10.3367	0.4886	0.0953	0.0224	0.7744	42.7088	0.92848
50211-2	HCC1806	10482-114-1	Bleomycin	Radiation	Misc	8.9432	0.4813	0.1206	0.0253	0.8891	1.9034	0.96208
50211-2	HCC1806	10338-101-1	Ipatasertib	AKT	PI3K/mTOR	Inf	0.9450	0.0145	-0.0020	0.0000	Inf	0.32254
50211-2	HCC1806	10233-101-1	Alpelisib	PI3Ka	PI3K/mTOR	24.5643	0.7260	0.0386	0.0042	0.9323	42.9713	0.94371
50211-2	HCC1806	10445-101-1	Taselisib	PI3Ka, g, d	PI3K/mTOR	1.5787	-0.0297	0.2583	0.0605	0.5749	10.6705	0.98019
50211-2	HCC1806	10171-101-1	TGX221	PI3Kb	PI3K/mTOR	Inf	0.9819	-0.0154	0.0035	0.0000	Inf	-0.19348
50211-2	HCC1806	10080-101-1	Torin2	mTOR/ATM/ATR	PI3K/mTOR	0.03581	-0.1402	0.3877	0.1005	0.9893	0.048229	0.99141
50211-2	HCC1806	10235-101-1	Everolimus	mTOR1	PI3K/mTOR	Inf	0.8168	0.1972	0.0004	0.0000	Inf	-2.9998e-08
50211-2	HCC1806	10205-101-1	INK-128	mTORC1/2	PI3K/mTOR	0.052338	0.2620	0.3895	0.0353	0.9021	0.019916	0.9778
50211-2	HCC1806	10404-101-1	PF-4708671	p70S6K	PI3K/mTOR	Inf	1.0500	-0.0207	-0.0033	0.0000	Inf	-0.67606
50211-2	HCC1806	10147-101-1	Buparlisib	pan PI3K	PI3K/mTOR	1.0455	-0.2692	0.3051	0.1247	2.2933	1.2847	0.99486
50211-2	HCC1806	10047-101-1	Pictilisib	pan PI3K	PI3K/mTOR	5.8714	0.1936	0.1178	0.0220	1.3031	13.6419	0.96395
50211-2	HCC1806	10394-101-1	Ceritinib	ALK	RTK	2.1149	-0.4060	0.1766	0.0793	2.2387	2.8712	0.99364
50211-2	HCC1806	10018-101-1	Neratinib	EGFR/HER2	RTK	0.77903	-0.0883	0.1927	0.0757	0.8116	3.0161	0.95894
50211-2	HCC1806	10131-101-1	Tivantinib	MET	RTK	0.27161	-0.2185	0.4464	0.1810	3.1555	0.30267	0.99849
50211-2	HCC1806	10444-101-1	Cediranib	VEGFR/cKIT	RTK	4.9315	0.0954	0.0645	0.0363	4.9998	4.7786	0.98723
50211-2	HCC1806	10194-106-1	Cabozantinib	VEGFR2/MET	RTK	11.367	0.6905	-0.0025	0.0050	4.9955	13.3217	0.89668
50238-2	Hs 578T	10390-103-1	Abemaciclib	CDK4/6	Cell cycle	0.077629	-0.5825	0.6343	0.1966	0.4160	1.0889	0.95772
50238-2	Hs 578T	10071-101-1	Palbociclib	CDK4/6	Cell cycle	0.15611	0.3049	0.3195	0.0363	0.7223	0.037735	0.98196
50238-2	Hs 578T	10006-101-1	AZD7762	CHK1/2	Cell cycle	0.015096	-0.5983	0.8646	0.4133	1.8783	0.01967	0.95944
50238-2	Hs 578T	10387-101-1	Volasertib	PLK	Cell cycle	0.0025675	-0.3123	0.8198	0.3337	3.0081	0.0029864	0.9987
50238-2	Hs 578T	10287-101-2	Dinaciclib	pan CDK	Cell cycle	0.0089363	-0.2388	0.6160	0.2121	4.9934	0.0096082	0.99916
50238-2	Hs 578T	10245-999-4	Cisplatin	Chemo	Chemotherapy	1.5413	0.0125	0.2347	0.0930	1.4392	1.6968	0.99339
50238-2	Hs 578T	10248-102-3	Doxorubicin	Chemo	Chemotherapy	0.0041078	-0.3466	0.8007	0.2450	1.2269	0.0052684	0.96807
50238-2	Hs 578T	10102-101-4	Taxol	Chemo	Chemotherapy	0.0010154	-0.3752	0.9535	0.4788	1.2811	0.0015458	0.95438
50238-2	Hs 578T	10278-102-2	Topotecan	Topo I	Chemotherapy	0.0049855	-0.4488	1.0175	0.4717	1.1814	0.0076404	0.9429
50238-2	Hs 578T	10250-101-3	Etoposide	Topo II	Chemotherapy	0.41322	-0.1361	0.3770	0.1666	2.0332	0.46109	0.99901
50238-2	Hs 578T	10020-101-1	Dasatinib	BCR/ABL	MAPK/nRTK	0.038606	-0.2442	0.7103	0.2679	0.9749	0.059157	0.98877
50238-2	Hs 578T	10142-101-1	Trametinib	MEK	MAPK/nRTK	0.0063584	0.1931	0.4907	0.0713	0.9022	0.0036513	0.99154
50238-2	Hs 578T	10032-101-1	Saracatinib	SRC	MAPK/nRTK	4.0375	0.1890	0.1594	0.0291	0.7110	18.9291	0.97543
50238-2	Hs 578T	10179-101-1	ABT-737	Bcl2/XL	Misc	Inf	0.7755	0.0260	0.0177	1.3421	4.2689	0.94189
50238-2	Hs 578T	10282-101-2	Vorinostat	HDAC	Misc	0.90288	-0.1689	0.2728	0.1049	2.2431	1.0225	0.99568
50238-2	Hs 578T	10161-101-1	Luminespib	HSP90	Misc	0.0032976	-0.1144	0.6699	0.2289	2.5765	0.0035402	0.99828
50238-2	Hs 578T	10478-102-1	A-1210477	Mcl-1	Misc	Inf	0.9419	-0.0065	-0.0001	0.0000	Inf	0.41975
50238-2	Hs 578T	10144-101-3	Olaparib	PARP	Misc	8.9082	0.4435	0.0997	0.0101	1.0369	25.6993	0.93656
50238-2	Hs 578T	10482-114-1	Bleomycin	Radiation	Misc	0.25197	-0.1966	0.4462	0.2094	0.9580	0.37819	0.99872
50238-2	Hs 578T	10338-101-1	Ipatasertib	AKT	PI3K/mTOR	4.5924	0.4423	0.2458	0.0093	0.5006	0.34659	0.98155
50238-2	Hs 578T	10233-101-1	Alpelisib	PI3Ka	PI3K/mTOR	11.8954	0.5308	0.0905	0.0063	0.7199	54.7171	0.9693
50238-2	Hs 578T	10445-101-1	Taselisib	PI3Ka, g, d	PI3K/mTOR	0.57529	-0.0179	0.3736	0.0734	0.3919	8.8945	0.98886
50238-2	Hs 578T	10171-101-1	TGX221	PI3Kb	PI3K/mTOR	34.4921	0.7094	0.0668	0.0103	0.5623	243.351	0.9333
50238-2	Hs 578T	10080-101-1	Torin2	mTOR/ATM/ATR	PI3K/mTOR	0.0070774	-0.2174	0.5683	0.1373	0.7608	0.010409	0.98427
50238-2	Hs 578T	10235-101-1	Everolimus	mTOR1	PI3K/mTOR	0.0056053	0.4204	0.5273	0.0278	0.4084	2.87e-05	0.64462
50238-2	Hs 578T	10205-101-1	INK-128	mTORC1/2	PI3K/mTOR	0.0090588	-0.0708	0.6226	0.1010	1.2366	0.0087974	0.98428
50238-2	Hs 578T	10404-101-1	PF-4708671	p70S6K	PI3K/mTOR	Inf	0.9143	0.0252	0.0005	2.0096	0.1778	0.76824
50238-2	Hs 578T	10147-101-1	Buparlisib	pan PI3K	PI3K/mTOR	0.68631	-0.3434	0.3760	0.1520	1.4596	1.0562	0.9918
50238-2	Hs 578T	10047-101-1	Pictilisib	pan PI3K	PI3K/mTOR	1.1555	0.0345	0.3109	0.0488	0.4397	14.0561	0.97858
50238-2	Hs 578T	10394-101-1	Ceritinib	ALK	RTK	0.96543	-0.4356	0.3052	0.1254	0.8330	3.6097	0.98175
50238-2	Hs 578T	10018-101-1	Neratinib	EGFR/HER2	RTK	0.6444	-0.1608	0.2025	0.0665	0.8744	2.2637	0.98743
50238-2	Hs 578T	10131-101-1	Tivantinib	MET	RTK	0.33668	-0.3204	0.4411	0.2071	2.0560	0.42597	0.99878
50238-2	Hs 578T	10444-101-1	Cediranib	VEGFR/cKIT	RTK	0.55083	-0.5723	0.3937	0.1358	0.6641	2.8803	0.96002
50238-2	Hs 578T	10194-106-1	Cabozantinib	VEGFR2/MET	RTK	6.3728	0.2155	0.1335	0.0452	1.3885	14.0588	0.89112
50583-6	MCF 10A	10390-103-1	Abemaciclib	CDK4/6	Cell cycle	0.34027	0.1513	0.3811	-0.0012	0.5714	0.28176	0.99756
50583-6	MCF 10A	10071-101-1	Palbociclib	CDK4/6	Cell cycle	1.9503	0.4544	0.1883	-0.0047	0.6492	0.23713	0.99244
50583-6	MCF 10A	10006-101-1	AZD7762	CHK1/2	Cell cycle	1.8064	-0.1800	0.2246	0.0802	0.8472	6.6065	0.99793
50583-6	MCF 10A	10387-101-1	Volasertib	PLK	Cell cycle	0.022128	-0.0887	0.4466	0.1711	3.5358	0.023168	0.99997
50583-6	MCF 10A	10287-101-2	Dinaciclib	pan CDK	Cell cycle	0.016244	-0.2300	0.5279	0.2344	5.0000	0.017523	0.99904
50583-6	MCF 10A	10245-999-4	Cisplatin	Chemo	Chemotherapy	4.2937	0.3794	0.0952	0.0149	2.1287	2.4561	0.99519
50583-6	MCF 10A	10248-102-3	Doxorubicin	Chemo	Chemotherapy	0.010766	-0.3242	0.6549	0.1054	1.4229	0.012388	0.96407
50583-6	MCF 10A	10102-101-4	Taxol	Chemo	Chemotherapy	0.0026843	-0.1256	0.7023	0.2576	1.8234	0.003018	0.9967
50583-6	MCF 10A	10278-102-2	Topotecan	Topo I	Chemotherapy	0.009871	-0.2000	0.7653	0.1401	1.1478	0.01069	0.95965
50583-6	MCF 10A	10250-101-3	Etoposide	Topo II	Chemotherapy	0.28398	-0.0699	0.4155	0.0691	1.3527	0.31593	0.99713
50583-6	MCF 10A	10020-101-1	Dasatinib	BCR/ABL	MAPK/nRTK	0.70911	-0.0146	0.3385	0.0619	0.5303	2.8391	0.99012
50583-6	MCF 10A	10142-101-1	Trametinib	MEK	MAPK/nRTK	0.0033619	0.2252	0.5266	-0.0015	1.2096	0.0021432	0.99763
50583-6	MCF 10A	10032-101-1	Saracatinib	SRC	MAPK/nRTK	4.8259	0.1485	0.1247	0.0066	1.0801	13.3454	0.99696
50583-6	MCF 10A	10179-101-1	ABT-737	Bcl2/XL	Misc	Inf	0.8170	0.0104	0.0055	4.1268	4.3547	0.98669
50583-6	MCF 10A	10282-101-2	Vorinostat	HDAC	Misc	2.5293	0.0566	0.1675	0.0065	1.2709	3.1489	0.99982
50583-6	MCF 10A	10161-101-1	Luminespib	HSP90	Misc	0.0076226	-0.1717	0.6131	0.2622	3.1403	0.0083878	0.9999
50583-6	MCF 10A	10478-102-1	A-1210477	Mcl-1	Misc	Inf	0.9527	0.0018	0.0006	4.5125	3.8181	0.94609
50583-6	MCF 10A	10144-101-3	Olaparib	PARP	Misc	59.3998	0.7945	0.0408	-0.0007	0.6167	350.419	0.98306
50583-6	MCF 10A	10482-114-1	Bleomycin	Radiation	Misc	0.1774	0.0378	0.4490	0.0692	0.9923	0.1791	0.99758
50583-6	MCF 10A	10338-101-1	Ipatasertib	AKT	PI3K/mTOR	Inf	0.6472	0.0600	-0.0019	1.0758	4.7959	0.99868
50583-6	MCF 10A	10233-101-1	Alpelisib	PI3Ka	PI3K/mTOR	17.193	0.5787	0.1126	-0.0029	0.4411	201.6709	0.99492
50583-6	MCF 10A	10445-101-1	Taselisib	PI3Ka, g, d	PI3K/mTOR	0.11877	0.0593	0.4844	-0.0002	0.5049	0.12632	0.99608
50583-6	MCF 10A	10171-101-1	TGX221	PI3Kb	PI3K/mTOR	Inf	0.9505	0.0050	0.0003	0.8181	270.4333	0.86411
50583-6	MCF 10A	10080-101-1	Torin2	mTOR/ATM/ATR	PI3K/mTOR	0.032009	0.1275	0.3368	0.0011	1.3839	0.02463	0.99809
50583-6	MCF 10A	10235-101-1	Everolimus	mTOR1	PI3K/mTOR	Inf	0.7889	0.1130	0.0000	0.4668	0.070049	0.96385
50583-6	MCF 10A	10205-101-1	INK-128	mTORC1/2	PI3K/mTOR	0.024199	0.1716	0.4673	-0.0027	1.3149	0.017581	0.99992
50583-6	MCF 10A	10404-101-1	PF-4708671	p70S6K	PI3K/mTOR	Inf	0.7207	0.0475	-0.0020	1.0315	4.381	0.99443
50583-6	MCF 10A	10147-101-1	Buparlisib	pan PI3K	PI3K/mTOR	1.465	-0.1604	0.2493	0.0444	1.6479	1.8654	0.99356
50583-6	MCF 10A	10047-101-1	Pictilisib	pan PI3K	PI3K/mTOR	1.8745	0.1934	0.2623	-0.0025	0.4160	26.2875	0.97592
50583-6	MCF 10A	10394-101-1	Ceritinib	ALK	RTK	2.9867	-0.3186	0.1843	0.0521	1.3962	6.5603	0.98775
50583-6	MCF 10A	10018-101-1	Neratinib	EGFR/HER2	RTK	0.10243	0.0959	0.3443	0.0215	1.1138	0.081751	0.99316
50583-6	MCF 10A	10131-101-1	Tivantinib	MET	RTK	0.18116	-0.1502	0.4509	0.1498	2.3782	0.1918	0.99221
50583-6	MCF 10A	10444-101-1	Cediranib	VEGFR/cKIT	RTK	9.6397	0.4781	0.0310	0.0012	3.3546	8.1	0.99825
50583-6	MCF 10A	10194-106-1	Cabozantinib	VEGFR2/MET	RTK	25.9104	0.8434	-0.0114	0.0040	4.9998	11.7694	0.81226
50029-2	MCF7	10390-103-1	Abemaciclib	CDK4/6	Cell cycle	0.023572	-0.2684	0.7018	0.0913	0.3795	0.13917	0.95433
50029-2	MCF7	10071-101-1	Palbociclib	CDK4/6	Cell cycle	0.074952	0.2542	0.3461	0.0139	1.0473	0.035667	0.99237
50029-2	MCF7	10006-101-1	AZD7762	CHK1/2	Cell cycle	0.04144	-0.1856	0.5977	0.1318	0.8993	0.048851	0.95892
50029-2	MCF7	10387-101-1	Volasertib	PLK	Cell cycle	0.0028671	-0.0338	0.6070	0.1245	4.2176	0.002824	0.99423
50029-2	MCF7	10287-101-2	Dinaciclib	pan CDK	Cell cycle	0.0083068	-0.2493	0.6441	0.1256	3.5461	0.009348	0.9995
50029-2	MCF7	10245-999-4	Cisplatin	Chemo	Chemotherapy	9.3237	0.4749	0.0631	0.0037	1.0987	15.5357	0.99433
50029-2	MCF7	10248-102-3	Doxorubicin	Chemo	Chemotherapy	0.016105	-0.2856	0.6363	0.1012	0.9326	0.024539	0.97476
50029-2	MCF7	10102-101-4	Taxol	Chemo	Chemotherapy	0.0013771	-0.1059	0.7722	0.1589	1.1560	0.0016261	0.94939
50029-2	MCF7	10278-102-2	Topotecan	Topo I	Chemotherapy	0.0060429	-0.2711	0.8540	0.1220	1.1751	0.0071167	0.95657
50029-2	MCF7	10250-101-3	Etoposide	Topo II	Chemotherapy	0.13489	-0.0441	0.4992	0.0261	1.3301	0.14783	0.99669
50029-2	MCF7	10020-101-1	Dasatinib	BCR/ABL	MAPK/nRTK	0.069398	0.1574	0.4829	0.0400	1.6265	0.055227	0.99565
50029-2	MCF7	10142-101-1	Trametinib	MEK	MAPK/nRTK	Inf	0.5581	0.2767	0.0114	1.2083	0.0027903	0.99413
50029-2	MCF7	10032-101-1	Saracatinib	SRC	MAPK/nRTK	0.57707	0.2735	0.3223	0.0241	0.6671	0.25342	0.9907
50029-2	MCF7	10179-101-1	ABT-737	Bcl2/XL	Misc	22.5968	0.7267	0.0146	0.0115	1.1080	29.1513	0.88699
50029-2	MCF7	10282-101-2	Vorinostat	HDAC	Misc	0.54198	-0.1752	0.3494	0.0792	1.1946	0.72813	0.99735
50029-2	MCF7	10161-101-1	Luminespib	HSP90	Misc	0.0087135	0.0015	0.5132	0.0620	2.7505	0.008705	0.99839
50029-2	MCF7	10478-102-1	A-1210477	Mcl-1	Misc	Inf	0.8774	-0.0002	0.0007	1.8795	11.2338	0.74456
50029-2	MCF7	10144-101-3	Olaparib	PARP	Misc	10.3196	0.5137	0.0554	0.0074	1.4485	14.0349	0.99551
50029-2	MCF7	10482-114-1	Bleomycin	Radiation	Misc	0.07723	-0.0459	0.5554	0.0443	1.2323	0.083522	0.99888
50029-2	MCF7	10338-101-1	Ipatasertib	AKT	PI3K/mTOR	1.2964	0.2497	0.2597	0.0350	0.6498	0.91468	0.99756
50029-2	MCF7	10233-101-1	Alpelisib	PI3Ka	PI3K/mTOR	0.58502	0.0207	0.3259	0.0518	0.6552	0.82437	0.98733
50029-2	MCF7	10445-101-1	Taselisib	PI3Ka, g, d	PI3K/mTOR	0.0083619	-0.2545	0.7677	0.1823	0.5107	0.014367	0.95432
50029-2	MCF7	10171-101-1	TGX221	PI3Kb	PI3K/mTOR	15.3151	0.7893	-0.0068	0.0019	3.9246	12.6094	0.85557
50029-2	MCF7	10080-101-1	Torin2	mTOR/ATM/ATR	PI3K/mTOR	0.0045641	-0.1330	0.6027	0.1279	0.9398	0.0052657	0.98973
50029-2	MCF7	10235-101-1	Everolimus	mTOR1	PI3K/mTOR	0.0026919	0.3865	0.5643	0.0341	0.2603	1.8439e-05	0.90097
50029-2	MCF7	10205-101-1	INK-128	mTORC1/2	PI3K/mTOR	0.00298	-0.0450	0.7258	0.1347	1.1028	0.0028216	0.99089
50029-2	MCF7	10404-101-1	PF-4708671	p70S6K	PI3K/mTOR	14.8089	0.5577	0.0586	0.0041	1.0532	5.6554	0.96631
50029-2	MCF7	10147-101-1	Buparlisib	pan PI3K	PI3K/mTOR	0.18746	-0.2690	0.5035	0.1162	0.8936	0.34198	0.99189
50029-2	MCF7	10047-101-1	Pictilisib	pan PI3K	PI3K/mTOR	0.13012	-0.1594	0.5057	0.1018	0.6167	0.24212	0.99423
50029-2	MCF7	10394-101-1	Ceritinib	ALK	RTK	0.34376	-0.6157	0.4566	0.1487	0.9502	0.88109	0.9932
50029-2	MCF7	10018-101-1	Neratinib	EGFR/HER2	RTK	1.2629	0.0582	0.1421	0.0220	1.0034	3.7746	0.97694
50029-2	MCF7	10131-101-1	Tivantinib	MET	RTK	0.1513	-0.0512	0.4534	0.0984	1.7693	0.15446	0.99667
50029-2	MCF7	10444-101-1	Cediranib	VEGFR/cKIT	RTK	5.7041	0.1149	0.0758	0.0191	1.5383	11.6508	0.98993
50029-2	MCF7	10194-106-1	Cabozantinib	VEGFR2/MET	RTK	4.8819	-0.0993	0.1069	0.0302	1.8080	8.9638	0.99698
50058-2	MDA-MB-231	10390-103-1	Abemaciclib	CDK4/6	Cell cycle	0.046803	-0.4875	0.6754	0.1393	0.3863	0.73058	0.97904
50058-2	MDA-MB-231	10071-101-1	Palbociclib	CDK4/6	Cell cycle	0.11065	0.2066	0.3469	0.0101	0.7428	0.05699	0.98815
50058-2	MDA-MB-231	10006-101-1	AZD7762	CHK1/2	Cell cycle	0.15977	-0.4632	0.5380	0.2422	0.9378	0.33846	0.98568
50058-2	MDA-MB-231	10387-101-1	Volasertib	PLK	Cell cycle	0.0043583	-0.0186	0.5873	0.1359	3.6103	0.0044117	0.99795
50058-2	MDA-MB-231	10287-101-2	Dinaciclib	pan CDK	Cell cycle	0.010273	-0.4203	0.6627	0.2555	2.6877	0.012709	0.99722
50058-2	MDA-MB-231	10245-999-4	Cisplatin	Chemo	Chemotherapy	2.415	0.2721	0.1500	0.0084	1.6944	1.6486	0.99899
50058-2	MDA-MB-231	10248-102-3	Doxorubicin	Chemo	Chemotherapy	0.0050428	-0.4864	0.8179	0.2092	1.0560	0.0077676	0.95921
50058-2	MDA-MB-231	10102-101-4	Taxol	Chemo	Chemotherapy	0.0023185	-0.1204	0.7021	0.2576	1.1720	0.0026636	0.96432
50058-2	MDA-MB-231	10278-102-2	Topotecan	Topo I	Chemotherapy	0.029665	-0.3241	0.7044	0.0793	0.6645	0.059258	0.94327
50058-2	MDA-MB-231	10250-101-3	Etoposide	Topo II	Chemotherapy	0.7036	0.1203	0.2978	0.0095	1.5558	0.62323	0.99162
50058-2	MDA-MB-231	10020-101-1	Dasatinib	BCR/ABL	MAPK/nRTK	0.02942	-0.1256	0.6475	0.1153	0.6812	0.03753	0.98521
50058-2	MDA-MB-231	10142-101-1	Trametinib	MEK	MAPK/nRTK	0.0026306	-0.1785	0.7224	0.2816	1.1618	0.0033911	0.99829
50058-2	MDA-MB-231	10032-101-1	Saracatinib	SRC	MAPK/nRTK	2.3337	0.2801	0.2687	0.0262	0.3311	64.4143	0.98467
50058-2	MDA-MB-231	10179-101-1	ABT-737	Bcl2/XL	Misc	3.031	-0.1204	0.1616	0.0795	1.1097	8.1572	0.99586
50058-2	MDA-MB-231	10282-101-2	Vorinostat	HDAC	Misc	1.2388	-0.3848	0.2821	0.1116	1.7685	1.7699	0.99365
50058-2	MDA-MB-231	10161-101-1	Luminespib	HSP90	Misc	0.0057951	-0.1782	0.6452	0.2269	3.8625	0.006261	0.99815
50058-2	MDA-MB-231	10478-102-1	A-1210477	Mcl-1	Misc	Inf	0.9569	0.0519	0.0034	0.0000	Inf	-8.5977e-09
50058-2	MDA-MB-231	10144-101-3	Olaparib	PARP	Misc	14.6165	0.6179	0.0581	0.0050	0.9419	46.7541	0.98031
50058-2	MDA-MB-231	10482-114-1	Bleomycin	Radiation	Misc	6.333	0.4365	0.1320	0.0030	1.0810	2.968	0.97684
50058-2	MDA-MB-231	10338-101-1	Ipatasertib	AKT	PI3K/mTOR	Inf	0.9254	0.0073	-0.0008	0.0000	Inf	0.28623
50058-2	MDA-MB-231	10233-101-1	Alpelisib	PI3Ka	PI3K/mTOR	48.2918	0.6904	0.0895	0.0045	0.4504	553.5356	0.61498
50058-2	MDA-MB-231	10445-101-1	Taselisib	PI3Ka, g, d	PI3K/mTOR	2.1958	0.0709	0.2540	0.0294	0.4838	21.2709	0.9085
50058-2	MDA-MB-231	10171-101-1	TGX221	PI3Kb	PI3K/mTOR	Inf	0.8508	0.0154	0.0050	0.6946	20.4646	0.68698
50058-2	MDA-MB-231	10080-101-1	Torin2	mTOR/ATM/ATR	PI3K/mTOR	0.0251	-0.0262	0.3856	0.0478	1.0287	0.023885	0.98855
50058-2	MDA-MB-231	10235-101-1	Everolimus	mTOR1	PI3K/mTOR	Inf	0.7110	0.2246	-0.0006	0.0000	Inf	0.54965
50058-2	MDA-MB-231	10205-101-1	INK-128	mTORC1/2	PI3K/mTOR	0.021834	0.1013	0.4860	0.0253	1.0516	0.015209	0.98917
50058-2	MDA-MB-231	10404-101-1	PF-4708671	p70S6K	PI3K/mTOR	Inf	0.8544	0.0105	0.0068	4.2838	3.8501	0.8794
50058-2	MDA-MB-231	10147-101-1	Buparlisib	pan PI3K	PI3K/mTOR	1.5103	-0.2351	0.2751	0.0596	1.9855	1.8969	0.98328
50058-2	MDA-MB-231	10047-101-1	Pictilisib	pan PI3K	PI3K/mTOR	5.3159	0.3053	0.2062	0.0120	0.3649	107.9707	0.87205
50058-2	MDA-MB-231	10394-101-1	Ceritinib	ALK	RTK	0.86565	-0.3326	0.3444	0.1014	1.9065	1.1609	0.99581
50058-2	MDA-MB-231	10018-101-1	Neratinib	EGFR/HER2	RTK	1.4329	-0.0957	0.1056	0.0516	1.6284	2.8124	0.99527
50058-2	MDA-MB-231	10131-101-1	Tivantinib	MET	RTK	0.41694	-0.0845	0.3330	0.1029	2.2640	0.43275	0.99134
50058-2	MDA-MB-231	10444-101-1	Cediranib	VEGFR/cKIT	RTK	5.0964	-0.3620	0.1160	0.0659	2.7537	7.595	0.99835
50058-2	MDA-MB-231	10194-106-1	Cabozantinib	VEGFR2/MET	RTK	4.8325	0.0749	0.1413	0.0336	1.2384	11.7338	0.95871
50057-2	SK-BR-3	10390-103-1	Abemaciclib	CDK4/6	Cell cycle	0.035311	0.1432	0.5363	0.0387	0.6381	0.016543	0.96857
50057-2	SK-BR-3	10071-101-1	Palbociclib	CDK4/6	Cell cycle	0.17601	0.3503	0.2849	0.0218	0.9678	0.038204	0.97912
50057-2	SK-BR-3	10006-101-1	AZD7762	CHK1/2	Cell cycle	0.02013	-0.4509	0.9023	0.2866	3.0174	0.024464	0.99546
50057-2	SK-BR-3	10387-101-1	Volasertib	PLK	Cell cycle	0.0054419	-0.3494	0.7044	0.2799	4.1140	0.0060939	0.9976
50057-2	SK-BR-3	10287-101-2	Dinaciclib	pan CDK	Cell cycle	0.0068129	-0.6209	0.8362	0.3009	3.4320	0.008573	0.99807
50057-2	SK-BR-3	10245-999-4	Cisplatin	Chemo	Chemotherapy	5.1075	0.2490	0.0978	0.0114	1.4151	5.7965	0.99044
50057-2	SK-BR-3	10248-102-3	Doxorubicin	Chemo	Chemotherapy	0.0067336	-0.6156	0.9421	0.3142	1.5278	0.010801	0.99572
50057-2	SK-BR-3	10102-101-4	Taxol	Chemo	Chemotherapy	0.0019068	-0.3401	0.8905	0.3665	2.3888	0.0023578	0.96349
50057-2	SK-BR-3	10278-102-2	Topotecan	Topo I	Chemotherapy	0.016549	-0.2711	0.7941	0.1919	1.9350	0.01923	0.98214
50057-2	SK-BR-3	10250-101-3	Etoposide	Topo II	Chemotherapy	0.39826	-0.3169	0.4040	0.1186	1.5701	0.532	0.99524
50057-2	SK-BR-3	10020-101-1	Dasatinib	BCR/ABL	MAPK/nRTK	3.6452	0.0810	0.0617	0.0233	5.0000	3.5272	0.98252
50057-2	SK-BR-3	10142-101-1	Trametinib	MEK	MAPK/nRTK	Inf	0.6828	0.1817	0.0154	1.1257	0.0059643	0.93505
50057-2	SK-BR-3	10032-101-1	Saracatinib	SRC	MAPK/nRTK	4.9166	0.2786	0.0221	0.0102	5.0000	4.2128	0.96696
50057-2	SK-BR-3	10179-101-1	ABT-737	Bcl2/XL	Misc	Inf	0.9470	-0.0148	0.0045	0.0000	Inf	0.12804
50057-2	SK-BR-3	10282-101-2	Vorinostat	HDAC	Misc	0.7625	-0.6322	0.3637	0.1534	2.3291	1.0657	0.99404
50057-2	SK-BR-3	10161-101-1	Luminespib	HSP90	Misc	0.0022783	-0.0766	0.7140	0.1099	2.5203	0.0024311	0.9977
50057-2	SK-BR-3	10478-102-1	A-1210477	Mcl-1	Misc	11.3859	0.6275	0.0389	0.0040	4.3303	10.9082	0.92796
50057-2	SK-BR-3	10144-101-3	Olaparib	PARP	Misc	12.0744	0.5653	0.0429	0.0174	1.0158	35.3887	0.93619
50057-2	SK-BR-3	10482-114-1	Bleomycin	Radiation	Misc	1.0576	0.1871	0.2604	0.0618	0.8229	0.85134	0.98455
50057-2	SK-BR-3	10338-101-1	Ipatasertib	AKT	PI3K/mTOR	3.3435	0.3560	0.1553	0.0254	0.8518	1.1231	0.9503
50057-2	SK-BR-3	10233-101-1	Alpelisib	PI3Ka	PI3K/mTOR	0.48468	-0.1428	0.3788	0.0660	0.4911	2.8836	0.98115
50057-2	SK-BR-3	10445-101-1	Taselisib	PI3Ka, g, d	PI3K/mTOR	0.0061659	-0.2068	0.8068	0.1477	0.6730	0.0081626	0.97463
50057-2	SK-BR-3	10171-101-1	TGX221	PI3Kb	PI3K/mTOR	Inf	0.7496	-0.0084	0.0076	4.9846	4.3561	0.86723
50057-2	SK-BR-3	10080-101-1	Torin2	mTOR/ATM/ATR	PI3K/mTOR	0.0036122	-0.3416	0.7338	0.1751	1.3620	0.0050857	0.99744
50057-2	SK-BR-3	10235-101-1	Everolimus	mTOR1	PI3K/mTOR	-Inf	0.1182	0.7944	0.1209	0.1000	6.3064e-07	0.84606
50057-2	SK-BR-3	10205-101-1	INK-128	mTORC1/2	PI3K/mTOR	0.0026508	-0.5064	0.9712	0.2693	1.0983	0.0044617	0.98817
50057-2	SK-BR-3	10404-101-1	PF-4708671	p70S6K	PI3K/mTOR	Inf	0.7342	0.0214	0.0056	1.2557	6.3033	0.91227
50057-2	SK-BR-3	10147-101-1	Buparlisib	pan PI3K	PI3K/mTOR	0.13982	-0.3731	0.5845	0.1589	0.9631	0.2774	0.98702
50057-2	SK-BR-3	10047-101-1	Pictilisib	pan PI3K	PI3K/mTOR	0.11448	-0.1267	0.5120	0.0731	0.6701	0.17544	0.99532
50057-2	SK-BR-3	10394-101-1	Ceritinib	ALK	RTK	0.98319	-0.8254	0.3174	0.0975	1.2454	2.3754	0.98337
50057-2	SK-BR-3	10018-101-1	Neratinib	EGFR/HER2	RTK	0.0016518	-0.2530	0.8909	0.2029	0.7723	0.0025421	0.9721
50057-2	SK-BR-3	10131-101-1	Tivantinib	MET	RTK	0.27263	-0.3523	0.4830	0.2060	2.4177	0.34098	0.99571
50057-2	SK-BR-3	10444-101-1	Cediranib	VEGFR/cKIT	RTK	6.1955	-0.5397	0.0755	0.0528	4.8242	7.7773	0.99548
50057-2	SK-BR-3	10194-106-1	Cabozantinib	VEGFR2/MET	RTK	9.7073	0.4422	0.0013	0.0011	5.0000	12.0523	0.95604
50105-2	BT-20	10390-103-1	Abemaciclib	CDK4/6	Cell cycle	0.061268	-0.2160	0.5694	0.0435	0.4177	0.17789	0.93347
50105-2	BT-20	10071-101-1	Palbociclib	CDK4/6	Cell cycle	0.043794	0.1624	0.3972	0.0216	1.2275	0.030066	0.99055
50105-2	BT-20	10006-101-1	AZD7762	CHK1/2	Cell cycle	1.081	-0.5785	0.2831	0.1722	1.5948	1.8464	0.99406
50105-2	BT-20	10387-101-1	Volasertib	PLK	Cell cycle	0.0056337	-0.5339	0.7904	0.3461	2.3226	0.0076094	0.99851
50105-2	BT-20	10287-101-2	Dinaciclib	pan CDK	Cell cycle	0.018482	-0.6979	0.6791	0.3193	3.4864	0.02362	0.99822
50105-2	BT-20	10245-999-4	Cisplatin	Chemo	Chemotherapy	0.79098	-0.3367	0.3338	0.0794	0.9579	1.7289	0.98666
50105-2	BT-20	10248-102-3	Doxorubicin	Chemo	Chemotherapy	0.0087386	-0.4813	0.8279	0.3024	1.4443	0.013048	0.9861
50105-2	BT-20	10102-101-4	Taxol	Chemo	Chemotherapy	0.0020158	-0.5760	0.9854	0.4456	2.0677	0.0028795	0.99355
50105-2	BT-20	10278-102-2	Topotecan	Topo I	Chemotherapy	0.012333	-0.6410	1.0284	0.3794	0.9448	0.029071	0.99592
50105-2	BT-20	10250-101-3	Etoposide	Topo II	Chemotherapy	0.30148	-0.3834	0.4591	0.1362	1.2176	0.48057	0.99643
50105-2	BT-20	10020-101-1	Dasatinib	BCR/ABL	MAPK/nRTK	0.67985	0.2835	0.3289	0.0839	0.5423	0.27245	0.98321
50105-2	BT-20	10142-101-1	Trametinib	MEK	MAPK/nRTK	2.3446	0.5034	0.1768	0.0535	0.6346	0.053945	0.96232
50105-2	BT-20	10032-101-1	Saracatinib	SRC	MAPK/nRTK	4.8514	0.3103	0.1591	0.0406	0.5845	31.7814	0.9851
50105-2	BT-20	10179-101-1	ABT-737	Bcl2/XL	Misc	12.6171	0.5926	0.0250	0.0397	1.1740	32.0424	0.93473
50105-2	BT-20	10282-101-2	Vorinostat	HDAC	Misc	2.217	-0.1134	0.1610	0.0705	1.6271	2.8626	0.99345
50105-2	BT-20	10161-101-1	Luminespib	HSP90	Misc	0.005967	-0.0490	0.5621	0.1453	4.4759	0.0060667	0.99656
50105-2	BT-20	10478-102-1	A-1210477	Mcl-1	Misc	14.9935	0.8209	-0.0262	0.0007	4.9994	12.3309	0.67398
50105-2	BT-20	10144-101-3	Olaparib	PARP	Misc	15.2735	0.6064	0.0657	0.0087	0.8235	57.982	0.94742
50105-2	BT-20	10482-114-1	Bleomycin	Radiation	Misc	0.4878	-0.1286	0.3764	0.0970	0.9564	0.75174	0.99474
50105-2	BT-20	10338-101-1	Ipatasertib	AKT	PI3K/mTOR	0.64483	0.1015	0.3111	0.0476	0.7459	0.59909	0.98219
50105-2	BT-20	10233-101-1	Alpelisib	PI3Ka	PI3K/mTOR	2.0326	-0.1181	0.2014	0.0639	0.8192	7.7705	0.99071
50105-2	BT-20	10445-101-1	Taselisib	PI3Ka, g, d	PI3K/mTOR	0.018077	-0.3749	0.7363	0.2005	0.7541	0.028401	0.95352
50105-2	BT-20	10171-101-1	TGX221	PI3Kb	PI3K/mTOR	Inf	1.0152	-0.0415	-0.0034	0.0000	Inf	-7.4504
50105-2	BT-20	10080-101-1	Torin2	mTOR/ATM/ATR	PI3K/mTOR	0.008897	-0.2891	0.5365	0.1367	0.8675	0.012533	0.97198
50105-2	BT-20	10235-101-1	Everolimus	mTOR1	PI3K/mTOR	Inf	0.3900	0.5932	0.0889	0.0000	Inf	0.031152
50105-2	BT-20	10205-101-1	INK-128	mTORC1/2	PI3K/mTOR	0.012881	-0.0045	0.5675	0.1137	1.3697	0.01193	0.99574
50105-2	BT-20	10404-101-1	PF-4708671	p70S6K	PI3K/mTOR	15.1446	0.6601	0.0129	0.0102	1.1942	37.9666	0.89476
50105-2	BT-20	10147-101-1	Buparlisib	pan PI3K	PI3K/mTOR	0.63756	-0.5514	0.3662	0.1474	1.2077	1.2887	0.99431
50105-2	BT-20	10047-101-1	Pictilisib	pan PI3K	PI3K/mTOR	0.90394	-0.1650	0.2960	0.0736	0.9819	1.5458	0.99177
50105-2	BT-20	10394-101-1	Ceritinib	ALK	RTK	1.5315	-0.7365	0.2591	0.1255	1.7439	2.7905	0.99717
50105-2	BT-20	10018-101-1	Neratinib	EGFR/HER2	RTK	1.2826	0.3026	0.1496	0.0391	0.6768	2.19	0.97744
50105-2	BT-20	10131-101-1	Tivantinib	MET	RTK	0.47342	-0.4883	0.4183	0.1893	2.5782	0.60346	0.99447
50105-2	BT-20	10444-101-1	Cediranib	VEGFR/cKIT	RTK	5.6982	0.2210	0.0383	0.0150	2.7852	5.3221	0.97585
50105-2	BT-20	10194-106-1	Cabozantinib	VEGFR2/MET	RTK	5.3516	-0.2030	0.0566	0.0432	4.9846	5.8613	0.99079
50108-2	BT-549	10390-103-1	Abemaciclib	CDK4/6	Cell cycle	3.9707	0.0333	0.1267	0.0188	1.2825	7.5655	0.99654
50108-2	BT-549	10071-101-1	Palbociclib	CDK4/6	Cell cycle	Inf	1.0500	-0.0401	-0.0011	0.0000	Inf	-9.2879
50108-2	BT-549	10006-101-1	AZD7762	CHK1/2	Cell cycle	0.066029	-0.4824	0.6356	0.2312	1.6999	0.087287	0.97383
50108-2	BT-549	10387-101-1	Volasertib	PLK	Cell cycle	0.0088352	-0.2289	0.5676	0.1490	2.4967	0.0098732	0.99586
50108-2	BT-549	10287-101-2	Dinaciclib	pan CDK	Cell cycle	0.012371	-0.2923	0.5913	0.1485	3.7837	0.013904	0.99899
50108-2	BT-549	10245-999-4	Cisplatin	Chemo	Chemotherapy	1.016	0.0674	0.2835	0.0552	1.0827	1.0937	0.98489
50108-2	BT-549	10248-102-3	Doxorubicin	Chemo	Chemotherapy	0.006482	-0.3312	0.7603	0.1972	1.5744	0.0079126	0.9824
50108-2	BT-549	10102-101-4	Taxol	Chemo	Chemotherapy	0.0027257	-0.2074	0.6989	0.2304	1.9420	0.0030953	0.98743
50108-2	BT-549	10278-102-2	Topotecan	Topo I	Chemotherapy	0.0084727	-0.2410	0.8509	0.2269	1.4734	0.010061	0.9801
50108-2	BT-549	10250-101-3	Etoposide	Topo II	Chemotherapy	0.181	-0.1948	0.4726	0.1408	1.1701	0.22766	0.99526
50108-2	BT-549	10020-101-1	Dasatinib	BCR/ABL	MAPK/nRTK	0.59323	0.3705	0.2386	0.0271	1.7859	0.13859	0.96413
50108-2	BT-549	10142-101-1	Trametinib	MEK	MAPK/nRTK	5.2409	0.5983	0.1292	0.0152	0.5005	0.36186	0.97942
50108-2	BT-549	10032-101-1	Saracatinib	SRC	MAPK/nRTK	Inf	0.5558	0.0348	0.0015	3.3790	3.6758	0.97565
50108-2	BT-549	10179-101-1	ABT-737	Bcl2/XL	Misc	Inf	0.9359	-0.0225	0.0062	0.0000	Inf	0.067883
50108-2	BT-549	10282-101-2	Vorinostat	HDAC	Misc	2.3739	0.1131	0.1887	0.0291	0.8756	3.9571	0.99525
50108-2	BT-549	10161-101-1	Luminespib	HSP90	Misc	0.0053858	-0.1064	0.6123	0.1201	5.0000	0.0055748	0.99911
50108-2	BT-549	10478-102-1	A-1210477	Mcl-1	Misc	Inf	0.9540	0.0083	0.0018	0.0000	Inf	0.34182
50108-2	BT-549	10144-101-3	Olaparib	PARP	Misc	11.948	0.5432	0.0657	0.0130	0.9548	37.7564	0.91931
50108-2	BT-549	10482-114-1	Bleomycin	Radiation	Misc	0.17998	-0.0141	0.4667	0.1506	1.0031	0.20287	0.99525
50108-2	BT-549	10338-101-1	Ipatasertib	AKT	PI3K/mTOR	12.6362	0.4956	0.1735	0.0097	0.5079	1.6786	0.97652
50108-2	BT-549	10233-101-1	Alpelisib	PI3Ka	PI3K/mTOR	17.5141	0.6841	0.0322	0.0099	1.0429	49.8384	0.95639
50108-2	BT-549	10445-101-1	Taselisib	PI3Ka, g, d	PI3K/mTOR	2.2065	0.0950	0.2229	0.0263	0.5717	15.0749	0.99278
50108-2	BT-549	10171-101-1	TGX221	PI3Kb	PI3K/mTOR	Inf	0.8097	0.0568	0.0017	0.6702	0.72927	0.89208
50108-2	BT-549	10080-101-1	Torin2	mTOR/ATM/ATR	PI3K/mTOR	0.0095129	-0.0209	0.4905	0.0692	1.0018	0.0092175	0.99224
50108-2	BT-549	10235-101-1	Everolimus	mTOR1	PI3K/mTOR	Inf	0.5197	0.4386	0.0304	0.0000	Inf	0.48985
50108-2	BT-549	10205-101-1	INK-128	mTORC1/2	PI3K/mTOR	0.016573	0.0717	0.5339	0.0484	1.5295	0.014683	0.99934
50108-2	BT-549	10404-101-1	PF-4708671	p70S6K	PI3K/mTOR	Inf	0.7437	-0.0070	0.0034	2.5979	8.243	0.85998
50108-2	BT-549	10147-101-1	Buparlisib	pan PI3K	PI3K/mTOR	1.419	-0.2716	0.2487	0.0802	2.0178	1.8107	0.99484
50108-2	BT-549	10047-101-1	Pictilisib	pan PI3K	PI3K/mTOR	2.7775	0.1463	0.2083	0.0210	0.6027	17.1916	0.98946
50108-2	BT-549	10394-101-1	Ceritinib	ALK	RTK	2.961	-0.2284	0.1416	0.0526	1.8781	4.216	0.99556
50108-2	BT-549	10018-101-1	Neratinib	EGFR/HER2	RTK	1.9856	0.2081	0.0800	0.0141	1.4334	4.2733	0.98836
50108-2	BT-549	10131-101-1	Tivantinib	MET	RTK	0.58217	-0.2649	0.3472	0.1072	2.4717	0.68658	0.99761
50108-2	BT-549	10444-101-1	Cediranib	VEGFR/cKIT	RTK	3.6412	-0.1347	0.1497	0.0414	1.3011	8.4712	0.98092
50108-2	BT-549	10194-106-1	Cabozantinib	VEGFR2/MET	RTK	10.1855	0.5329	0.0124	0.0096	5.0000	12.5665	0.95054
50216-2	HCC38	10390-103-1	Abemaciclib	CDK4/6	Cell cycle	0.044561	-0.3272	0.6404	0.0910	0.4303	0.21535	0.96385
50216-2	HCC38	10071-101-1	Palbociclib	CDK4/6	Cell cycle	0.059804	0.1474	0.3722	0.0411	1.0985	0.037879	0.98636
50216-2	HCC38	10006-101-1	AZD7762	CHK1/2	Cell cycle	0.0094764	-0.3341	0.9185	0.2951	2.0434	0.01177	0.98869
50216-2	HCC38	10387-101-1	Volasertib	PLK	Cell cycle	0.0081934	-0.2598	0.6001	0.1943	3.2088	0.0091367	0.99678
50216-2	HCC38	10287-101-2	Dinaciclib	pan CDK	Cell cycle	0.012678	-0.4422	0.6326	0.2241	4.1199	0.014763	0.99821
50216-2	HCC38	10245-999-4	Cisplatin	Chemo	Chemotherapy	0.99272	-0.1031	0.2567	0.1098	1.4350	1.1794	0.99675
50216-2	HCC38	10248-102-3	Doxorubicin	Chemo	Chemotherapy	0.0095452	-0.4061	0.7803	0.2872	1.4810	0.01343	0.99228
50216-2	HCC38	10102-101-4	Taxol	Chemo	Chemotherapy	0.0014659	-0.3078	0.8432	0.2758	2.3201	0.0017274	0.99328
50216-2	HCC38	10278-102-2	Topotecan	Topo I	Chemotherapy	0.0068073	-0.5041	1.0724	0.3904	1.2181	0.011735	0.99338
50216-2	HCC38	10250-101-3	Etoposide	Topo II	Chemotherapy	0.33384	-0.4242	0.4494	0.1891	1.4384	0.50554	0.99763
50216-2	HCC38	10020-101-1	Dasatinib	BCR/ABL	MAPK/nRTK	5.6901	0.3322	0.1453	0.0365	0.6048	34.9918	0.97158
50216-2	HCC38	10142-101-1	Trametinib	MEK	MAPK/nRTK	0.22023	0.1854	0.2076	0.0234	0.6910	0.35783	0.98881
50216-2	HCC38	10032-101-1	Saracatinib	SRC	MAPK/nRTK	29.3313	0.6139	0.1013	0.0162	0.4862	24.1837	0.94737
50216-2	HCC38	10179-101-1	ABT-737	Bcl2/XL	Misc	0.99805	-0.4209	0.2963	0.1000	0.9364	2.8897	0.99657
50216-2	HCC38	10282-101-2	Vorinostat	HDAC	Misc	0.95999	-0.2851	0.2909	0.1227	1.6239	1.3226	0.99701
50216-2	HCC38	10161-101-1	Luminespib	HSP90	Misc	0.0071367	-0.2087	0.6295	0.1926	5.0000	0.0076296	0.99771
50216-2	HCC38	10478-102-1	A-1210477	Mcl-1	Misc	14.9391	0.8870	0.0151	0.0032	4.9989	15.3353	0.65537
50216-2	HCC38	10144-101-3	Olaparib	PARP	Misc	8.4247	0.4254	0.0719	0.0230	1.0282	24.5229	0.97772
50216-2	HCC38	10482-114-1	Bleomycin	Radiation	Misc	0.19854	-0.2318	0.4852	0.1896	1.1991	0.27457	0.99721
50216-2	HCC38	10338-101-1	Ipatasertib	AKT	PI3K/mTOR	Inf	0.7055	0.1225	0.0092	1.1410	0.22841	0.9721
50216-2	HCC38	10233-101-1	Alpelisib	PI3Ka	PI3K/mTOR	22.4126	0.6801	0.0440	0.0092	0.7155	102.9667	0.92013
50216-2	HCC38	10445-101-1	Taselisib	PI3Ka, g, d	PI3K/mTOR	2.7028	0.0628	0.2018	0.0249	0.6728	13.8343	0.97542
50216-2	HCC38	10171-101-1	TGX221	PI3Kb	PI3K/mTOR	Inf	0.9515	-0.0246	0.0013	0.0000	Inf	-0.17011
50216-2	HCC38	10080-101-1	Torin2	mTOR/ATM/ATR	PI3K/mTOR	0.01047	-0.2107	0.5383	0.0927	0.8737	0.015621	0.99367
50216-2	HCC38	10235-101-1	Everolimus	mTOR1	PI3K/mTOR	Inf	0.4735	0.4865	0.0140	0.0000	Inf	0.060078
50216-2	HCC38	10205-101-1	INK-128	mTORC1/2	PI3K/mTOR	0.01911	-0.0087	0.5361	0.0402	1.3664	0.018127	0.99621
50216-2	HCC38	10404-101-1	PF-4708671	p70S6K	PI3K/mTOR	Inf	0.9760	-0.0258	-0.0006	0.0000	Inf	-0.90907
50216-2	HCC38	10147-101-1	Buparlisib	pan PI3K	PI3K/mTOR	1.2697	-0.2762	0.2554	0.0711	1.4831	1.8745	0.99552
50216-2	HCC38	10047-101-1	Pictilisib	pan PI3K	PI3K/mTOR	6.5531	0.3569	0.1182	0.0066	0.7184	30.2402	0.97968
50216-2	HCC38	10394-101-1	Ceritinib	ALK	RTK	1.8283	-0.4039	0.2184	0.0883	2.6153	2.323	0.99573
50216-2	HCC38	10018-101-1	Neratinib	EGFR/HER2	RTK	3.1556	0.4571	0.1019	0.0168	0.7043	15.0154	0.87632
50216-2	HCC38	10131-101-1	Tivantinib	MET	RTK	0.30919	-0.2702	0.4367	0.1297	1.8013	0.39141	0.99767
50216-2	HCC38	10444-101-1	Cediranib	VEGFR/cKIT	RTK	1.5907	-0.2044	0.2096	0.0416	1.0695	3.1564	0.98723
50216-2	HCC38	10194-106-1	Cabozantinib	VEGFR2/MET	RTK	8.2108	0.3009	0.0376	0.0168	4.3352	8.1748	0.98657
50219-2	HCC70	10390-103-1	Abemaciclib	CDK4/6	Cell cycle	1.885	-0.8264	0.2315	0.0832	2.5102	2.8439	0.99569
50219-2	HCC70	10071-101-1	Palbociclib	CDK4/6	Cell cycle	Inf	0.9361	-0.0281	-0.0013	0.0000	Inf	-0.054738
50219-2	HCC70	10006-101-1	AZD7762	CHK1/2	Cell cycle	0.040563	-0.7002	0.8995	0.3250	2.5054	0.056277	0.99456
50219-2	HCC70	10387-101-1	Volasertib	PLK	Cell cycle	0.0065224	-0.2049	0.6421	0.1395	3.2698	0.0072379	0.9841
50219-2	HCC70	10287-101-2	Dinaciclib	pan CDK	Cell cycle	0.01286	-0.9093	0.8338	0.3254	5.0000	0.015807	0.9991
50219-2	HCC70	10245-999-4	Cisplatin	Chemo	Chemotherapy	1.3073	-0.6832	0.2650	0.0820	1.3165	3.0116	0.99076
50219-2	HCC70	10248-102-3	Doxorubicin	Chemo	Chemotherapy	0.010621	-0.7794	0.7867	0.1459	2.0410	0.014138	0.93856
50219-2	HCC70	10102-101-4	Taxol	Chemo	Chemotherapy	0.0013411	-0.5065	0.9773	0.3742	1.1642	0.0024269	0.99734
50219-2	HCC70	10278-102-2	Topotecan	Topo I	Chemotherapy	0.0094575	-0.8614	1.0593	0.2429	0.6102	0.049603	0.96643
50219-2	HCC70	10250-101-3	Etoposide	Topo II	Chemotherapy	0.36498	-0.1518	0.4535	0.0513	2.1004	0.41879	0.96872
50219-2	HCC70	10020-101-1	Dasatinib	BCR/ABL	MAPK/nRTK	0.0096376	-0.5787	1.0609	0.1267	1.0559	0.020015	0.98982
50219-2	HCC70	10142-101-1	Trametinib	MEK	MAPK/nRTK	0.0019047	-0.0393	0.6924	0.1954	0.8693	0.0021049	0.98467
50219-2	HCC70	10032-101-1	Saracatinib	SRC	MAPK/nRTK	0.063682	-0.1718	0.5795	0.0595	0.9276	0.081014	0.97522
50219-2	HCC70	10179-101-1	ABT-737	Bcl2/XL	Misc	2.7474	-0.0638	0.1562	0.0632	0.9362	8.8827	0.97385
50219-2	HCC70	10282-101-2	Vorinostat	HDAC	Misc	0.40578	-0.4765	0.4082	0.0748	0.8914	1.0253	0.99218
50219-2	HCC70	10161-101-1	Luminespib	HSP90	Misc	0.007646	-0.5826	0.7792	0.2409	5.0000	0.0088695	0.99752
50219-2	HCC70	10478-102-1	A-1210477	Mcl-1	Misc	Inf	0.9380	0.0054	0.0123	0.0000	Inf	0.17964
50219-2	HCC70	10144-101-3	Olaparib	PARP	Misc	27.0584	0.7191	0.0232	-0.0045	0.7530	116.2527	0.78542
50219-2	HCC70	10482-114-1	Bleomycin	Radiation	Misc	0.39804	-0.1146	0.4192	0.0530	0.9765	0.54995	0.95046
50219-2	HCC70	10338-101-1	Ipatasertib	AKT	PI3K/mTOR	0.1397	-0.2624	0.4974	0.0860	0.8534	0.21677	0.98567
50219-2	HCC70	10233-101-1	Alpelisib	PI3Ka	PI3K/mTOR	4.4987	0.0981	0.1182	0.0196	1.0448	12.8744	0.95143
50219-2	HCC70	10445-101-1	Taselisib	PI3Ka, g, d	PI3K/mTOR	0.15092	-0.6846	0.5796	0.1546	0.7043	0.64661	0.98584
50219-2	HCC70	10171-101-1	TGX221	PI3Kb	PI3K/mTOR	0.092754	0.0049	0.4729	0.0591	0.8818	0.076452	0.9787
50219-2	HCC70	10080-101-1	Torin2	mTOR/ATM/ATR	PI3K/mTOR	0.0058452	-0.5550	0.6451	0.1234	0.5307	0.026938	0.94991
50219-2	HCC70	10235-101-1	Everolimus	mTOR1	PI3K/mTOR	0.24351	0.3727	0.4764	0.0448	0.1135	51.0339	0.79604
50219-2	HCC70	10205-101-1	INK-128	mTORC1/2	PI3K/mTOR	0.0048011	-0.1620	0.7024	0.0912	1.1840	0.0050026	0.97794
50219-2	HCC70	10404-101-1	PF-4708671	p70S6K	PI3K/mTOR	Inf	0.9348	-0.0227	0.0035	0.0000	Inf	0.040075
50219-2	HCC70	10147-101-1	Buparlisib	pan PI3K	PI3K/mTOR	0.43342	-0.7274	0.4614	0.1434	1.1927	1.0047	0.99537
50219-2	HCC70	10047-101-1	Pictilisib	pan PI3K	PI3K/mTOR	0.16052	-0.5972	0.5726	0.1167	0.7256	0.58082	0.99601
50219-2	HCC70	10394-101-1	Ceritinib	ALK	RTK	3.1923	-0.8808	0.1379	0.0703	5.0000	3.9213	0.99483
50219-2	HCC70	10018-101-1	Neratinib	EGFR/HER2	RTK	0.16013	0.0595	0.3178	0.0405	1.0555	0.15156	0.99467
50219-2	HCC70	10131-101-1	Tivantinib	MET	RTK	0.3335	-0.5657	0.4968	0.1515	2.0000	0.48673	0.99617
50219-2	HCC70	10444-101-1	Cediranib	VEGFR/cKIT	RTK	4.5386	-0.3262	0.0890	0.0440	2.2440	7.4053	0.99062
50219-2	HCC70	10194-106-1	Cabozantinib	VEGFR2/MET	RTK	1.5024	-0.0911	0.2658	0.0226	0.5892	9.6961	0.92355
51134-1	PDX1258	10390-103-1	Abemaciclib	CDK4/6	Cell cycle	0.67289	-0.3305	0.3350	0.0542	1.0569	1.2734	0.99626
51134-1	PDX1258	10071-101-1	Palbociclib	CDK4/6	Cell cycle	Inf	1.0159	-0.0479	0.0014	0.0000	Inf	-18.593
51134-1	PDX1258	10006-101-1	AZD7762	CHK1/2	Cell cycle	0.014946	-0.4528	0.9199	0.3234	1.6838	0.021221	0.99249
51134-1	PDX1258	10387-101-1	Volasertib	PLK	Cell cycle	0.0073734	-0.2320	0.5602	0.1765	1.8198	0.0083258	0.98847
51134-1	PDX1258	10287-101-2	Dinaciclib	pan CDK	Cell cycle	0.011566	-0.6173	0.7036	0.2838	3.5943	0.014366	0.99779
51134-1	PDX1258	10245-999-4	Cisplatin	Chemo	Chemotherapy	2.5568	0.3181	0.1555	0.0433	1.6027	1.5449	0.99079
51134-1	PDX1258	10248-102-3	Doxorubicin	Chemo	Chemotherapy	0.0091389	-0.4928	0.7540	0.2368	1.1844	0.013938	0.97567
51134-1	PDX1258	10102-101-4	Taxol	Chemo	Chemotherapy	0.0021522	-0.0818	0.6797	0.2357	1.2501	0.0022935	0.98829
51134-1	PDX1258	10278-102-2	Topotecan	Topo I	Chemotherapy	0.013472	-0.4565	0.8673	0.2817	0.8122	0.026852	0.98013
51134-1	PDX1258	10250-101-3	Etoposide	Topo II	Chemotherapy	0.31701	-0.1807	0.3942	0.1360	1.0906	0.41876	0.99346
51134-1	PDX1258	10020-101-1	Dasatinib	BCR/ABL	MAPK/nRTK	0.021598	-0.1339	0.7143	0.0924	1.3176	0.024774	0.99367
51134-1	PDX1258	10142-101-1	Trametinib	MEK	MAPK/nRTK	Inf	0.8500	0.0424	0.0050	4.9997	0.028253	0.88698
51134-1	PDX1258	10032-101-1	Saracatinib	SRC	MAPK/nRTK	0.7252	0.1837	0.2770	0.0370	0.8198	0.50742	0.98008
51134-1	PDX1258	10179-101-1	ABT-737	Bcl2/XL	Misc	Inf	0.7580	0.0124	0.0237	0.9162	13.677	0.78603
51134-1	PDX1258	10282-101-2	Vorinostat	HDAC	Misc	1.5746	-0.0232	0.2113	0.0249	1.3725	1.8225	0.99287
51134-1	PDX1258	10161-101-1	Luminespib	HSP90	Misc	0.01007	-0.2899	0.6101	0.1943	5.0000	0.011049	0.99799
51134-1	PDX1258	10478-102-1	A-1210477	Mcl-1	Misc	Inf	0.9187	-0.0034	0.0025	2.4151	15.1662	0.71902
51134-1	PDX1258	10144-101-3	Olaparib	PARP	Misc	11.9912	0.5770	0.0287	0.0113	1.2287	29.2905	0.94883
51134-1	PDX1258	10482-114-1	Bleomycin	Radiation	Misc	0.78329	0.0721	0.2946	0.0937	0.8662	0.88979	0.99416
51134-1	PDX1258	10338-101-1	Ipatasertib	AKT	PI3K/mTOR	4.4024	0.3985	0.1556	0.0120	0.7553	1.2185	0.94717
51134-1	PDX1258	10233-101-1	Alpelisib	PI3Ka	PI3K/mTOR	17.8572	0.6307	0.0589	0.0069	0.7348	79.6392	0.9089
51134-1	PDX1258	10445-101-1	Taselisib	PI3Ka, g, d	PI3K/mTOR	0.99608	0.1062	0.2777	0.0362	0.6747	1.3027	0.98871
51134-1	PDX1258	10171-101-1	TGX221	PI3Kb	PI3K/mTOR	Inf	0.9970	-0.0328	0.0026	0.0000	Inf	-2.2747
51134-1	PDX1258	10080-101-1	Torin2	mTOR/ATM/ATR	PI3K/mTOR	0.035598	-0.2066	0.3637	0.0836	1.5171	0.041875	0.98779
51134-1	PDX1258	10235-101-1	Everolimus	mTOR1	PI3K/mTOR	Inf	0.6306	0.3069	0.0224	0.5438	0.0017976	0.96445
51134-1	PDX1258	10205-101-1	INK-128	mTORC1/2	PI3K/mTOR	0.044023	-0.1381	0.4558	0.0805	1.5509	0.046987	0.98841
51134-1	PDX1258	10404-101-1	PF-4708671	p70S6K	PI3K/mTOR	37.9842	0.7746	0.0101	0.0075	0.8732	50.5425	0.81305
51134-1	PDX1258	10147-101-1	Buparlisib	pan PI3K	PI3K/mTOR	1.3631	-0.3924	0.2516	0.0862	1.2064	2.8058	0.99443
51134-1	PDX1258	10047-101-1	Pictilisib	pan PI3K	PI3K/mTOR	1.6968	0.0518	0.2298	0.0223	0.6139	6.9112	0.98576
51134-1	PDX1258	10394-101-1	Ceritinib	ALK	RTK	2.081	-0.6841	0.2165	0.0876	1.5671	4.1949	0.9759
51134-1	PDX1258	10018-101-1	Neratinib	EGFR/HER2	RTK	1.0987	0.2030	0.1614	0.0244	0.6264	6.3474	0.97433
51134-1	PDX1258	10131-101-1	Tivantinib	MET	RTK	0.39607	-0.2089	0.3834	0.1084	1.2903	0.54289	0.9956
51134-1	PDX1258	10444-101-1	Cediranib	VEGFR/cKIT	RTK	4.7159	-0.5611	0.0744	0.0681	4.9799	5.5703	0.99375
51134-1	PDX1258	10194-106-1	Cabozantinib	VEGFR2/MET	RTK	8.2309	0.2796	0.0244	0.0160	3.8695	8.9263	0.98303
51135-1	PDX1328	10390-103-1	Abemaciclib	CDK4/6	Cell cycle	0.0036552	-0.7514	0.8680	0.0940	0.2489	0.30192	0.79917
51135-1	PDX1328	10071-101-1	Palbociclib	CDK4/6	Cell cycle	0.028878	0.1110	0.4289	-0.0020	1.3039	0.020889	0.9674
51135-1	PDX1328	10006-101-1	AZD7762	CHK1/2	Cell cycle	0.035587	-0.8228	0.8326	0.1855	1.2761	0.066257	0.96822
51135-1	PDX1328	10387-101-1	Volasertib	PLK	Cell cycle	0.0025124	-0.5731	0.9694	0.2182	2.8453	0.0032751	0.99856
51135-1	PDX1328	10287-101-2	Dinaciclib	pan CDK	Cell cycle	0.011496	-0.7107	0.7519	0.2292	3.5560	0.014708	0.9982
51135-1	PDX1328	10245-999-4	Cisplatin	Chemo	Chemotherapy	0.77968	-0.4217	0.3154	0.0259	1.3251	1.2886	0.9879
51135-1	PDX1328	10248-102-3	Doxorubicin	Chemo	Chemotherapy	0.013267	-0.7789	0.8023	0.1468	1.4934	0.021574	0.96338
51135-1	PDX1328	10102-101-4	Taxol	Chemo	Chemotherapy	0.002983	-0.5332	0.9047	0.1888	3.1886	0.0036802	0.98401
51135-1	PDX1328	10278-102-2	Topotecan	Topo I	Chemotherapy	0.0059222	-0.9128	1.0720	0.1509	0.4616	0.063175	0.94441
51135-1	PDX1328	10250-101-3	Etoposide	Topo II	Chemotherapy	0.80493	-0.2805	0.3502	0.0172	1.4732	1.1571	0.98432
51135-1	PDX1328	10020-101-1	Dasatinib	BCR/ABL	MAPK/nRTK	0.035818	-0.3368	0.6929	0.0612	0.7466	0.064434	0.94799
51135-1	PDX1328	10142-101-1	Trametinib	MEK	MAPK/nRTK	0.018054	0.2490	0.3349	0.0167	1.3148	0.0076303	0.97089
51135-1	PDX1328	10032-101-1	Saracatinib	SRC	MAPK/nRTK	0.82476	-0.0349	0.3256	0.0293	0.4526	9.3443	0.92264
51135-1	PDX1328	10179-101-1	ABT-737	Bcl2/XL	Misc	1.0279	-0.8967	0.3548	0.1542	1.3255	2.3546	0.97784
51135-1	PDX1328	10282-101-2	Vorinostat	HDAC	Misc	0.41708	-0.5588	0.4597	0.0854	1.1909	0.83181	0.99216
51135-1	PDX1328	10161-101-1	Luminespib	HSP90	Misc	0.0023764	-0.4697	0.8697	0.1444	1.9222	0.0032941	0.9864
51135-1	PDX1328	10478-102-1	A-1210477	Mcl-1	Misc	29.0724	0.7094	0.0609	0.0135	0.6451	128.4233	0.82503
51135-1	PDX1328	10144-101-3	Olaparib	PARP	Misc	Inf	0.7634	0.0268	-0.0025	5.0000	1.7254	0.86133
51135-1	PDX1328	10482-114-1	Bleomycin	Radiation	Misc	4.0022	0.3061	0.1994	0.0033	0.4524	45.3783	0.95786
51135-1	PDX1328	10338-101-1	Ipatasertib	AKT	PI3K/mTOR	4.7978	0.3012	0.1323	0.0153	0.6377	26.7942	0.95509
51135-1	PDX1328	10233-101-1	Alpelisib	PI3Ka	PI3K/mTOR	0.31193	-0.0050	0.3735	0.0319	0.8438	0.32361	0.95669
51135-1	PDX1328	10445-101-1	Taselisib	PI3Ka, g, d	PI3K/mTOR	0.0071031	-0.2439	0.7440	0.0558	0.2650	0.08641	0.88652
51135-1	PDX1328	10171-101-1	TGX221	PI3Kb	PI3K/mTOR	22.8162	0.7594	0.0116	0.0024	1.1153	60.9221	0.6986
51135-1	PDX1328	10080-101-1	Torin2	mTOR/ATM/ATR	PI3K/mTOR	0.0028919	-0.3715	0.7187	0.0739	0.8875	0.004646	0.98005
51135-1	PDX1328	10235-101-1	Everolimus	mTOR1	PI3K/mTOR	Inf	0.2825	0.6902	0.0347	0.0000	Inf	0.15246
51135-1	PDX1328	10205-101-1	INK-128	mTORC1/2	PI3K/mTOR	0.0042182	-0.2955	0.8098	0.0628	1.2155	0.0054971	0.99054
51135-1	PDX1328	10404-101-1	PF-4708671	p70S6K	PI3K/mTOR	8.0727	0.3935	0.0744	0.0073	1.0548	22.8735	0.93815
51135-1	PDX1328	10147-101-1	Buparlisib	pan PI3K	PI3K/mTOR	0.29807	-0.5321	0.5596	0.0928	1.0980	0.65313	0.96818
51135-1	PDX1328	10047-101-1	Pictilisib	pan PI3K	PI3K/mTOR	0.2981	-0.2326	0.4385	0.0405	0.5373	1.3322	0.97906
51135-1	PDX1328	10394-101-1	Ceritinib	ALK	RTK	0.25503	-0.9426	0.5536	0.1190	0.8974	0.86749	0.9878
51135-1	PDX1328	10018-101-1	Neratinib	EGFR/HER2	RTK	0.13115	-0.4202	0.4254	0.0466	0.5621	0.92594	0.97874
51135-1	PDX1328	10131-101-1	Tivantinib	MET	RTK	0.20199	-0.5501	0.5704	0.1178	1.7021	0.31184	0.99706
51135-1	PDX1328	10444-101-1	Cediranib	VEGFR/cKIT	RTK	0.95412	-0.8534	0.3764	0.0972	1.1127	2.5609	0.95134
51135-1	PDX1328	10194-106-1	Cabozantinib	VEGFR2/MET	RTK	1.8826	-0.1622	0.2366	0.0206	0.7816	7.6768	0.95877
50327-2	MDA-MB-134-VI	10390-103-1	Abemaciclib	CDK4/6	Cell cycle	Inf	-0.9986	0.5722	0.0709	0.0000	Inf	0.086291
50327-2	MDA-MB-134-VI	10071-101-1	Palbociclib	CDK4/6	Cell cycle	0.0092186	0.1787	0.5339	-0.0169	1.7301	0.0071324	0.98727
50327-2	MDA-MB-134-VI	10006-101-1	AZD7762	CHK1/2	Cell cycle	0.10625	-0.6459	0.6552	0.1488	1.1125	0.22232	0.99438
50327-2	MDA-MB-134-VI	10387-101-1	Volasertib	PLK	Cell cycle	0.0027209	-0.6274	1.0260	0.2671	5.0000	0.0032225	0.99553
50327-2	MDA-MB-134-VI	10287-101-2	Dinaciclib	pan CDK	Cell cycle	0.010529	-0.8440	0.7452	0.1522	2.1701	0.015963	0.99365
50327-2	MDA-MB-134-VI	10245-999-4	Cisplatin	Chemo	Chemotherapy	10.3229	0.5019	0.0719	-0.0064	0.7594	36.1235	0.92643
50327-2	MDA-MB-134-VI	10248-102-3	Doxorubicin	Chemo	Chemotherapy	0.0033105	-0.9458	1.1481	0.2491	0.9132	0.010163	0.97259
50327-2	MDA-MB-134-VI	10102-101-4	Taxol	Chemo	Chemotherapy	0.00012515	-0.7183	1.3004	0.3511	0.5352	0.00075273	0.89205
50327-2	MDA-MB-134-VI	10278-102-2	Topotecan	Topo I	Chemotherapy	0.0099907	-0.8909	1.0405	0.1644	0.5440	0.071904	0.95834
50327-2	MDA-MB-134-VI	10250-101-3	Etoposide	Topo II	Chemotherapy	0.086844	-0.5248	0.6635	0.0687	0.6849	0.28885	0.9792
50327-2	MDA-MB-134-VI	10020-101-1	Dasatinib	BCR/ABL	MAPK/nRTK	Inf	0.8878	-0.0289	0.0187	0.0000	Inf	0.37857
50327-2	MDA-MB-134-VI	10142-101-1	Trametinib	MEK	MAPK/nRTK	0.0020578	-0.2707	0.7601	0.0782	1.0824	0.0028809	0.99008
50327-2	MDA-MB-134-VI	10032-101-1	Saracatinib	SRC	MAPK/nRTK	Inf	1.0500	-0.0500	0.0181	0.0000	Inf	-Inf
50327-2	MDA-MB-134-VI	10179-101-1	ABT-737	Bcl2/XL	Misc	1.7727	-0.8735	0.2629	0.1112	1.9770	3.09	0.99496
50327-2	MDA-MB-134-VI	10282-101-2	Vorinostat	HDAC	Misc	2.4577	-0.5014	0.1748	0.0365	5.0000	2.8258	0.99386
50327-2	MDA-MB-134-VI	10161-101-1	Luminespib	HSP90	Misc	0.0047553	-0.7660	0.9424	0.2076	3.5318	0.006139	0.99851
50327-2	MDA-MB-134-VI	10478-102-1	A-1210477	Mcl-1	Misc	Inf	1.0500	-0.0366	-0.0033	0.0000	Inf	-3.0589
50327-2	MDA-MB-134-VI	10144-101-3	Olaparib	PARP	Misc	Inf	0.5510	0.0145	-0.0006	4.9904	4.9955	0.86393
50327-2	MDA-MB-134-VI	10482-114-1	Bleomycin	Radiation	Misc	1.7911	0.0193	0.2734	0.0108	0.5040	15.841	0.87961
50327-2	MDA-MB-134-VI	10338-101-1	Ipatasertib	AKT	PI3K/mTOR	8.0392	0.4925	0.0150	0.0096	4.9968	3.7717	0.94642
50327-2	MDA-MB-134-VI	10233-101-1	Alpelisib	PI3Ka	PI3K/mTOR	Inf	0.5331	0.0625	0.0075	2.3500	2.8559	0.92762
50327-2	MDA-MB-134-VI	10445-101-1	Taselisib	PI3Ka, g, d	PI3K/mTOR	0.90746	-0.5146	0.3883	0.0576	0.7496	3.9293	0.88898
50327-2	MDA-MB-134-VI	10171-101-1	TGX221	PI3Kb	PI3K/mTOR	Inf	0.8589	-0.0381	-0.0029	0.0000	Inf	0.38211
50327-2	MDA-MB-134-VI	10080-101-1	Torin2	mTOR/ATM/ATR	PI3K/mTOR	0.0051713	-0.9461	0.8935	0.2182	1.1423	0.01301	0.99597
50327-2	MDA-MB-134-VI	10235-101-1	Everolimus	mTOR1	PI3K/mTOR	0.00017047	-0.2444	1.1669	0.1034	0.5948	0.00034979	0.96485
50327-2	MDA-MB-134-VI	10205-101-1	INK-128	mTORC1/2	PI3K/mTOR	0.0033793	-0.8853	1.2003	0.2512	1.2527	0.007425	0.99747
50327-2	MDA-MB-134-VI	10404-101-1	PF-4708671	p70S6K	PI3K/mTOR	11.8417	0.7092	-0.0287	-0.0026	5.0000	12.2595	0.80506
50327-2	MDA-MB-134-VI	10147-101-1	Buparlisib	pan PI3K	PI3K/mTOR	0.15425	-0.8251	0.6432	0.1617	0.9833	0.45209	0.98862
50327-2	MDA-MB-134-VI	10047-101-1	Pictilisib	pan PI3K	PI3K/mTOR	2.6892	-0.1516	0.1775	0.0232	0.9649	8.3966	0.94749
50327-2	MDA-MB-134-VI	10394-101-1	Ceritinib	ALK	RTK	0.13159	-0.9992	0.6654	0.1723	0.9173	0.43587	0.98922
50327-2	MDA-MB-134-VI	10018-101-1	Neratinib	EGFR/HER2	RTK	1.1559	-0.0388	0.0807	0.0241	3.1061	1.2211	0.98626
50327-2	MDA-MB-134-VI	10131-101-1	Tivantinib	MET	RTK	0.15045	-0.6776	0.6505	0.1737	2.2582	0.21541	0.99657
50327-2	MDA-MB-134-VI	10444-101-1	Cediranib	VEGFR/cKIT	RTK	4.2103	-0.9999	0.0977	0.0979	5.0000	5.2449	0.99321
50327-2	MDA-MB-134-VI	10194-106-1	Cabozantinib	VEGFR2/MET	RTK	10.9194	0.6362	-0.0167	-0.0063	5.0000	12.725	0.88168
50328-2	MDA-MB-157	10390-103-1	Abemaciclib	CDK4/6	Cell cycle	1.7983	-0.6042	0.2687	0.0667	1.1925	4.518	0.93286
50328-2	MDA-MB-157	10071-101-1	Palbociclib	CDK4/6	Cell cycle	Inf	0.9754	0.0019	0.0010	0.0000	Inf	0.023059
50328-2	MDA-MB-157	10006-101-1	AZD7762	CHK1/2	Cell cycle	0.015418	-0.7858	0.9840	0.3122	0.8223	0.045445	0.98837
50328-2	MDA-MB-157	10387-101-1	Volasertib	PLK	Cell cycle	0.0069232	-0.6644	0.8547	0.2325	4.1331	0.0084606	0.99754
50328-2	MDA-MB-157	10287-101-2	Dinaciclib	pan CDK	Cell cycle	0.017724	-0.9106	0.7675	0.3195	3.8857	0.023072	0.99901
50328-2	MDA-MB-157	10245-999-4	Cisplatin	Chemo	Chemotherapy	5.2381	0.1885	0.1168	0.0072	1.3335	8.7509	0.97923
50328-2	MDA-MB-157	10248-102-3	Doxorubicin	Chemo	Chemotherapy	0.0032329	-0.7766	0.9661	0.1885	0.9535	0.006701	0.93404
50328-2	MDA-MB-157	10102-101-4	Taxol	Chemo	Chemotherapy	0.002046	-0.6700	0.9482	0.3487	1.9966	0.0029397	0.97064
50328-2	MDA-MB-157	10278-102-2	Topotecan	Topo I	Chemotherapy	0.0059504	-0.8333	1.0843	0.2143	0.6347	0.024255	0.91127
50328-2	MDA-MB-157	10250-101-3	Etoposide	Topo II	Chemotherapy	0.11187	-0.4340	0.6092	0.0639	1.5161	0.15792	0.98866
50328-2	MDA-MB-157	10020-101-1	Dasatinib	BCR/ABL	MAPK/nRTK	0.060542	0.0683	0.5182	0.0617	0.8087	0.044777	0.98717
50328-2	MDA-MB-157	10142-101-1	Trametinib	MEK	MAPK/nRTK	0.11147	0.4063	0.3010	0.0221	0.6435	0.009777	0.98841
50328-2	MDA-MB-157	10032-101-1	Saracatinib	SRC	MAPK/nRTK	5.2322	0.3548	0.1697	0.0119	0.4524	59.3534	0.96508
50328-2	MDA-MB-157	10179-101-1	ABT-737	Bcl2/XL	Misc	6.4038	0.2011	0.0582	0.0297	1.5309	13.1248	0.97403
50328-2	MDA-MB-157	10282-101-2	Vorinostat	HDAC	Misc	1.0981	-0.4130	0.2980	0.0489	1.0997	2.487	0.9968
50328-2	MDA-MB-157	10161-101-1	Luminespib	HSP90	Misc	0.0041789	-0.0490	0.6146	0.0676	4.3520	0.004258	0.99849
50328-2	MDA-MB-157	10478-102-1	A-1210477	Mcl-1	Misc	13.1155	0.7884	0.0063	0.0017	4.9648	12.9049	0.88212
50328-2	MDA-MB-157	10144-101-3	Olaparib	PARP	Misc	5.3864	0.1575	0.1149	0.0097	1.2271	13.1864	0.97814
50328-2	MDA-MB-157	10482-114-1	Bleomycin	Radiation	Misc	1.2881	-0.2808	0.2810	0.0510	1.0930	2.6193	0.99197
50328-2	MDA-MB-157	10338-101-1	Ipatasertib	AKT	PI3K/mTOR	16.8543	0.5956	0.0813	0.0021	0.5783	112.0316	0.9146
50328-2	MDA-MB-157	10233-101-1	Alpelisib	PI3Ka	PI3K/mTOR	9.7515	0.4924	0.1041	0.0114	0.6775	11.4208	0.96993
50328-2	MDA-MB-157	10445-101-1	Taselisib	PI3Ka, g, d	PI3K/mTOR	1.3579	0.2114	0.3387	0.0410	0.2335	150.0406	0.92986
50328-2	MDA-MB-157	10171-101-1	TGX221	PI3Kb	PI3K/mTOR	Inf	0.8240	0.0006	0.0043	1.2013	6.2128	0.76213
50328-2	MDA-MB-157	10080-101-1	Torin2	mTOR/ATM/ATR	PI3K/mTOR	0.034383	-0.2158	0.4096	0.0362	0.9233	0.05557	0.99647
50328-2	MDA-MB-157	10235-101-1	Everolimus	mTOR1	PI3K/mTOR	11.3532	0.4810	0.3940	0.0028	0.1258	0.038427	0.93626
50328-2	MDA-MB-157	10205-101-1	INK-128	mTORC1/2	PI3K/mTOR	0.031794	-0.0331	0.5141	0.0195	0.9151	0.034655	0.99803
50328-2	MDA-MB-157	10404-101-1	PF-4708671	p70S6K	PI3K/mTOR	3.8142	0.1104	0.1302	0.0024	0.9701	10.2569	0.97748
50328-2	MDA-MB-157	10147-101-1	Buparlisib	pan PI3K	PI3K/mTOR	1.2833	-0.6411	0.3016	0.0968	1.2812	3.025	0.9961
50328-2	MDA-MB-157	10047-101-1	Pictilisib	pan PI3K	PI3K/mTOR	2.0533	0.1874	0.2583	0.0226	0.3801	36.9459	0.95358
50328-2	MDA-MB-157	10394-101-1	Ceritinib	ALK	RTK	0.48405	-0.9264	0.4600	0.1138	0.9467	1.5449	0.97503
50328-2	MDA-MB-157	10018-101-1	Neratinib	EGFR/HER2	RTK	0.79635	0.1171	0.1909	0.0062	0.7168	2.4082	0.99273
50328-2	MDA-MB-157	10131-101-1	Tivantinib	MET	RTK	0.77712	-0.4822	0.3884	0.1115	3.2233	0.95786	0.99861
50328-2	MDA-MB-157	10444-101-1	Cediranib	VEGFR/cKIT	RTK	0.82468	-0.5845	0.3490	0.0876	0.8086	3.2088	0.96454
50328-2	MDA-MB-157	10194-106-1	Cabozantinib	VEGFR2/MET	RTK	2.7778	0.1490	0.2101	0.0326	0.5335	21.7804	0.97157
50331-2	MDA-MB-361	10390-103-1	Abemaciclib	CDK4/6	Cell cycle	0.0053492	-0.3418	0.8279	0.0335	0.5371	0.0096902	0.8686
50331-2	MDA-MB-361	10071-101-1	Palbociclib	CDK4/6	Cell cycle	0.019625	0.1481	0.4822	0.0065	2.1670	0.01672	0.99444
50331-2	MDA-MB-361	10006-101-1	AZD7762	CHK1/2	Cell cycle	0.0076402	-0.6753	1.0533	0.2116	2.0458	0.010426	0.97675
50331-2	MDA-MB-361	10387-101-1	Volasertib	PLK	Cell cycle	0.0035439	-0.4972	0.8204	0.1921	4.6311	0.0040451	0.98886
50331-2	MDA-MB-361	10287-101-2	Dinaciclib	pan CDK	Cell cycle	0.011817	-0.2748	0.6004	0.0836	5.0000	0.013067	0.99187
50331-2	MDA-MB-361	10245-999-4	Cisplatin	Chemo	Chemotherapy	2.6294	-0.3498	0.1809	0.0253	2.1659	3.6196	0.98908
50331-2	MDA-MB-361	10248-102-3	Doxorubicin	Chemo	Chemotherapy	0.012289	-0.7224	0.9125	0.1900	2.1676	0.017167	0.96442
50331-2	MDA-MB-361	10102-101-4	Taxol	Chemo	Chemotherapy	0.0031082	-0.6090	0.9738	0.2561	2.5508	0.0042111	0.9201
50331-2	MDA-MB-361	10278-102-2	Topotecan	Topo I	Chemotherapy	0.011361	-0.7622	1.1276	0.2239	1.9673	0.01715	0.98983
50331-2	MDA-MB-361	10250-101-3	Etoposide	Topo II	Chemotherapy	1.1915	-0.5173	0.3432	0.0513	1.6855	1.9175	0.9862
50331-2	MDA-MB-361	10020-101-1	Dasatinib	BCR/ABL	MAPK/nRTK	0.26737	0.0805	0.3513	0.0255	1.3524	0.20359	0.98324
50331-2	MDA-MB-361	10142-101-1	Trametinib	MEK	MAPK/nRTK	1.0029	0.5021	0.2191	0.0194	0.4857	0.060413	0.90885
50331-2	MDA-MB-361	10032-101-1	Saracatinib	SRC	MAPK/nRTK	0.42599	-0.1780	0.4058	0.0330	0.4194	5.848	0.98077
50331-2	MDA-MB-361	10179-101-1	ABT-737	Bcl2/XL	Misc	Inf	0.8441	-0.0067	0.0094	2.5452	4.5021	0.68512
50331-2	MDA-MB-361	10282-101-2	Vorinostat	HDAC	Misc	0.76224	-0.9392	0.4607	0.1761	2.2187	1.2401	0.99784
50331-2	MDA-MB-361	10161-101-1	Luminespib	HSP90	Misc	0.0071417	-0.8855	0.9781	0.3455	4.9987	0.0087421	0.9995
50331-2	MDA-MB-361	10478-102-1	A-1210477	Mcl-1	Misc	Inf	0.9850	-0.0083	0.0037	0.0000	Inf	-0.045307
50331-2	MDA-MB-361	10144-101-3	Olaparib	PARP	Misc	4.8624	0.0945	0.1038	0.0095	1.2844	11.0203	0.97233
50331-2	MDA-MB-361	10482-114-1	Bleomycin	Radiation	Misc	0.75794	-0.2660	0.3607	0.0429	0.8418	1.9803	0.97757
50331-2	MDA-MB-361	10338-101-1	Ipatasertib	AKT	PI3K/mTOR	0.31325	-0.5798	0.4548	0.0905	0.7404	1.2042	0.98932
50331-2	MDA-MB-361	10233-101-1	Alpelisib	PI3Ka	PI3K/mTOR	0.22264	-0.7994	0.5323	0.1181	0.6802	1.1196	0.97671
50331-2	MDA-MB-361	10445-101-1	Taselisib	PI3Ka, g, d	PI3K/mTOR	0.0017737	-0.9902	1.4103	0.4329	0.6207	0.010237	0.9975
50331-2	MDA-MB-361	10171-101-1	TGX221	PI3Kb	PI3K/mTOR	13.225	0.7989	-0.0336	0.0006	4.9995	13.1104	0.64936
50331-2	MDA-MB-361	10080-101-1	Torin2	mTOR/ATM/ATR	PI3K/mTOR	0.0050713	-0.9642	0.8689	0.2561	0.9911	0.014575	0.99687
50331-2	MDA-MB-361	10235-101-1	Everolimus	mTOR1	PI3K/mTOR	0.00027478	0.0574	0.8497	0.0502	0.7979	0.00019313	0.7172
50331-2	MDA-MB-361	10205-101-1	INK-128	mTORC1/2	PI3K/mTOR	0.0036192	-0.8457	1.0956	0.2779	1.1991	0.0074773	0.98876
50331-2	MDA-MB-361	10404-101-1	PF-4708671	p70S6K	PI3K/mTOR	7.2299	0.1918	0.0684	0.0066	2.1808	11.9649	0.98055
50331-2	MDA-MB-361	10147-101-1	Buparlisib	pan PI3K	PI3K/mTOR	0.21797	-0.9584	0.6114	0.1763	0.9709	0.67584	0.99384
50331-2	MDA-MB-361	10047-101-1	Pictilisib	pan PI3K	PI3K/mTOR	0.079201	-0.9375	0.7161	0.1619	0.6291	0.45409	0.98391
50331-2	MDA-MB-361	10394-101-1	Ceritinib	ALK	RTK	0.26636	-0.9910	0.5462	0.1443	0.8263	1.0067	0.97236
50331-2	MDA-MB-361	10018-101-1	Neratinib	EGFR/HER2	RTK	0.15196	-0.5277	0.4246	0.0772	0.5626	1.0709	0.91404
50331-2	MDA-MB-361	10131-101-1	Tivantinib	MET	RTK	0.34234	-0.6060	0.5161	0.1344	1.7286	0.54407	0.99764
50331-2	MDA-MB-361	10444-101-1	Cediranib	VEGFR/cKIT	RTK	2.2171	-0.9803	0.2895	0.1040	2.2939	3.5791	0.96048
50331-2	MDA-MB-361	10194-106-1	Cabozantinib	VEGFR2/MET	RTK	Inf	0.6624	0.0628	-0.0003	4.9832	4.0443	0.74358
50333-2	MDA-MB-436	10390-103-1	Abemaciclib	CDK4/6	Cell cycle	2.1015	-0.3331	0.1897	0.0464	1.1593	5.3251	0.99054
50333-2	MDA-MB-436	10071-101-1	Palbociclib	CDK4/6	Cell cycle	Inf	1.0500	-0.0343	-0.0002	0.0000	Inf	-9.0203
50333-2	MDA-MB-436	10006-101-1	AZD7762	CHK1/2	Cell cycle	0.039886	-0.2809	0.6566	0.0949	1.4724	0.049236	0.98291
50333-2	MDA-MB-436	10387-101-1	Volasertib	PLK	Cell cycle	0.0051788	-0.1792	0.6616	0.1034	3.6059	0.0056092	0.99947
50333-2	MDA-MB-436	10287-101-2	Dinaciclib	pan CDK	Cell cycle	0.014324	-0.1440	0.4903	0.0235	4.8527	0.014993	0.99777
50333-2	MDA-MB-436	10245-999-4	Cisplatin	Chemo	Chemotherapy	0.4173	-0.0204	0.3606	0.0365	1.2366	0.44452	0.99287
50333-2	MDA-MB-436	10248-102-3	Doxorubicin	Chemo	Chemotherapy	0.0076138	-0.1288	0.7061	0.0611	1.3442	0.0088093	0.99253
50333-2	MDA-MB-436	10102-101-4	Taxol	Chemo	Chemotherapy	0.0037097	-0.2183	0.7083	0.1530	3.2043	0.0040962	0.99739
50333-2	MDA-MB-436	10278-102-2	Topotecan	Topo I	Chemotherapy	0.0059389	-0.1398	0.8768	0.0855	1.0160	0.0074925	0.99666
50333-2	MDA-MB-436	10250-101-3	Etoposide	Topo II	Chemotherapy	0.26013	-0.1571	0.4348	0.0454	0.9014	0.38084	0.99169
50333-2	MDA-MB-436	10020-101-1	Dasatinib	BCR/ABL	MAPK/nRTK	Inf	0.6528	0.1022	0.0098	0.0000	Inf	0.40773
50333-2	MDA-MB-436	10142-101-1	Trametinib	MEK	MAPK/nRTK	Inf	0.5572	0.1820	0.0015	1.0351	0.021252	0.93697
50333-2	MDA-MB-436	10032-101-1	Saracatinib	SRC	MAPK/nRTK	37.3252	0.7236	0.0385	0.0048	0.7263	42.6009	0.88237
50333-2	MDA-MB-436	10179-101-1	ABT-737	Bcl2/XL	Misc	26.1321	0.8154	0.0064	0.0038	1.3541	40.6846	0.74833
50333-2	MDA-MB-436	10282-101-2	Vorinostat	HDAC	Misc	2.6793	0.0330	0.1632	0.0301	1.6566	2.98	0.99632
50333-2	MDA-MB-436	10161-101-1	Luminespib	HSP90	Misc	0.0039107	-0.0492	0.6326	0.0393	3.6046	0.004027	0.999
50333-2	MDA-MB-436	10478-102-1	A-1210477	Mcl-1	Misc	Inf	0.8728	0.0140	0.0010	0.0000	Inf	0.42977
50333-2	MDA-MB-436	10144-101-3	Olaparib	PARP	Misc	1.536	0.2383	0.3050	0.0296	0.3132	51.2767	0.98251
50333-2	MDA-MB-436	10482-114-1	Bleomycin	Radiation	Misc	0.85488	-0.1198	0.3092	0.0484	0.9195	1.4366	0.98079
50333-2	MDA-MB-436	10338-101-1	Ipatasertib	AKT	PI3K/mTOR	25.8679	0.6111	0.1038	0.0116	0.4073	383.9431	0.92516
50333-2	MDA-MB-436	10233-101-1	Alpelisib	PI3Ka	PI3K/mTOR	36.7582	0.7252	0.0552	0.0073	0.6026	226.7201	0.84658
50333-2	MDA-MB-436	10445-101-1	Taselisib	PI3Ka, g, d	PI3K/mTOR	4.6563	0.2431	0.1736	0.0143	0.6355	26.2348	0.92245
50333-2	MDA-MB-436	10171-101-1	TGX221	PI3Kb	PI3K/mTOR	22.0461	0.7221	0.0019	0.0048	1.3022	18.6589	0.84405
50333-2	MDA-MB-436	10080-101-1	Torin2	mTOR/ATM/ATR	PI3K/mTOR	0.041679	0.1227	0.3390	0.0305	0.6859	0.029409	0.97813
50333-2	MDA-MB-436	10235-101-1	Everolimus	mTOR1	PI3K/mTOR	Inf	0.6148	0.3144	0.0169	0.7543	0.00065027	0.85083
50333-2	MDA-MB-436	10205-101-1	INK-128	mTORC1/2	PI3K/mTOR	0.024105	0.2111	0.4295	0.0250	1.0988	0.010706	0.97335
50333-2	MDA-MB-436	10404-101-1	PF-4708671	p70S6K	PI3K/mTOR	4.7528	0.1938	0.0918	0.0048	1.3212	6.5976	0.98815
50333-2	MDA-MB-436	10147-101-1	Buparlisib	pan PI3K	PI3K/mTOR	1.1815	-0.2866	0.2925	0.0578	1.6196	1.6556	0.99244
50333-2	MDA-MB-436	10047-101-1	Pictilisib	pan PI3K	PI3K/mTOR	5.2741	0.2850	0.1328	0.0124	0.7767	21.6999	0.98441
50333-2	MDA-MB-436	10394-101-1	Ceritinib	ALK	RTK	0.49893	-0.6974	0.4169	0.1006	0.9667	1.4927	0.99602
50333-2	MDA-MB-436	10018-101-1	Neratinib	EGFR/HER2	RTK	0.71562	0.0162	0.1879	0.0162	0.8626	1.6615	0.98931
50333-2	MDA-MB-436	10131-101-1	Tivantinib	MET	RTK	0.3675	-0.2711	0.4215	0.0897	2.2220	0.44342	0.99833
50333-2	MDA-MB-436	10444-101-1	Cediranib	VEGFR/cKIT	RTK	3.6098	-0.3824	0.1610	0.0446	1.8229	6.595	0.98039
50333-2	MDA-MB-436	10194-106-1	Cabozantinib	VEGFR2/MET	RTK	6.5187	0.0862	0.0592	0.0149	2.1788	10.7014	0.98785
50334-2	MDA-MB-453	10390-103-1	Abemaciclib	CDK4/6	Cell cycle	0.0057723	-0.7647	0.8495	0.1526	0.2725	0.32512	0.73985
50334-2	MDA-MB-453	10071-101-1	Palbociclib	CDK4/6	Cell cycle	0.042838	0.0416	0.4402	0.0770	1.2886	0.039852	0.99219
50334-2	MDA-MB-453	10006-101-1	AZD7762	CHK1/2	Cell cycle	0.011509	-0.2157	0.8564	0.1405	1.6714	0.014102	0.99393
50334-2	MDA-MB-453	10387-101-1	Volasertib	PLK	Cell cycle	0.0071952	-0.2013	0.5350	0.1191	2.7557	0.0074665	0.98353
50334-2	MDA-MB-453	10287-101-2	Dinaciclib	pan CDK	Cell cycle	0.011359	-0.2569	0.5807	0.1358	3.4728	0.012824	0.99835
50334-2	MDA-MB-453	10245-999-4	Cisplatin	Chemo	Chemotherapy	3.4106	0.1328	0.0938	-0.0013	3.0256	3.151	0.9887
50334-2	MDA-MB-453	10248-102-3	Doxorubicin	Chemo	Chemotherapy	0.0058313	-0.3476	0.7915	0.1805	1.7510	0.0071438	0.98132
50334-2	MDA-MB-453	10102-101-4	Taxol	Chemo	Chemotherapy	0.002374	0.0356	0.6674	0.1683	1.2620	0.0023576	0.81734
50334-2	MDA-MB-453	10278-102-2	Topotecan	Topo I	Chemotherapy	0.0066897	-0.5289	0.9258	0.1604	1.0131	0.010358	0.92364
50334-2	MDA-MB-453	10250-101-3	Etoposide	Topo II	Chemotherapy	0.38265	-0.0601	0.3658	0.0418	1.5864	0.41689	0.99692
50334-2	MDA-MB-453	10020-101-1	Dasatinib	BCR/ABL	MAPK/nRTK	11.2977	0.5486	0.0776	0.0229	1.2179	27.8439	0.76835
50334-2	MDA-MB-453	10142-101-1	Trametinib	MEK	MAPK/nRTK	0.034423	0.0489	0.3253	0.0542	1.5373	0.031553	0.98454
50334-2	MDA-MB-453	10032-101-1	Saracatinib	SRC	MAPK/nRTK	8.3734	0.3925	0.0634	0.0273	1.5016	17.4019	0.95549
50334-2	MDA-MB-453	10179-101-1	ABT-737	Bcl2/XL	Misc	5.9702	0.1516	0.0227	0.0377	4.9881	5.7097	0.9783
50334-2	MDA-MB-453	10282-101-2	Vorinostat	HDAC	Misc	0.9215	-0.6076	0.3291	0.1421	3.3225	1.1628	0.99512
50334-2	MDA-MB-453	10161-101-1	Luminespib	HSP90	Misc	0.0032643	-0.4995	0.8803	0.2734	2.6468	0.0042685	0.99671
50334-2	MDA-MB-453	10478-102-1	A-1210477	Mcl-1	Misc	Inf	0.9330	-0.0364	0.0157	0.0000	Inf	-0.33803
50334-2	MDA-MB-453	10144-101-3	Olaparib	PARP	Misc	1.6695	-0.0358	0.2414	0.0284	0.7989	4.3612	0.99257
50334-2	MDA-MB-453	10482-114-1	Bleomycin	Radiation	Misc	1.3087	0.0154	0.2124	0.0259	1.2776	1.4452	0.99022
50334-2	MDA-MB-453	10338-101-1	Ipatasertib	AKT	PI3K/mTOR	0.53911	-0.1551	0.3144	0.0753	1.3090	0.65666	0.98992
50334-2	MDA-MB-453	10233-101-1	Alpelisib	PI3Ka	PI3K/mTOR	0.53182	-0.3068	0.3532	0.0861	0.7133	1.648	0.979
50334-2	MDA-MB-453	10445-101-1	Taselisib	PI3Ka, g, d	PI3K/mTOR	0.0034639	-0.6347	1.0079	0.2403	0.8199	0.0064512	0.90769
50334-2	MDA-MB-453	10171-101-1	TGX221	PI3Kb	PI3K/mTOR	15.3342	0.8281	-0.0281	0.0177	4.9457	12.4514	0.62788
50334-2	MDA-MB-453	10080-101-1	Torin2	mTOR/ATM/ATR	PI3K/mTOR	0.0083807	-0.8141	0.6934	0.2249	0.9084	0.023455	0.98046
50334-2	MDA-MB-453	10235-101-1	Everolimus	mTOR1	PI3K/mTOR	Inf	0.0309	0.8879	0.1169	0.0000	Inf	0.43273
50334-2	MDA-MB-453	10205-101-1	INK-128	mTORC1/2	PI3K/mTOR	0.009907	-0.4684	0.7631	0.1914	1.6470	0.01349	0.98649
50334-2	MDA-MB-453	10404-101-1	PF-4708671	p70S6K	PI3K/mTOR	4.291	0.0482	0.0418	0.0294	4.9998	4.2285	0.98022
50334-2	MDA-MB-453	10147-101-1	Buparlisib	pan PI3K	PI3K/mTOR	0.69073	-0.6073	0.3442	0.1124	1.2215	1.4247	0.9883
50334-2	MDA-MB-453	10047-101-1	Pictilisib	pan PI3K	PI3K/mTOR	0.45409	-0.3736	0.3924	0.0999	0.7355	1.4609	0.99053
50334-2	MDA-MB-453	10394-101-1	Ceritinib	ALK	RTK	0.36617	-0.6866	0.4840	0.1577	1.1705	0.84209	0.99139
50334-2	MDA-MB-453	10018-101-1	Neratinib	EGFR/HER2	RTK	0.036055	-0.3216	0.5532	0.1255	0.4562	0.2347	0.98118
50334-2	MDA-MB-453	10131-101-1	Tivantinib	MET	RTK	0.20059	-0.0719	0.4182	0.1017	2.2407	0.20744	0.99393
50334-2	MDA-MB-453	10444-101-1	Cediranib	VEGFR/cKIT	RTK	2.7824	-0.6894	0.1569	0.0768	3.0858	3.7659	0.99464
50334-2	MDA-MB-453	10194-106-1	Cabozantinib	VEGFR2/MET	RTK	9.0899	0.4645	-0.0045	0.0208	4.5355	6.5788	0.94161
50335-2	MDA-MB-468	10390-103-1	Abemaciclib	CDK4/6	Cell cycle	2.3386	-0.2881	0.1766	0.0681	1.5630	3.8065	0.9935
50335-2	MDA-MB-468	10071-101-1	Palbociclib	CDK4/6	Cell cycle	Inf	1.0457	-0.0214	0.0005	0.0000	Inf	-0.58792
50335-2	MDA-MB-468	10006-101-1	AZD7762	CHK1/2	Cell cycle	0.28495	-0.5860	0.4932	0.2129	1.0622	0.63742	0.99549
50335-2	MDA-MB-468	10387-101-1	Volasertib	PLK	Cell cycle	0.002104	-0.4485	0.9279	0.3934	2.9173	0.0026072	0.99938
50335-2	MDA-MB-468	10287-101-2	Dinaciclib	pan CDK	Cell cycle	0.015576	-0.4131	0.5681	0.1843	2.8840	0.018635	0.99641
50335-2	MDA-MB-468	10245-999-4	Cisplatin	Chemo	Chemotherapy	1.2638	-0.2866	0.2872	0.0977	1.4057	1.9559	0.99503
50335-2	MDA-MB-468	10248-102-3	Doxorubicin	Chemo	Chemotherapy	0.0054214	-0.3392	0.9121	0.3191	2.4137	0.0067542	0.99424
50335-2	MDA-MB-468	10102-101-4	Taxol	Chemo	Chemotherapy	0.001354	-0.5218	1.0076	0.5243	1.2795	0.0023644	0.95471
50335-2	MDA-MB-468	10278-102-2	Topotecan	Topo I	Chemotherapy	0.015779	-0.6577	1.0692	0.4464	2.1036	0.023029	0.99528
50335-2	MDA-MB-468	10250-101-3	Etoposide	Topo II	Chemotherapy	0.48754	-0.5132	0.4291	0.1644	1.8475	0.69756	0.99577
50335-2	MDA-MB-468	10020-101-1	Dasatinib	BCR/ABL	MAPK/nRTK	4.4311	0.3393	0.1447	0.0458	0.7091	5.6436	0.97277
50335-2	MDA-MB-468	10142-101-1	Trametinib	MEK	MAPK/nRTK	0.4421	0.4075	0.2132	0.0255	0.4592	0.27448	0.99227
50335-2	MDA-MB-468	10032-101-1	Saracatinib	SRC	MAPK/nRTK	4.9591	0.1778	0.1388	0.0508	0.9811	15.1962	0.9691
50335-2	MDA-MB-468	10179-101-1	ABT-737	Bcl2/XL	Misc	6.0269	0.1420	0.0860	0.0547	1.5887	12.0342	0.98897
50335-2	MDA-MB-468	10282-101-2	Vorinostat	HDAC	Misc	1.5734	-0.1191	0.2172	0.0608	1.9840	1.8053	0.99971
50335-2	MDA-MB-468	10161-101-1	Luminespib	HSP90	Misc	0.0048347	-0.1738	0.6478	0.1563	4.7025	0.0051177	0.99878
50335-2	MDA-MB-468	10478-102-1	A-1210477	Mcl-1	Misc	Inf	0.9299	0.0206	0.0057	0.3898	963.6809	0.60314
50335-2	MDA-MB-468	10144-101-3	Olaparib	PARP	Misc	7.9202	0.3408	0.0576	0.0179	1.6505	15.4105	0.98176
50335-2	MDA-MB-468	10482-114-1	Bleomycin	Radiation	Misc	0.82322	-0.2103	0.3246	0.1050	0.8733	1.7869	0.99409
50335-2	MDA-MB-468	10338-101-1	Ipatasertib	AKT	PI3K/mTOR	2.3697	0.3091	0.2229	0.0266	0.5702	1.4742	0.96355
50335-2	MDA-MB-468	10233-101-1	Alpelisib	PI3Ka	PI3K/mTOR	15.9683	0.7142	0.0314	0.0171	1.4955	33.2195	0.92719
50335-2	MDA-MB-468	10445-101-1	Taselisib	PI3Ka, g, d	PI3K/mTOR	2.3526	0.0046	0.2170	0.0736	0.6960	11.4039	0.97997
50335-2	MDA-MB-468	10171-101-1	TGX221	PI3Kb	PI3K/mTOR	Inf	0.7230	0.1032	0.0343	0.5264	0.7426	0.94963
50335-2	MDA-MB-468	10080-101-1	Torin2	mTOR/ATM/ATR	PI3K/mTOR	0.016032	-0.0415	0.4371	0.1010	0.9482	0.015849	0.98843
50335-2	MDA-MB-468	10235-101-1	Everolimus	mTOR1	PI3K/mTOR	Inf	0.5275	0.4288	0.0743	0.2018	1.1048e-05	0.70612
50335-2	MDA-MB-468	10205-101-1	INK-128	mTORC1/2	PI3K/mTOR	0.023529	0.0573	0.5025	0.1038	1.2151	0.020647	0.99651
50335-2	MDA-MB-468	10404-101-1	PF-4708671	p70S6K	PI3K/mTOR	4.1732	0.0813	0.1176	0.0094	1.1782	8.8804	0.99743
50335-2	MDA-MB-468	10147-101-1	Buparlisib	pan PI3K	PI3K/mTOR	0.83168	-0.5157	0.3573	0.2010	2.1267	1.1738	0.99824
50335-2	MDA-MB-468	10047-101-1	Pictilisib	pan PI3K	PI3K/mTOR	2.3306	-0.0613	0.2054	0.0776	0.7959	9.2675	0.99096
50335-2	MDA-MB-468	10394-101-1	Ceritinib	ALK	RTK	0.76749	-0.7415	0.4050	0.1730	1.6622	1.3833	0.99574
50335-2	MDA-MB-468	10018-101-1	Neratinib	EGFR/HER2	RTK	0.15781	-0.3825	0.3861	0.1513	0.8303	0.41607	0.99579
50335-2	MDA-MB-468	10131-101-1	Tivantinib	MET	RTK	0.30706	-0.4549	0.4903	0.2341	2.9835	0.37002	0.99499
50335-2	MDA-MB-468	10444-101-1	Cediranib	VEGFR/cKIT	RTK	3.9154	-0.7083	0.1649	0.0970	3.0423	5.6183	0.9962
50335-2	MDA-MB-468	10194-106-1	Cabozantinib	VEGFR2/MET	RTK	8.9681	0.4233	0.0441	0.0115	1.7711	16.6732	0.9812
50008-2	CAL-51	10390-103-1	Abemaciclib	CDK4/6	Cell cycle	0.11268	-0.4637	0.5776	0.0890	0.4136	1.605	0.97536
50008-2	CAL-51	10071-101-1	Palbociclib	CDK4/6	Cell cycle	0.37241	0.3607	0.2498	-0.0215	0.8353	0.084749	0.99265
50008-2	CAL-51	10006-101-1	AZD7762	CHK1/2	Cell cycle	0.044603	-0.5186	0.7151	0.2631	1.2331	0.070405	0.98322
50008-2	CAL-51	10387-101-1	Volasertib	PLK	Cell cycle	0.0059136	-0.3372	0.6787	0.2411	3.0715	0.0068268	0.99697
50008-2	CAL-51	10287-101-2	Dinaciclib	pan CDK	Cell cycle	0.014709	-0.3585	0.5985	0.2374	3.5319	0.017105	0.99939
50008-2	CAL-51	10245-999-4	Cisplatin	Chemo	Chemotherapy	2.0989	-0.0329	0.2145	0.0322	0.9070	4.8677	0.9969
50008-2	CAL-51	10248-102-3	Doxorubicin	Chemo	Chemotherapy	0.0085841	-0.4803	0.7954	0.2347	1.0881	0.014188	0.98761
50008-2	CAL-51	10102-101-4	Taxol	Chemo	Chemotherapy	0.004167	-0.2200	0.6694	0.1963	1.3689	0.0053072	0.99639
50008-2	CAL-51	10278-102-2	Topotecan	Topo I	Chemotherapy	0.019146	-0.5303	0.8558	0.2745	1.1807	0.031097	0.97872
50008-2	CAL-51	10250-101-3	Etoposide	Topo II	Chemotherapy	0.24029	-0.2097	0.4669	0.0707	1.1885	0.32971	0.99772
50008-2	CAL-51	10020-101-1	Dasatinib	BCR/ABL	MAPK/nRTK	0.058089	0.0983	0.5161	0.1625	0.8670	0.042316	0.9975
50008-2	CAL-51	10142-101-1	Trametinib	MEK	MAPK/nRTK	Inf	0.7064	0.0662	0.0124	0.8944	0.19105	0.98439
50008-2	CAL-51	10032-101-1	Saracatinib	SRC	MAPK/nRTK	1.8499	0.2582	0.2271	0.0547	0.6810	1.6055	0.99804
50008-2	CAL-51	10179-101-1	ABT-737	Bcl2/XL	Misc	30.4739	0.8756	0.0125	0.0091	1.7501	30.7264	0.93007
50008-2	CAL-51	10282-101-2	Vorinostat	HDAC	Misc	1.8294	-0.0506	0.1862	0.0337	1.4510	2.2081	0.98967
50008-2	CAL-51	10161-101-1	Luminespib	HSP90	Misc	0.0063934	-0.3386	0.7043	0.2784	3.0050	0.0075437	0.9995
50008-2	CAL-51	10478-102-1	A-1210477	Mcl-1	Misc	Inf	0.9919	0.0073	0.0004	0.0000	Inf	0.00046652
50008-2	CAL-51	10144-101-3	Olaparib	PARP	Misc	7.1917	0.3596	0.1163	0.0073	0.8214	27.3972	0.94373
50008-2	CAL-51	10482-114-1	Bleomycin	Radiation	Misc	0.1694	-0.1344	0.4855	0.0479	0.8490	0.24736	0.9994
50008-2	CAL-51	10338-101-1	Ipatasertib	AKT	PI3K/mTOR	2.978	0.3866	0.2238	0.0226	0.5898	0.68363	0.98798
50008-2	CAL-51	10233-101-1	Alpelisib	PI3Ka	PI3K/mTOR	6.1028	0.3436	0.1490	0.0190	0.5874	39.608	0.96055
50008-2	CAL-51	10445-101-1	Taselisib	PI3Ka, g, d	PI3K/mTOR	0.13353	-0.4129	0.5460	0.1721	0.4106	1.9394	0.97937
50008-2	CAL-51	10171-101-1	TGX221	PI3Kb	PI3K/mTOR	Inf	0.9105	-0.0094	0.0003	0.0000	Inf	0.56048
50008-2	CAL-51	10080-101-1	Torin2	mTOR/ATM/ATR	PI3K/mTOR	0.017867	-0.1520	0.4562	0.1029	0.8686	0.02383	0.99351
50008-2	CAL-51	10235-101-1	Everolimus	mTOR1	PI3K/mTOR	Inf	0.5477	0.4319	0.0326	1.0020	0.00038398	0.74949
50008-2	CAL-51	10205-101-1	INK-128	mTORC1/2	PI3K/mTOR	0.014971	0.0529	0.5532	0.1010	0.9663	0.012822	0.99761
50008-2	CAL-51	10404-101-1	PF-4708671	p70S6K	PI3K/mTOR	37.1287	0.7337	0.0491	0.0022	0.6083	225.4809	0.97513
50008-2	CAL-51	10147-101-1	Buparlisib	pan PI3K	PI3K/mTOR	0.9892	-0.3883	0.3283	0.1186	1.5630	1.5215	0.99245
50008-2	CAL-51	10047-101-1	Pictilisib	pan PI3K	PI3K/mTOR	2.8949	0.0266	0.1896	0.0461	0.7844	11.7472	0.98461
50008-2	CAL-51	10394-101-1	Ceritinib	ALK	RTK	0.47536	-0.4763	0.4172	0.1229	1.1654	0.88025	0.99344
50008-2	CAL-51	10018-101-1	Neratinib	EGFR/HER2	RTK	2.2484	0.2802	0.0910	0.0109	1.5163	4.6402	0.98601
50008-2	CAL-51	10131-101-1	Tivantinib	MET	RTK	0.58755	-0.2821	0.3592	0.1039	1.5478	0.80088	0.99945
50008-2	CAL-51	10444-101-1	Cediranib	VEGFR/cKIT	RTK	3.0488	-0.1033	0.1710	0.0517	1.0331	8.8303	0.9776
50008-2	CAL-51	10194-106-1	Cabozantinib	VEGFR2/MET	RTK	7.7705	0.3063	0.0598	0.0166	1.8325	14.1514	0.98918
50206-2	HCC1395	10390-103-1	Abemaciclib	CDK4/6	Cell cycle	0.11228	-0.5202	0.5623	0.0665	0.3941	1.8243	0.93379
50206-2	HCC1395	10071-101-1	Palbociclib	CDK4/6	Cell cycle	0.096119	0.3481	0.2811	0.0192	1.5258	0.037341	0.98658
50206-2	HCC1395	10006-101-1	AZD7762	CHK1/2	Cell cycle	0.02128	-0.6899	0.8845	0.2607	2.2723	0.028104	0.96763
50206-2	HCC1395	10387-101-1	Volasertib	PLK	Cell cycle	0.0032085	-0.2962	0.7641	0.1714	2.7096	0.00378	0.99662
50206-2	HCC1395	10287-101-2	Dinaciclib	pan CDK	Cell cycle	0.012405	-0.4966	0.6520	0.1554	2.9854	0.015612	0.99791
50206-2	HCC1395	10245-999-4	Cisplatin	Chemo	Chemotherapy	0.49099	-0.2215	0.3857	0.0943	0.9090	0.84369	0.97444
50206-2	HCC1395	10248-102-3	Doxorubicin	Chemo	Chemotherapy	0.01793	-0.4166	0.6370	0.1543	1.1158	0.025315	0.96347
50206-2	HCC1395	10102-101-4	Taxol	Chemo	Chemotherapy	0.003883	-0.4582	0.8386	0.2364	2.6973	0.0049059	0.99722
50206-2	HCC1395	10278-102-2	Topotecan	Topo I	Chemotherapy	0.0027504	-0.5835	1.0761	0.3115	0.5889	0.0088299	0.93292
50206-2	HCC1395	10250-101-3	Etoposide	Topo II	Chemotherapy	0.42007	-0.2253	0.3885	0.1200	1.3744	0.55409	0.99622
50206-2	HCC1395	10020-101-1	Dasatinib	BCR/ABL	MAPK/nRTK	0.074545	-0.3369	0.6018	0.0918	1.9595	0.089698	0.98974
50206-2	HCC1395	10142-101-1	Trametinib	MEK	MAPK/nRTK	0.17156	0.4498	0.1903	0.0218	1.7439	0.023111	0.97973
50206-2	HCC1395	10032-101-1	Saracatinib	SRC	MAPK/nRTK	3.7809	0.1199	0.1181	0.0202	0.9275	10.2114	0.93832
50206-2	HCC1395	10179-101-1	ABT-737	Bcl2/XL	Misc	Inf	0.8607	-0.0001	0.0132	4.9721	4.7028	0.58916
50206-2	HCC1395	10282-101-2	Vorinostat	HDAC	Misc	3.2812	-0.0589	0.1137	0.0365	2.1496	3.8175	0.99171
50206-2	HCC1395	10161-101-1	Luminespib	HSP90	Misc	0.0049953	-0.1520	0.6195	0.0752	3.9193	0.0052747	0.99634
50206-2	HCC1395	10478-102-1	A-1210477	Mcl-1	Misc	14.7951	0.8591	0.0009	0.0010	5.0000	13.8656	0.73508
50206-2	HCC1395	10144-101-3	Olaparib	PARP	Misc	1.8714	0.0945	0.2530	0.0681	0.4756	18.8563	0.97211
50206-2	HCC1395	10482-114-1	Bleomycin	Radiation	Misc	0.10419	-0.4023	0.6070	0.1775	0.6889	0.30452	0.9971
50206-2	HCC1395	10338-101-1	Ipatasertib	AKT	PI3K/mTOR	0.93351	0.1903	0.2795	0.0199	0.6198	0.7738	0.97632
50206-2	HCC1395	10233-101-1	Alpelisib	PI3Ka	PI3K/mTOR	14.2707	0.6375	0.0319	0.0088	1.2066	35.4714	0.90001
50206-2	HCC1395	10445-101-1	Taselisib	PI3Ka, g, d	PI3K/mTOR	2.1401	-0.0177	0.2078	0.0314	0.6939	10.4247	0.98026
50206-2	HCC1395	10171-101-1	TGX221	PI3Kb	PI3K/mTOR	8.4625	0.4581	0.0950	0.0125	0.6815	16.0341	0.94431
50206-2	HCC1395	10080-101-1	Torin2	mTOR/ATM/ATR	PI3K/mTOR	0.014555	-0.1424	0.4547	0.0604	1.6344	0.015746	0.98865
50206-2	HCC1395	10235-101-1	Everolimus	mTOR1	PI3K/mTOR	0.0025601	0.4042	0.5551	0.0370	0.4448	5.3346e-05	0.76727
50206-2	HCC1395	10205-101-1	INK-128	mTORC1/2	PI3K/mTOR	0.010854	-0.0258	0.5582	0.0314	1.5212	0.0094351	0.98264
50206-2	HCC1395	10404-101-1	PF-4708671	p70S6K	PI3K/mTOR	Inf	0.6588	0.0192	0.0018	1.5703	5.6441	0.9103
50206-2	HCC1395	10147-101-1	Buparlisib	pan PI3K	PI3K/mTOR	0.93021	-0.5056	0.3091	0.0850	1.4869	1.5691	0.99654
50206-2	HCC1395	10047-101-1	Pictilisib	pan PI3K	PI3K/mTOR	1.4354	-0.0143	0.2288	0.0238	0.8947	2.3303	0.98423
50206-2	HCC1395	10394-101-1	Ceritinib	ALK	RTK	1.6025	-0.6268	0.2363	0.0809	1.8434	2.6534	0.99554
50206-2	HCC1395	10018-101-1	Neratinib	EGFR/HER2	RTK	0.95453	0.0167	0.1503	0.0198	0.8768	3.3415	0.98547
50206-2	HCC1395	10131-101-1	Tivantinib	MET	RTK	0.47525	-0.4835	0.4006	0.1208	1.5047	0.75467	0.99624
50206-2	HCC1395	10444-101-1	Cediranib	VEGFR/cKIT	RTK	1.571	-0.4825	0.2460	0.0671	1.0270	4.579	0.97022
50206-2	HCC1395	10194-106-1	Cabozantinib	VEGFR2/MET	RTK	5.5518	0.1138	0.0722	0.0131	1.6522	9.2961	0.98977
50207-2	HCC1419	10390-103-1	Abemaciclib	CDK4/6	Cell cycle	0.10375	0.2278	0.4350	-0.0030	0.6549	0.0234	0.9117
50207-2	HCC1419	10071-101-1	Palbociclib	CDK4/6	Cell cycle	0.48725	0.4414	0.2239	-0.0054	1.2398	0.053717	0.97241
50207-2	HCC1419	10006-101-1	AZD7762	CHK1/2	Cell cycle	0.068618	-0.0826	0.5614	0.1156	2.0553	0.072481	0.98917
50207-2	HCC1419	10387-101-1	Volasertib	PLK	Cell cycle	0.020718	0.0685	0.3636	0.0462	1.8241	0.018178	0.98538
50207-2	HCC1419	10287-101-2	Dinaciclib	pan CDK	Cell cycle	0.026695	-0.4761	0.5131	0.1238	5.0000	0.030191	0.99589
50207-2	HCC1419	10245-999-4	Cisplatin	Chemo	Chemotherapy	1.7988	0.0949	0.2293	0.0086	1.0769	2.0814	0.93793
50207-2	HCC1419	10248-102-3	Doxorubicin	Chemo	Chemotherapy	0.025082	-0.4663	0.5904	0.0473	0.5199	0.10425	0.94593
50207-2	HCC1419	10102-101-4	Taxol	Chemo	Chemotherapy	0.0052608	0.2143	0.4700	0.0981	2.1841	0.0040283	0.97754
50207-2	HCC1419	10278-102-2	Topotecan	Topo I	Chemotherapy	0.0071886	-0.7857	0.9904	0.1711	0.4002	0.11192	0.94532
50207-2	HCC1419	10250-101-3	Etoposide	Topo II	Chemotherapy	0.73579	0.0317	0.3201	0.0034	1.8770	0.70309	0.96133
50207-2	HCC1419	10020-101-1	Dasatinib	BCR/ABL	MAPK/nRTK	0.82399	-0.1962	0.3189	0.0194	0.7548	2.3816	0.99358
50207-2	HCC1419	10142-101-1	Trametinib	MEK	MAPK/nRTK	0.031029	0.4259	0.2875	-0.0031	1.4893	0.0089457	0.98063
50207-2	HCC1419	10032-101-1	Saracatinib	SRC	MAPK/nRTK	0.91888	-0.1146	0.2758	0.0128	0.8021	1.8388	0.98394
50207-2	HCC1419	10179-101-1	ABT-737	Bcl2/XL	Misc	9.84	0.4715	0.0022	0.0163	5.0000	11.4973	0.95757
50207-2	HCC1419	10282-101-2	Vorinostat	HDAC	Misc	1.735	-0.2557	0.1917	0.0407	2.1116	2.1704	0.99173
50207-2	HCC1419	10161-101-1	Luminespib	HSP90	Misc	0.0069643	-0.2968	0.6506	0.1579	2.0439	0.0087353	0.99699
50207-2	HCC1419	10478-102-1	A-1210477	Mcl-1	Misc	14.536	0.7081	0.0402	0.0018	1.8053	26.3399	0.8672
50207-2	HCC1419	10144-101-3	Olaparib	PARP	Misc	Inf	0.6322	0.0273	-0.0012	2.1535	5.2752	0.95353
50207-2	HCC1419	10482-114-1	Bleomycin	Radiation	Misc	4.4662	0.3545	0.1588	-0.0001	0.8100	4.0786	0.85928
50207-2	HCC1419	10338-101-1	Ipatasertib	AKT	PI3K/mTOR	Inf	0.5051	0.1071	0.0007	1.4251	0.82031	0.95841
50207-2	HCC1419	10233-101-1	Alpelisib	PI3Ka	PI3K/mTOR	0.66882	-0.0020	0.3558	0.0157	0.3922	11.0132	0.94051
50207-2	HCC1419	10445-101-1	Taselisib	PI3Ka, g, d	PI3K/mTOR	0.0091784	-0.4046	0.8523	0.0945	0.5809	0.022714	0.98223
50207-2	HCC1419	10171-101-1	TGX221	PI3Kb	PI3K/mTOR	Inf	0.7941	-0.0049	0.0002	5.0000	3.889	0.79312
50207-2	HCC1419	10080-101-1	Torin2	mTOR/ATM/ATR	PI3K/mTOR	0.0054867	-0.3722	0.6345	0.0796	0.8272	0.0093689	0.98036
50207-2	HCC1419	10235-101-1	Everolimus	mTOR1	PI3K/mTOR	Inf	0.1803	0.7242	0.0249	0.0000	Inf	0.37602
50207-2	HCC1419	10205-101-1	INK-128	mTORC1/2	PI3K/mTOR	0.0047477	-0.1472	0.7635	0.0603	1.3112	0.0056144	0.99448
50207-2	HCC1419	10404-101-1	PF-4708671	p70S6K	PI3K/mTOR	5.2795	0.3488	0.1117	-0.0019	1.0898	4.6502	0.97858
50207-2	HCC1419	10147-101-1	Buparlisib	pan PI3K	PI3K/mTOR	0.39623	-0.4961	0.4499	0.0745	0.8204	1.2651	0.99188
50207-2	HCC1419	10047-101-1	Pictilisib	pan PI3K	PI3K/mTOR	0.17196	-0.2103	0.5118	0.0340	0.5444	0.61152	0.99425
50207-2	HCC1419	10394-101-1	Ceritinib	ALK	RTK	2.6149	-0.8670	0.2083	0.0855	2.5745	4.0066	0.99248
50207-2	HCC1419	10018-101-1	Neratinib	EGFR/HER2	RTK	0.0011485	-0.5015	0.9927	0.1818	0.5367	0.0038194	0.97246
50207-2	HCC1419	10131-101-1	Tivantinib	MET	RTK	0.47955	0.1634	0.2618	0.0408	2.6512	0.40663	0.98985
50207-2	HCC1419	10444-101-1	Cediranib	VEGFR/cKIT	RTK	5.0599	-0.0329	0.0545	0.0124	4.9952	5.1984	0.99032
50207-2	HCC1419	10194-106-1	Cabozantinib	VEGFR2/MET	RTK	10.7779	0.6224	-0.0111	-0.0016	5.0000	12.9768	0.90031
50579-1	HCC1500	10390-103-1	Abemaciclib	CDK4/6	Cell cycle	0.53346	0.2196	0.3452	-0.0085	0.4860	0.1477	0.84102
50579-1	HCC1500	10071-101-1	Palbociclib	CDK4/6	Cell cycle	Inf	0.5744	0.1570	0.0053	2.6346	0.039317	0.93709
50579-1	HCC1500	10006-101-1	AZD7762	CHK1/2	Cell cycle	0.035943	-0.2559	0.6218	0.1217	1.0434	0.037616	0.91391
50579-1	HCC1500	10387-101-1	Volasertib	PLK	Cell cycle	0.011592	0.2861	0.3454	0.0484	5.0000	0.0099361	0.97732
50579-1	HCC1500	10287-101-2	Dinaciclib	pan CDK	Cell cycle	0.013792	-0.5720	0.6616	0.1978	2.3762	0.018927	0.99749
50579-1	HCC1500	10245-999-4	Cisplatin	Chemo	Chemotherapy	3.4531	0.2076	0.1210	-0.0094	5.0000	3.1071	0.92762
50579-1	HCC1500	10248-102-3	Doxorubicin	Chemo	Chemotherapy	0.016258	-0.7134	0.7518	0.1833	0.7212	0.058468	0.98572
50579-1	HCC1500	10102-101-4	Taxol	Chemo	Chemotherapy	0.0038131	-0.0589	0.6182	0.1433	1.8138	0.0038924	0.96247
50579-1	HCC1500	10278-102-2	Topotecan	Topo I	Chemotherapy	0.0054632	-0.8011	1.2171	0.1857	0.7137	0.022012	0.99509
50579-1	HCC1500	10250-101-3	Etoposide	Topo II	Chemotherapy	1.4287	-0.0766	0.2499	-0.0148	1.3319	1.7871	0.95725
50579-1	HCC1500	10020-101-1	Dasatinib	BCR/ABL	MAPK/nRTK	0.0034818	-0.1594	0.9249	0.0829	0.7537	0.0052374	0.99634
50579-1	HCC1500	10142-101-1	Trametinib	MEK	MAPK/nRTK	0.14491	0.3439	0.2190	0.0408	0.9370	0.049167	0.9913
50579-1	HCC1500	10032-101-1	Saracatinib	SRC	MAPK/nRTK	0.25821	-0.1966	0.4364	0.0562	0.5724	0.7598	0.97739
50579-1	HCC1500	10179-101-1	ABT-737	Bcl2/XL	Misc	0.0085142	-0.7359	1.1288	0.3716	0.9283	0.022222	0.99554
50579-1	HCC1500	10282-101-2	Vorinostat	HDAC	Misc	0.95606	-0.5960	0.3173	0.1165	1.0951	2.5286	0.99617
50579-1	HCC1500	10161-101-1	Luminespib	HSP90	Misc	0.0084603	-0.2243	0.5973	0.1676	5.0000	0.009043	0.99641
50579-1	HCC1500	10478-102-1	A-1210477	Mcl-1	Misc	Inf	0.8719	-0.0368	0.0081	0.0000	Inf	0.32761
50579-1	HCC1500	10144-101-3	Olaparib	PARP	Misc	6.3506	0.2744	0.0985	0.0084	1.0887	17.4212	0.94589
50579-1	HCC1500	10482-114-1	Bleomycin	Radiation	Misc	2.3381	0.1740	0.1688	-0.0166	1.0174	2.4596	0.98358
50579-1	HCC1500	10338-101-1	Ipatasertib	AKT	PI3K/mTOR	Inf	1.0500	-0.0314	-0.0045	0.0000	Inf	-1.0541
50579-1	HCC1500	10233-101-1	Alpelisib	PI3Ka	PI3K/mTOR	12.7881	0.5807	0.0302	0.0118	1.1251	18.7215	0.91512
50579-1	HCC1500	10445-101-1	Taselisib	PI3Ka, g, d	PI3K/mTOR	1.8598	-0.2328	0.2303	0.0444	0.8754	6.5237	0.97328
50579-1	HCC1500	10171-101-1	TGX221	PI3Kb	PI3K/mTOR	10.1303	0.5035	0.0860	0.0066	0.8370	24.4491	0.82467
50579-1	HCC1500	10080-101-1	Torin2	mTOR/ATM/ATR	PI3K/mTOR	0.0017504	-0.4967	0.9053	0.2022	1.3577	0.0027734	0.99119
50579-1	HCC1500	10235-101-1	Everolimus	mTOR1	PI3K/mTOR	Inf	-0.3096	1.2601	0.2328	0.0000	Inf	0.51907
50579-1	HCC1500	10205-101-1	INK-128	mTORC1/2	PI3K/mTOR	0.00078427	-0.4693	1.2309	0.2717	1.2780	0.0013303	0.99127
50579-1	HCC1500	10404-101-1	PF-4708671	p70S6K	PI3K/mTOR	1.671	0.0495	0.1975	0.0284	1.0444	2.0815	0.99138
50579-1	HCC1500	10147-101-1	Buparlisib	pan PI3K	PI3K/mTOR	0.20179	-0.5459	0.5351	0.1146	0.8962	0.51424	0.99364
50579-1	HCC1500	10047-101-1	Pictilisib	pan PI3K	PI3K/mTOR	2.3061	-0.1317	0.2108	0.0313	0.8635	8.2307	0.96692
50579-1	HCC1500	10394-101-1	Ceritinib	ALK	RTK	1.4068	-0.9535	0.2988	0.1206	1.5745	2.8266	0.97255
50579-1	HCC1500	10018-101-1	Neratinib	EGFR/HER2	RTK	0.7842	-0.2872	0.1852	0.0616	1.1924	1.9705	0.99465
50579-1	HCC1500	10131-101-1	Tivantinib	MET	RTK	0.11523	-0.3304	0.5109	0.1445	1.9906	0.13024	0.97326
50579-1	HCC1500	10444-101-1	Cediranib	VEGFR/cKIT	RTK	3.8594	-0.8084	0.1304	0.0735	3.4916	5.2864	0.99235
50579-1	HCC1500	10194-106-1	Cabozantinib	VEGFR2/MET	RTK	4.6683	0.1837	0.0599	0.0128	4.9992	4.2912	0.97044
50212-2	HCC1937	10390-103-1	Abemaciclib	CDK4/6	Cell cycle	4.8534	0.3020	0.1062	0.0050	0.9638	6.1622	0.98334
50212-2	HCC1937	10071-101-1	Palbociclib	CDK4/6	Cell cycle	Inf	1.0500	-0.0406	-0.0017	0.0000	Inf	-4.6521
50212-2	HCC1937	10006-101-1	AZD7762	CHK1/2	Cell cycle	0.166	-0.3625	0.4881	0.1939	1.0122	0.26931	0.9768
50212-2	HCC1937	10387-101-1	Volasertib	PLK	Cell cycle	0.011931	-0.1480	0.4968	0.1111	1.6595	0.013417	0.99404
50212-2	HCC1937	10287-101-2	Dinaciclib	pan CDK	Cell cycle	0.021814	-0.2071	0.4822	0.0817	5.0000	0.02333	0.9981
50212-2	HCC1937	10245-999-4	Cisplatin	Chemo	Chemotherapy	0.7769	0.0060	0.3266	0.0782	0.6212	1.7561	0.98656
50212-2	HCC1937	10248-102-3	Doxorubicin	Chemo	Chemotherapy	0.012819	-0.1660	0.5790	0.1786	1.3570	0.012547	0.9584
50212-2	HCC1937	10102-101-4	Taxol	Chemo	Chemotherapy	0.0024514	0.0104	0.6576	0.2104	2.2541	0.0024561	0.99541
50212-2	HCC1937	10278-102-2	Topotecan	Topo I	Chemotherapy	0.0155	-0.4282	0.8369	0.2949	0.6712	0.03544	0.94323
50212-2	HCC1937	10250-101-3	Etoposide	Topo II	Chemotherapy	0.35445	-0.1182	0.3932	0.1412	0.8265	0.49943	0.98817
50212-2	HCC1937	10020-101-1	Dasatinib	BCR/ABL	MAPK/nRTK	0.11264	0.0153	0.4415	0.1071	1.7303	0.097801	0.98944
50212-2	HCC1937	10142-101-1	Trametinib	MEK	MAPK/nRTK	Inf	0.6885	0.1384	0.0485	1.0415	0.012758	0.98277
50212-2	HCC1937	10032-101-1	Saracatinib	SRC	MAPK/nRTK	Inf	0.6508	0.0392	0.0248	1.9114	3.8679	0.97821
50212-2	HCC1937	10179-101-1	ABT-737	Bcl2/XL	Misc	5.7613	0.2685	0.0849	0.0618	1.0314	14.9529	0.9843
50212-2	HCC1937	10282-101-2	Vorinostat	HDAC	Misc	1.9099	-0.0085	0.1933	0.0353	1.4929	2.1786	0.99505
50212-2	HCC1937	10161-101-1	Luminespib	HSP90	Misc	0.011448	-0.1867	0.5478	0.2244	4.8554	0.012181	0.99929
50212-2	HCC1937	10478-102-1	A-1210477	Mcl-1	Misc	Inf	0.7240	0.0060	0.0046	4.0529	5.9209	0.95858
50212-2	HCC1937	10144-101-3	Olaparib	PARP	Misc	26.5474	0.6855	0.0584	0.0092	0.6339	150.1948	0.9681
50212-2	HCC1937	10482-114-1	Bleomycin	Radiation	Misc	0.1866	0.1388	0.4157	0.1325	0.9803	0.14295	0.99691
50212-2	HCC1937	10338-101-1	Ipatasertib	AKT	PI3K/mTOR	Inf	0.5349	0.1565	0.0058	1.0014	0.36202	0.97156
50212-2	HCC1937	10233-101-1	Alpelisib	PI3Ka	PI3K/mTOR	18.8171	0.6577	0.0501	0.0085	0.8078	73.2808	0.94623
50212-2	HCC1937	10445-101-1	Taselisib	PI3Ka, g, d	PI3K/mTOR	1.2267	0.1206	0.2771	0.0422	0.5159	3.7186	0.99159
50212-2	HCC1937	10171-101-1	TGX221	PI3Kb	PI3K/mTOR	Inf	0.8377	0.0202	0.0070	0.6226	52.0493	0.74303
50212-2	HCC1937	10080-101-1	Torin2	mTOR/ATM/ATR	PI3K/mTOR	0.093408	0.0726	0.2910	0.0569	0.5617	0.18674	0.97982
50212-2	HCC1937	10235-101-1	Everolimus	mTOR1	PI3K/mTOR	Inf	0.6324	0.3348	0.0206	0.4211	0.00012787	0.92563
50212-2	HCC1937	10205-101-1	INK-128	mTORC1/2	PI3K/mTOR	0.051498	0.3579	0.3694	0.0196	1.0019	0.011127	0.99251
50212-2	HCC1937	10404-101-1	PF-4708671	p70S6K	PI3K/mTOR	Inf	0.7688	0.0390	0.0001	0.6190	21.7234	0.88762
50212-2	HCC1937	10147-101-1	Buparlisib	pan PI3K	PI3K/mTOR	1.4479	-0.2256	0.2634	0.0691	1.0878	2.8639	0.99474
50212-2	HCC1937	10047-101-1	Pictilisib	pan PI3K	PI3K/mTOR	2.4235	0.2784	0.2110	0.0249	0.5947	2.7026	0.99034
50212-2	HCC1937	10394-101-1	Ceritinib	ALK	RTK	3.5257	-0.5730	0.1368	0.0730	2.2956	5.6897	0.99584
50212-2	HCC1937	10018-101-1	Neratinib	EGFR/HER2	RTK	1.4603	0.2999	0.1711	0.0289	0.5189	12.13	0.97447
50212-2	HCC1937	10131-101-1	Tivantinib	MET	RTK	0.64919	-0.0621	0.2925	0.0799	2.1267	0.69626	0.99463
50212-2	HCC1937	10444-101-1	Cediranib	VEGFR/cKIT	RTK	7.9267	0.2784	0.0440	0.0316	3.5480	8.352	0.99376
50212-2	HCC1937	10194-106-1	Cabozantinib	VEGFR2/MET	RTK	14.4371	0.7602	0.0053	0.0067	4.9892	11.0339	0.95897
50213-3	HCC1954	10390-103-1	Abemaciclib	CDK4/6	Cell cycle	0.30182	-0.5049	0.4578	0.0869	0.4867	2.8851	0.937
50213-3	HCC1954	10071-101-1	Palbociclib	CDK4/6	Cell cycle	Inf	0.5256	0.1839	-0.0048	1.2148	0.056374	0.97285
50213-3	HCC1954	10006-101-1	AZD7762	CHK1/2	Cell cycle	0.12298	-0.3978	0.5593	0.2944	1.4965	0.1737	0.98591
50213-3	HCC1954	10387-101-1	Volasertib	PLK	Cell cycle	0.0065835	-0.1540	0.6139	0.2792	3.4968	0.0071308	0.99812
50213-3	HCC1954	10287-101-2	Dinaciclib	pan CDK	Cell cycle	0.012538	-0.4640	0.6411	0.3049	3.3292	0.015238	0.99808
50213-3	HCC1954	10245-999-4	Cisplatin	Chemo	Chemotherapy	1.2467	-0.0741	0.2747	0.0807	1.1281	1.7233	0.97383
50213-3	HCC1954	10248-102-3	Doxorubicin	Chemo	Chemotherapy	0.0071835	-0.3378	0.7296	0.2544	1.4590	0.0086345	0.96869
50213-3	HCC1954	10102-101-4	Taxol	Chemo	Chemotherapy	0.0024667	-0.3961	0.8347	0.4142	1.6514	0.0034177	0.98666
50213-3	HCC1954	10278-102-2	Topotecan	Topo I	Chemotherapy	0.011912	-0.4011	0.8695	0.3601	0.7510	0.02452	0.96722
50213-3	HCC1954	10250-101-3	Etoposide	Topo II	Chemotherapy	0.17121	-0.2651	0.5015	0.2166	0.9804	0.2578	0.98586
50213-3	HCC1954	10020-101-1	Dasatinib	BCR/ABL	MAPK/nRTK	1.9424	0.2744	0.2026	0.0810	0.7356	1.1887	0.97254
50213-3	HCC1954	10142-101-1	Trametinib	MEK	MAPK/nRTK	0.016729	0.2287	0.4005	0.0565	0.8524	0.0082359	0.9993
50213-3	HCC1954	10032-101-1	Saracatinib	SRC	MAPK/nRTK	2.1208	0.0936	0.1939	0.0551	0.7876	4.0749	0.98936
50213-3	HCC1954	10179-101-1	ABT-737	Bcl2/XL	Misc	9.9512	0.4962	0.0404	0.0618	1.0240	27.9634	0.94601
50213-3	HCC1954	10282-101-2	Vorinostat	HDAC	Misc	1.426	-0.1401	0.2339	0.0833	1.2390	2.0871	0.99732
50213-3	HCC1954	10161-101-1	Luminespib	HSP90	Misc	0.010331	-0.3745	0.6188	0.2958	2.6936	0.012628	0.99618
50213-3	HCC1954	10478-102-1	A-1210477	Mcl-1	Misc	Inf	0.8844	-0.0259	0.0076	0.0000	Inf	0.43063
50213-3	HCC1954	10144-101-3	Olaparib	PARP	Misc	11.1008	0.5266	0.0536	0.0095	1.2000	8.359	0.96291
50213-3	HCC1954	10482-114-1	Bleomycin	Radiation	Misc	0.043847	-0.0884	0.6166	0.2476	0.7506	0.05535	0.98102
50213-3	HCC1954	10338-101-1	Ipatasertib	AKT	PI3K/mTOR	1.4342	0.2509	0.2145	0.0288	0.9249	0.80694	0.98539
50213-3	HCC1954	10233-101-1	Alpelisib	PI3Ka	PI3K/mTOR	1.2292	-0.3408	0.2652	0.1073	0.8509	4.4679	0.99224
50213-3	HCC1954	10445-101-1	Taselisib	PI3Ka, g, d	PI3K/mTOR	0.0070107	-0.3632	0.9490	0.3748	1.0954	0.010784	0.99379
50213-3	HCC1954	10171-101-1	TGX221	PI3Kb	PI3K/mTOR	Inf	0.9607	-0.0374	-0.0050	0.0000	Inf	-1.0282
50213-3	HCC1954	10080-101-1	Torin2	mTOR/ATM/ATR	PI3K/mTOR	0.0096629	-0.3280	0.5536	0.1704	0.7380	0.018218	0.98125
50213-3	HCC1954	10235-101-1	Everolimus	mTOR1	PI3K/mTOR	Inf	0.3263	0.6531	0.1358	0.0000	Inf	0.52018
50213-3	HCC1954	10205-101-1	INK-128	mTORC1/2	PI3K/mTOR	0.014251	-0.0830	0.5651	0.1455	1.3479	0.013876	0.98856
50213-3	HCC1954	10404-101-1	PF-4708671	p70S6K	PI3K/mTOR	Inf	0.8349	-0.0093	-0.0064	1.3800	7.2097	0.65841
50213-3	HCC1954	10147-101-1	Buparlisib	pan PI3K	PI3K/mTOR	0.52073	-0.4576	0.4002	0.1883	1.6194	0.7982	0.9975
50213-3	HCC1954	10047-101-1	Pictilisib	pan PI3K	PI3K/mTOR	0.94449	-0.2272	0.3087	0.1077	0.8502	2.3595	0.9976
50213-3	HCC1954	10394-101-1	Ceritinib	ALK	RTK	2.3105	-0.4446	0.1668	0.0701	2.4217	3.1138	0.99363
50213-3	HCC1954	10018-101-1	Neratinib	EGFR/HER2	RTK	0.067164	-0.0909	0.4293	0.1185	0.6344	0.096489	0.97441
50213-3	HCC1954	10131-101-1	Tivantinib	MET	RTK	0.16715	-0.3846	0.5511	0.2533	1.4818	0.24265	0.99675
50213-3	HCC1954	10444-101-1	Cediranib	VEGFR/cKIT	RTK	4.092	-0.3202	0.0756	0.0534	4.9589	4.5507	0.99308
50213-3	HCC1954	10194-106-1	Cabozantinib	VEGFR2/MET	RTK	10.9106	0.6390	-0.0135	-0.0074	5.0000	13.0234	0.87916
51110-2	CAL-120	10390-103-1	Abemaciclib	CDK4/6	Cell cycle	0.247	-0.1408	0.4780	0.0849	0.3730	4.696	0.95026
51110-2	CAL-120	10071-101-1	Palbociclib	CDK4/6	Cell cycle	Inf	0.6687	0.1422	0.0012	1.4451	0.023318	0.96675
51110-2	CAL-120	10006-101-1	AZD7762	CHK1/2	Cell cycle	0.15216	-0.4949	0.5265	0.2150	1.1035	0.26511	0.97495
51110-2	CAL-120	10387-101-1	Volasertib	PLK	Cell cycle	0.0018536	0.0258	0.6758	0.2649	2.5191	0.001844	0.99276
51110-2	CAL-120	10287-101-2	Dinaciclib	pan CDK	Cell cycle	0.009892	-0.1320	0.5549	0.1203	4.4157	0.010404	0.99947
51110-2	CAL-120	10245-999-4	Cisplatin	Chemo	Chemotherapy	2.9328	0.1876	0.1824	0.0229	0.9231	4.0426	0.98856
51110-2	CAL-120	10248-102-3	Doxorubicin	Chemo	Chemotherapy	0.009438	-0.2475	0.6969	0.1356	1.3775	0.011488	0.99278
51110-2	CAL-120	10102-101-4	Taxol	Chemo	Chemotherapy	0.0028769	-0.1987	0.7463	0.3104	2.6390	0.0032354	0.97877
51110-2	CAL-120	10278-102-2	Topotecan	Topo I	Chemotherapy	0.007493	-0.3364	0.9130	0.2556	1.1649	0.010414	0.97973
51110-2	CAL-120	10250-101-3	Etoposide	Topo II	Chemotherapy	0.47956	-0.1663	0.3810	0.0949	1.2763	0.62593	0.99712
51110-2	CAL-120	10020-101-1	Dasatinib	BCR/ABL	MAPK/nRTK	0.049579	0.1763	0.5193	0.0672	1.3302	0.036844	0.97412
51110-2	CAL-120	10142-101-1	Trametinib	MEK	MAPK/nRTK	0.046732	0.4153	0.2938	0.0276	1.2901	0.011053	0.98433
51110-2	CAL-120	10032-101-1	Saracatinib	SRC	MAPK/nRTK	15.6396	0.5261	0.1730	0.0078	0.3429	33.0327	0.96689
51110-2	CAL-120	10179-101-1	ABT-737	Bcl2/XL	Misc	2.1471	-0.4339	0.1998	0.1107	1.5326	3.968	0.99796
51110-2	CAL-120	10282-101-2	Vorinostat	HDAC	Misc	1.3545	-0.2281	0.2409	0.0682	1.2739	2.1265	0.9951
51110-2	CAL-120	10161-101-1	Luminespib	HSP90	Misc	0.0028134	-0.1149	0.6933	0.1709	1.6073	0.0031386	0.99357
51110-2	CAL-120	10478-102-1	A-1210477	Mcl-1	Misc	Inf	0.9427	0.0152	0.0003	0.0000	Inf	0.34764
51110-2	CAL-120	10144-101-3	Olaparib	PARP	Misc	5.1241	0.2688	0.1427	0.0159	0.7347	22.8567	0.97745
51110-2	CAL-120	10482-114-1	Bleomycin	Radiation	Misc	1.687	0.0886	0.2320	0.0671	0.8116	2.7215	0.99732
51110-2	CAL-120	10338-101-1	Ipatasertib	AKT	PI3K/mTOR	58.682	0.5993	0.1297	-0.0033	0.4437	5.6283	0.9635
51110-2	CAL-120	10233-101-1	Alpelisib	PI3Ka	PI3K/mTOR	21.5328	0.6075	0.0922	-0.0015	0.5034	190.956	0.93579
51110-2	CAL-120	10445-101-1	Taselisib	PI3Ka, g, d	PI3K/mTOR	2.5327	0.1514	0.2349	0.0129	0.4887	23.9822	0.95866
51110-2	CAL-120	10171-101-1	TGX221	PI3Kb	PI3K/mTOR	Inf	1.0198	-0.0168	-0.0059	0.0000	Inf	-0.45144
51110-2	CAL-120	10080-101-1	Torin2	mTOR/ATM/ATR	PI3K/mTOR	0.010544	-0.0115	0.4872	0.0485	1.2658	0.010318	0.99716
51110-2	CAL-120	10235-101-1	Everolimus	mTOR1	PI3K/mTOR	Inf	0.5275	0.4163	-0.0050	0.1797	1.1993e-05	0.81569
51110-2	CAL-120	10205-101-1	INK-128	mTORC1/2	PI3K/mTOR	0.011487	-0.0097	0.6018	0.0545	1.3448	0.011154	0.99759
51110-2	CAL-120	10404-101-1	PF-4708671	p70S6K	PI3K/mTOR	Inf	0.9240	0.0139	-0.0025	0.0000	Inf	0.39826
51110-2	CAL-120	10147-101-1	Buparlisib	pan PI3K	PI3K/mTOR	0.70223	-0.2717	0.3393	0.0962	0.9615	1.3908	0.99923
51110-2	CAL-120	10047-101-1	Pictilisib	pan PI3K	PI3K/mTOR	2.072	0.1944	0.2550	0.0144	0.4073	30.7541	0.99232
51110-2	CAL-120	10394-101-1	Ceritinib	ALK	RTK	0.79939	-0.4322	0.3366	0.1170	1.0290	1.7983	0.99115
51110-2	CAL-120	10018-101-1	Neratinib	EGFR/HER2	RTK	0.59003	-0.2607	0.2238	0.0655	0.9310	1.9202	0.98923
51110-2	CAL-120	10131-101-1	Tivantinib	MET	RTK	0.25132	-0.2562	0.4649	0.1572	1.1267	0.37355	0.99876
51110-2	CAL-120	10444-101-1	Cediranib	VEGFR/cKIT	RTK	1.037	-0.1243	0.2989	0.0564	0.5757	6.9922	0.99099
51110-2	CAL-120	10194-106-1	Cabozantinib	VEGFR2/MET	RTK	7.3417	0.2574	0.0848	0.0071	1.8478	13.277	0.98262
51112-2	CAL-85-1	10390-103-1	Abemaciclib	CDK4/6	Cell cycle	1.3003	-0.2236	0.2357	0.0485	2.1239	1.5776	0.99317
51112-2	CAL-85-1	10071-101-1	Palbociclib	CDK4/6	Cell cycle	Inf	1.0500	-0.0418	-0.0009	0.0000	Inf	-4.681
51112-2	CAL-85-1	10006-101-1	AZD7762	CHK1/2	Cell cycle	0.040606	-0.3218	0.7076	0.2631	1.6067	0.053833	0.98746
51112-2	CAL-85-1	10387-101-1	Volasertib	PLK	Cell cycle	0.0032652	-0.2891	0.7316	0.1652	2.0442	0.0039314	0.99429
51112-2	CAL-85-1	10287-101-2	Dinaciclib	pan CDK	Cell cycle	0.0046904	-0.2406	0.6880	0.1122	2.1120	0.005589	0.99744
51112-2	CAL-85-1	10245-999-4	Cisplatin	Chemo	Chemotherapy	1.0309	0.0180	0.2294	0.0709	1.5157	1.0419	0.99209
51112-2	CAL-85-1	10248-102-3	Doxorubicin	Chemo	Chemotherapy	0.0055249	-0.3783	0.8476	0.2160	1.2228	0.008362	0.98762
51112-2	CAL-85-1	10102-101-4	Taxol	Chemo	Chemotherapy	0.0027273	-0.3464	0.7931	0.3351	2.0210	0.0033785	0.95638
51112-2	CAL-85-1	10278-102-2	Topotecan	Topo I	Chemotherapy	0.015768	-0.2957	0.8426	0.2732	1.2311	0.02233	0.99293
51112-2	CAL-85-1	10250-101-3	Etoposide	Topo II	Chemotherapy	0.41623	-0.2411	0.4065	0.1218	1.3731	0.57431	0.99814
51112-2	CAL-85-1	10020-101-1	Dasatinib	BCR/ABL	MAPK/nRTK	0.10548	-0.2438	0.5705	0.2154	1.9425	0.12743	0.99128
51112-2	CAL-85-1	10142-101-1	Trametinib	MEK	MAPK/nRTK	0.013202	0.2343	0.4101	0.1186	0.9630	0.007054	0.99004
51112-2	CAL-85-1	10032-101-1	Saracatinib	SRC	MAPK/nRTK	0.87395	0.1156	0.2171	0.0941	1.9351	0.73844	0.98771
51112-2	CAL-85-1	10179-101-1	ABT-737	Bcl2/XL	Misc	Inf	0.9343	-0.0283	0.0138	0.0000	Inf	-0.025903
51112-2	CAL-85-1	10282-101-2	Vorinostat	HDAC	Misc	1.1999	-0.1827	0.2194	0.0392	1.8241	1.4346	0.98796
51112-2	CAL-85-1	10161-101-1	Luminespib	HSP90	Misc	0.006517	-0.3836	0.7497	0.3002	4.8089	0.0073269	0.99963
51112-2	CAL-85-1	10478-102-1	A-1210477	Mcl-1	Misc	Inf	1.0052	0.0109	0.0047	0.0000	Inf	0.20764
51112-2	CAL-85-1	10144-101-3	Olaparib	PARP	Misc	5.0606	0.3870	0.1367	0.0158	0.7846	3.2235	0.97652
51112-2	CAL-85-1	10482-114-1	Bleomycin	Radiation	Misc	0.45343	-0.1075	0.3850	0.1072	0.7086	0.91411	0.99198
51112-2	CAL-85-1	10338-101-1	Ipatasertib	AKT	PI3K/mTOR	Inf	0.4714	0.1662	-0.0047	1.3900	0.27338	0.96561
51112-2	CAL-85-1	10233-101-1	Alpelisib	PI3Ka	PI3K/mTOR	3.6425	0.2928	0.1938	0.0110	0.4506	41.7026	0.9641
51112-2	CAL-85-1	10445-101-1	Taselisib	PI3Ka, g, d	PI3K/mTOR	0.06039	-0.0171	0.5499	0.0664	0.4393	0.084981	0.97865
51112-2	CAL-85-1	10171-101-1	TGX221	PI3Kb	PI3K/mTOR	Inf	0.9895	-0.0309	0.0002	0.0000	Inf	-1.0218
51112-2	CAL-85-1	10080-101-1	Torin2	mTOR/ATM/ATR	PI3K/mTOR	0.0086205	-0.1543	0.5396	0.0780	0.8828	0.01093	0.99167
51112-2	CAL-85-1	10235-101-1	Everolimus	mTOR1	PI3K/mTOR	0.0015471	0.3707	0.5762	0.0915	5.0000	0.0011149	0.86907
51112-2	CAL-85-1	10205-101-1	INK-128	mTORC1/2	PI3K/mTOR	0.0088347	0.0160	0.6258	0.0624	1.3592	0.0084516	0.99836
51112-2	CAL-85-1	10404-101-1	PF-4708671	p70S6K	PI3K/mTOR	Inf	1.0208	-0.0232	0.0035	0.0000	Inf	-0.61108
51112-2	CAL-85-1	10147-101-1	Buparlisib	pan PI3K	PI3K/mTOR	0.34255	-0.3199	0.4420	0.1137	0.9213	0.69609	0.99686
51112-2	CAL-85-1	10047-101-1	Pictilisib	pan PI3K	PI3K/mTOR	0.64687	-0.0252	0.3599	0.0411	0.3938	10.5271	0.97679
51112-2	CAL-85-1	10394-101-1	Ceritinib	ALK	RTK	0.74024	-0.5961	0.3725	0.0586	0.9797	2.2143	0.9988
51112-2	CAL-85-1	10018-101-1	Neratinib	EGFR/HER2	RTK	0.033863	-0.3264	0.5379	0.1694	0.6592	0.072972	0.9766
51112-2	CAL-85-1	10131-101-1	Tivantinib	MET	RTK	0.19824	-0.3263	0.5188	0.1982	1.5649	0.27534	0.99663
51112-2	CAL-85-1	10444-101-1	Cediranib	VEGFR/cKIT	RTK	2.4003	-0.2379	0.1869	0.0514	1.1002	6.5151	0.99569
51112-2	CAL-85-1	10194-106-1	Cabozantinib	VEGFR2/MET	RTK	5.3386	0.1728	0.1229	0.0278	1.1624	13.7367	0.96943
50205-2	HCC1143	10390-103-1	Abemaciclib	CDK4/6	Cell cycle	0.07025	-0.0787	0.5407	0.0153	0.5300	0.09592	0.97963
50205-2	HCC1143	10071-101-1	Palbociclib	CDK4/6	Cell cycle	0.27702	0.2820	0.2546	-0.0033	0.9158	0.11143	0.98993
50205-2	HCC1143	10006-101-1	AZD7762	CHK1/2	Cell cycle	0.05422	-0.3693	0.6563	0.2192	1.8612	0.067869	0.988
50205-2	HCC1143	10387-101-1	Volasertib	PLK	Cell cycle	0.0045882	-0.3453	0.7290	0.2418	1.8336	0.005996	0.99928
50205-2	HCC1143	10287-101-2	Dinaciclib	pan CDK	Cell cycle	0.015148	-0.2527	0.5451	0.1106	5.0000	0.016398	0.9989
50205-2	HCC1143	10245-999-4	Cisplatin	Chemo	Chemotherapy	0.83695	0.0754	0.3041	0.0403	1.3278	0.83273	0.96685
50205-2	HCC1143	10248-102-3	Doxorubicin	Chemo	Chemotherapy	0.0092688	-0.2511	0.7180	0.1402	1.1622	0.012302	0.98917
50205-2	HCC1143	10102-101-4	Taxol	Chemo	Chemotherapy	0.0020688	-0.3349	0.8388	0.3074	2.5955	0.0024565	0.99279
50205-2	HCC1143	10278-102-2	Topotecan	Topo I	Chemotherapy	0.0094142	-0.4304	0.9040	0.3002	1.1711	0.013874	0.94725
50205-2	HCC1143	10250-101-3	Etoposide	Topo II	Chemotherapy	0.46267	-0.1664	0.3837	0.1279	1.8259	0.55287	0.99758
50205-2	HCC1143	10020-101-1	Dasatinib	BCR/ABL	MAPK/nRTK	0.13934	0.2573	0.4469	0.1044	0.5121	0.046932	0.96213
50205-2	HCC1143	10142-101-1	Trametinib	MEK	MAPK/nRTK	0.0088297	-0.0225	0.5379	0.1187	0.5756	0.013291	0.99613
50205-2	HCC1143	10032-101-1	Saracatinib	SRC	MAPK/nRTK	3.0304	0.3881	0.2375	0.0437	0.4638	1.6973	0.97807
50205-2	HCC1143	10179-101-1	ABT-737	Bcl2/XL	Misc	6.1992	0.3758	0.1027	0.0110	0.8672	8.5825	0.98522
50205-2	HCC1143	10282-101-2	Vorinostat	HDAC	Misc	0.91041	-0.2533	0.2953	0.0977	1.9423	1.1249	0.99293
50205-2	HCC1143	10161-101-1	Luminespib	HSP90	Misc	0.0039434	-0.1922	0.7017	0.1659	3.6671	0.0042921	0.99512
50205-2	HCC1143	10478-102-1	A-1210477	Mcl-1	Misc	16.3987	0.6719	0.0640	0.0008	1.0821	44.847	0.81227
50205-2	HCC1143	10144-101-3	Olaparib	PARP	Misc	8.8262	0.4562	0.0925	0.0158	0.7545	37.8573	0.98047
50205-2	HCC1143	10482-114-1	Bleomycin	Radiation	Misc	0.04818	-0.2085	0.6578	0.1955	1.0629	0.066427	0.9974
50205-2	HCC1143	10338-101-1	Ipatasertib	AKT	PI3K/mTOR	80.6794	0.7509	0.0662	-0.0023	0.4354	999.9134	0.83579
50205-2	HCC1143	10233-101-1	Alpelisib	PI3Ka	PI3K/mTOR	9.8836	0.4797	0.1743	0.0189	0.3582	212.3193	0.93833
50205-2	HCC1143	10445-101-1	Taselisib	PI3Ka, g, d	PI3K/mTOR	0.21535	-0.0942	0.4758	0.0890	0.3239	6.4012	0.99147
50205-2	HCC1143	10171-101-1	TGX221	PI3Kb	PI3K/mTOR	Inf	0.9185	0.0347	0.0040	4.9981	0.020639	0.76284
50205-2	HCC1143	10080-101-1	Torin2	mTOR/ATM/ATR	PI3K/mTOR	0.044657	-0.1535	0.3642	0.0851	1.0643	0.061723	0.99242
50205-2	HCC1143	10235-101-1	Everolimus	mTOR1	PI3K/mTOR	Inf	0.5574	0.3426	0.0295	0.1006	0.071342	0.79962
50205-2	HCC1143	10205-101-1	INK-128	mTORC1/2	PI3K/mTOR	0.04046	0.0314	0.4743	0.0660	0.7035	0.039906	0.9903
50205-2	HCC1143	10404-101-1	PF-4708671	p70S6K	PI3K/mTOR	Inf	0.7394	0.0639	0.0042	0.6101	17.8472	0.96209
50205-2	HCC1143	10147-101-1	Buparlisib	pan PI3K	PI3K/mTOR	0.7249	-0.4360	0.3915	0.1265	1.3299	1.2866	0.98685
50205-2	HCC1143	10047-101-1	Pictilisib	pan PI3K	PI3K/mTOR	0.97831	-0.1291	0.3201	0.0583	0.5213	8.0489	0.97859
50205-2	HCC1143	10394-101-1	Ceritinib	ALK	RTK	1.4479	-0.4219	0.2848	0.0621	1.0347	4.1868	0.99172
50205-2	HCC1143	10018-101-1	Neratinib	EGFR/HER2	RTK	0.67229	0.0791	0.2379	0.0489	0.5527	4.9078	0.98415
50205-2	HCC1143	10131-101-1	Tivantinib	MET	RTK	0.27789	-0.3122	0.4977	0.1369	1.9433	0.35725	0.99341
50205-2	HCC1143	10444-101-1	Cediranib	VEGFR/cKIT	RTK	3.7314	0.0093	0.1653	0.0292	1.0590	10.5294	0.98332
50205-2	HCC1143	10194-106-1	Cabozantinib	VEGFR2/MET	RTK	10.6105	0.5122	0.1025	0.0156	0.9383	34.2157	0.84631
51136-1	PDXHCI002	10390-103-1	Abemaciclib	CDK4/6	Cell cycle	0.047944	-0.6767	0.7662	0.1664	0.6873	0.18848	0.98885
51136-1	PDXHCI002	10071-101-1	Palbociclib	CDK4/6	Cell cycle	0.12955	0.2766	0.2793	-0.0122	1.1851	0.053617	0.97783
51136-1	PDXHCI002	10006-101-1	AZD7762	CHK1/2	Cell cycle	0.067995	-0.5815	0.7079	0.2347	0.8162	0.19222	0.98921
51136-1	PDXHCI002	10387-101-1	Volasertib	PLK	Cell cycle	0.0037003	-0.5892	0.8480	0.3925	4.6276	0.0042869	0.99531
51136-1	PDXHCI002	10287-101-2	Dinaciclib	pan CDK	Cell cycle	0.012194	-0.3607	0.6030	0.2029	4.6252	0.01372	0.99728
51136-1	PDXHCI002	10245-999-4	Cisplatin	Chemo	Chemotherapy	1.7306	-0.0985	0.2044	-0.0257	1.2874	2.4053	0.98631
51136-1	PDXHCI002	10248-102-3	Doxorubicin	Chemo	Chemotherapy	0.0040539	-0.6545	0.9685	0.2951	0.9297	0.0087544	0.98094
51136-1	PDXHCI002	10102-101-4	Taxol	Chemo	Chemotherapy	0.0024935	-0.5117	0.9207	0.3881	2.7479	0.0031656	0.99139
51136-1	PDXHCI002	10278-102-2	Topotecan	Topo I	Chemotherapy	0.0066461	-0.7006	1.0199	0.1157	0.8130	0.015555	0.94766
51136-1	PDXHCI002	10250-101-3	Etoposide	Topo II	Chemotherapy	0.18199	-0.1795	0.4902	-0.0311	1.1589	0.23962	0.98993
51136-1	PDXHCI002	10020-101-1	Dasatinib	BCR/ABL	MAPK/nRTK	0.50855	0.0322	0.3757	0.0065	0.4070	3.0924	0.95256
51136-1	PDXHCI002	10142-101-1	Trametinib	MEK	MAPK/nRTK	Inf	0.6425	0.1995	0.0041	1.2187	0.0050548	0.98796
51136-1	PDXHCI002	10032-101-1	Saracatinib	SRC	MAPK/nRTK	0.080448	0.0015	0.5120	0.0185	0.6754	0.078329	0.98663
51136-1	PDXHCI002	10179-101-1	ABT-737	Bcl2/XL	Misc	5.6112	0.1456	0.0694	0.0306	1.3811	12.4316	0.97863
51136-1	PDXHCI002	10282-101-2	Vorinostat	HDAC	Misc	0.28215	-0.5830	0.5449	0.2572	1.5567	0.47533	0.99111
51136-1	PDXHCI002	10161-101-1	Luminespib	HSP90	Misc	0.0043954	-0.2805	0.7099	0.1525	3.6850	0.0049332	0.9976
51136-1	PDXHCI002	10478-102-1	A-1210477	Mcl-1	Misc	Inf	0.9814	-0.0380	0.0049	0.0000	Inf	-2.2577
51136-1	PDXHCI002	10144-101-3	Olaparib	PARP	Misc	3.9307	0.2648	0.1679	0.0173	0.5697	27.0413	0.98896
51136-1	PDXHCI002	10482-114-1	Bleomycin	Radiation	Misc	1.1636	-0.1199	0.2715	-0.0373	0.9659	2.0671	0.9892
51136-1	PDXHCI002	10338-101-1	Ipatasertib	AKT	PI3K/mTOR	Inf	1.0500	-0.0488	-0.0112	0.0000	Inf	-59.6281
51136-1	PDXHCI002	10233-101-1	Alpelisib	PI3Ka	PI3K/mTOR	30.4631	0.6296	0.0630	-0.0034	0.7047	10.7379	0.92415
51136-1	PDXHCI002	10445-101-1	Taselisib	PI3Ka, g, d	PI3K/mTOR	0.6002	-0.1369	0.3740	0.0320	0.4025	9.1998	0.95462
51136-1	PDXHCI002	10171-101-1	TGX221	PI3Kb	PI3K/mTOR	Inf	0.8545	-0.0204	-0.0045	5.0000	4.5889	0.61889
51136-1	PDXHCI002	10080-101-1	Torin2	mTOR/ATM/ATR	PI3K/mTOR	0.12881	-0.1017	0.2036	0.0001	1.3377	0.15771	0.9736
51136-1	PDXHCI002	10235-101-1	Everolimus	mTOR1	PI3K/mTOR	Inf	0.9869	-0.0453	-0.0479	0.0000	Inf	-4.5815
51136-1	PDXHCI002	10205-101-1	INK-128	mTORC1/2	PI3K/mTOR	0.20621	0.2290	0.2366	-0.0367	1.3099	0.11357	0.97533
51136-1	PDXHCI002	10404-101-1	PF-4708671	p70S6K	PI3K/mTOR	Inf	0.8732	-0.0268	-0.0011	0.0000	Inf	0.45924
51136-1	PDXHCI002	10147-101-1	Buparlisib	pan PI3K	PI3K/mTOR	1.4379	-0.4797	0.2447	0.1228	3.2385	1.7721	0.99509
51136-1	PDXHCI002	10047-101-1	Pictilisib	pan PI3K	PI3K/mTOR	2.2488	-0.0101	0.2122	0.0264	0.6580	11.9412	0.96622
51136-1	PDXHCI002	10394-101-1	Ceritinib	ALK	RTK	0.33749	-0.6341	0.5101	0.1873	1.5133	0.59866	0.99609
51136-1	PDXHCI002	10018-101-1	Neratinib	EGFR/HER2	RTK	0.16177	-0.1614	0.3672	0.0401	0.5156	0.9064	0.97354
51136-1	PDXHCI002	10131-101-1	Tivantinib	MET	RTK	0.23837	-0.4868	0.5347	0.2564	2.4382	0.31389	0.99794
51136-1	PDXHCI002	10444-101-1	Cediranib	VEGFR/cKIT	RTK	1.4694	-0.4324	0.2592	0.0666	0.9820	4.4977	0.98683
51136-1	PDXHCI002	10194-106-1	Cabozantinib	VEGFR2/MET	RTK	7.2097	0.2341	0.0443	0.0248	1.8969	12.8614	0.98302
51082-2	SUM149PT	10390-103-1	Abemaciclib	CDK4/6	Cell cycle	0.6361	0.0949	0.3411	0.0126	0.4432	1.358	0.96302
51082-2	SUM149PT	10071-101-1	Palbociclib	CDK4/6	Cell cycle	Inf	0.4873	0.1904	0.0015	1.0410	0.074418	0.98402
51082-2	SUM149PT	10006-101-1	AZD7762	CHK1/2	Cell cycle	0.076952	-0.4731	0.6669	0.3256	2.0090	0.10282	0.99241
51082-2	SUM149PT	10387-101-1	Volasertib	PLK	Cell cycle	0.011968	-0.3041	0.5727	0.2215	2.4715	0.014187	0.99692
51082-2	SUM149PT	10287-101-2	Dinaciclib	pan CDK	Cell cycle	0.013311	-0.5676	0.6891	0.3611	4.0226	0.016068	0.99946
51082-2	SUM149PT	10245-999-4	Cisplatin	Chemo	Chemotherapy	0.57047	-0.2290	0.3547	0.1535	0.9378	0.98129	0.99267
51082-2	SUM149PT	10248-102-3	Doxorubicin	Chemo	Chemotherapy	0.0081537	-0.3172	0.7479	0.2385	1.2885	0.010846	0.97733
51082-2	SUM149PT	10102-101-4	Taxol	Chemo	Chemotherapy	0.0015927	-0.2583	0.8405	0.3816	3.1045	0.0017914	0.99574
51082-2	SUM149PT	10278-102-2	Topotecan	Topo I	Chemotherapy	0.0056894	-0.4596	0.9408	0.4257	1.0455	0.0084398	0.94
51082-2	SUM149PT	10250-101-3	Etoposide	Topo II	Chemotherapy	0.12658	-0.1961	0.5269	0.2243	1.3281	0.1575	0.99818
51082-2	SUM149PT	10020-101-1	Dasatinib	BCR/ABL	MAPK/nRTK	0.08634	-0.1819	0.5341	0.1716	0.9560	0.10672	0.98352
51082-2	SUM149PT	10142-101-1	Trametinib	MEK	MAPK/nRTK	0.011187	0.2403	0.3945	0.0459	1.4411	0.0067433	0.99389
51082-2	SUM149PT	10032-101-1	Saracatinib	SRC	MAPK/nRTK	2.4005	0.1835	0.1378	0.0347	1.6265	1.991	0.98615
51082-2	SUM149PT	10179-101-1	ABT-737	Bcl2/XL	Misc	3.4891	-0.2913	0.1507	0.1119	1.5959	6.9452	0.99743
51082-2	SUM149PT	10282-101-2	Vorinostat	HDAC	Misc	1.3518	-0.0716	0.2279	0.0446	1.5465	1.5699	0.9993
51082-2	SUM149PT	10161-101-1	Luminespib	HSP90	Misc	0.005116	-0.3912	0.7555	0.3563	2.6742	0.0063272	0.99952
51082-2	SUM149PT	10478-102-1	A-1210477	Mcl-1	Misc	6.739	0.3670	0.0401	0.0212	3.5192	5.1433	0.99123
51082-2	SUM149PT	10144-101-3	Olaparib	PARP	Misc	3.9064	0.2077	0.1842	0.0580	0.6218	22.8637	0.96271
51082-2	SUM149PT	10482-114-1	Bleomycin	Radiation	Misc	0.038963	-0.3154	0.6829	0.2765	0.9065	0.060428	0.99208
51082-2	SUM149PT	10338-101-1	Ipatasertib	AKT	PI3K/mTOR	4.6451	0.2929	0.1261	0.0067	0.9023	6.7816	0.99801
51082-2	SUM149PT	10233-101-1	Alpelisib	PI3Ka	PI3K/mTOR	Inf	0.8446	0.0387	0.0076	0.5903	8.2866	0.80431
51082-2	SUM149PT	10445-101-1	Taselisib	PI3Ka, g, d	PI3K/mTOR	2.4708	-0.2343	0.2099	0.0774	1.0520	7.0204	0.98198
51082-2	SUM149PT	10171-101-1	TGX221	PI3Kb	PI3K/mTOR	Inf	1.0138	-0.0216	0.0006	0.0000	Inf	-4.4171
51082-2	SUM149PT	10080-101-1	Torin2	mTOR/ATM/ATR	PI3K/mTOR	0.14108	0.0001	0.2579	0.0501	0.5792	0.76606	0.99281
51082-2	SUM149PT	10235-101-1	Everolimus	mTOR1	PI3K/mTOR	Inf	0.7389	0.2003	0.0098	0.2094	0.00021362	0.67353
51082-2	SUM149PT	10205-101-1	INK-128	mTORC1/2	PI3K/mTOR	0.16131	0.2613	0.3199	0.0092	0.6928	0.056936	0.98747
51082-2	SUM149PT	10404-101-1	PF-4708671	p70S6K	PI3K/mTOR	20.5582	0.7287	0.0241	0.0090	1.0700	53.3219	0.95776
51082-2	SUM149PT	10147-101-1	Buparlisib	pan PI3K	PI3K/mTOR	1.4121	-0.3357	0.2539	0.1216	1.9093	1.9133	0.99941
51082-2	SUM149PT	10047-101-1	Pictilisib	pan PI3K	PI3K/mTOR	5.8499	0.3333	0.1214	0.0038	0.7167	27.0916	0.9899
51082-2	SUM149PT	10394-101-1	Ceritinib	ALK	RTK	1.6908	-0.4396	0.2518	0.1219	2.1905	2.3199	0.99787
51082-2	SUM149PT	10018-101-1	Neratinib	EGFR/HER2	RTK	0.067993	0.1521	0.3623	0.0339	1.2974	0.048589	0.99455
51082-2	SUM149PT	10131-101-1	Tivantinib	MET	RTK	0.27624	-0.2313	0.4502	0.1850	2.3039	0.32281	0.99937
51082-2	SUM149PT	10444-101-1	Cediranib	VEGFR/cKIT	RTK	5.5644	0.0656	0.0552	0.0262	2.8599	6.1559	0.99049
51082-2	SUM149PT	10194-106-1	Cabozantinib	VEGFR2/MET	RTK	5.7589	0.2895	0.0383	0.0198	4.7896	4.9143	0.99303
50541-3	T47D	10390-103-1	Abemaciclib	CDK4/6	Cell cycle	0.0042816	-0.0412	0.7664	0.0265	1.3858	0.0037683	0.95899
50541-3	T47D	10071-101-1	Palbociclib	CDK4/6	Cell cycle	0.027507	0.1166	0.4501	0.0077	1.5536	0.022367	0.99262
50541-3	T47D	10006-101-1	AZD7762	CHK1/2	Cell cycle	2.3432	-0.0573	0.1322	0.0195	2.6709	2.4809	0.98871
50541-3	T47D	10387-101-1	Volasertib	PLK	Cell cycle	0.031411	-0.1585	0.3959	0.0580	1.7544	0.036365	0.99393
50541-3	T47D	10287-101-2	Dinaciclib	pan CDK	Cell cycle	0.019853	-0.2109	0.4815	0.0484	5.0000	0.021113	0.99494
50541-3	T47D	10245-999-4	Cisplatin	Chemo	Chemotherapy	1.5698	0.1019	0.2147	0.0055	1.3290	1.5705	0.98121
50541-3	T47D	10248-102-3	Doxorubicin	Chemo	Chemotherapy	0.0018887	-0.3611	0.9189	0.1014	1.2268	0.0024801	0.96538
50541-3	T47D	10102-101-4	Taxol	Chemo	Chemotherapy	0.0035285	-0.1337	0.6636	0.2505	2.2353	0.0038792	0.99665
50541-3	T47D	10278-102-2	Topotecan	Topo I	Chemotherapy	0.0052275	-0.1971	0.9594	0.1261	1.3094	0.0068541	0.99083
50541-3	T47D	10250-101-3	Etoposide	Topo II	Chemotherapy	0.041662	-0.1861	0.6661	0.0533	1.1976	0.051932	0.98563
50541-3	T47D	10020-101-1	Dasatinib	BCR/ABL	MAPK/nRTK	12.5697	0.4961	0.1933	0.0086	0.2753	679.7315	0.95229
50541-3	T47D	10142-101-1	Trametinib	MEK	MAPK/nRTK	Inf	0.5801	0.2130	0.0041	0.9941	0.0048584	0.90394
50541-3	T47D	10032-101-1	Saracatinib	SRC	MAPK/nRTK	3.9647	0.3892	0.1722	0.0087	0.6928	1.6318	0.9752
50541-3	T47D	10179-101-1	ABT-737	Bcl2/XL	Misc	12.2023	0.5888	0.0010	0.0084	2.2890	9.7541	0.92156
50541-3	T47D	10282-101-2	Vorinostat	HDAC	Misc	1.8007	-0.1567	0.1750	0.0409	2.2684	2.0704	0.99157
50541-3	T47D	10161-101-1	Luminespib	HSP90	Misc	0.0060689	0.0212	0.5165	0.0278	4.3267	0.0059347	0.99479
50541-3	T47D	10478-102-1	A-1210477	Mcl-1	Misc	Inf	0.5752	0.0227	0.0055	5.0000	3.7781	0.96287
50541-3	T47D	10144-101-3	Olaparib	PARP	Misc	Inf	0.5304	0.0302	0.0015	4.9632	3.5388	0.95841
50541-3	T47D	10482-114-1	Bleomycin	Radiation	Misc	0.19877	-0.0840	0.4615	0.0190	0.9701	0.24632	0.9812
50541-3	T47D	10338-101-1	Ipatasertib	AKT	PI3K/mTOR	0.13653	0.1331	0.4303	0.0112	1.0853	0.10541	0.99474
50541-3	T47D	10233-101-1	Alpelisib	PI3Ka	PI3K/mTOR	0.15284	-0.0332	0.4568	0.0181	0.7816	0.17573	0.98947
50541-3	T47D	10445-101-1	Taselisib	PI3Ka, g, d	PI3K/mTOR	0.0017858	-0.1047	0.8990	0.0550	1.1740	0.0018197	0.97255
50541-3	T47D	10171-101-1	TGX221	PI3Kb	PI3K/mTOR	Inf	0.7986	-0.0066	-0.0002	2.2233	4.3807	0.7868
50541-3	T47D	10080-101-1	Torin2	mTOR/ATM/ATR	PI3K/mTOR	0.0060179	0.0099	0.5239	0.0218	1.4244	0.0056296	0.99382
50541-3	T47D	10235-101-1	Everolimus	mTOR1	PI3K/mTOR	-Inf	0.2975	0.6157	0.0150	0.1000	5.9599e-07	0.77906
50541-3	T47D	10205-101-1	INK-128	mTORC1/2	PI3K/mTOR	0.0052554	-0.0486	0.6885	0.0237	1.4713	0.0052599	0.99662
50541-3	T47D	10404-101-1	PF-4708671	p70S6K	PI3K/mTOR	3.7629	0.3659	0.1275	0.0024	1.0704	1.8083	0.98136
50541-3	T47D	10147-101-1	Buparlisib	pan PI3K	PI3K/mTOR	0.24826	-0.4183	0.4821	0.0867	0.7426	0.73229	0.99516
50541-3	T47D	10047-101-1	Pictilisib	pan PI3K	PI3K/mTOR	0.15529	-0.1470	0.4772	0.0336	0.7031	0.2394	0.99267
50541-3	T47D	10394-101-1	Ceritinib	ALK	RTK	1.5629	-0.8550	0.3123	0.1208	1.6029	3.1015	0.97809
50541-3	T47D	10018-101-1	Neratinib	EGFR/HER2	RTK	0.42314	0.1949	0.2741	0.0059	0.4966	0.81232	0.9874
50541-3	T47D	10131-101-1	Tivantinib	MET	RTK	0.3478	-0.1544	0.3824	0.1267	3.7033	0.37139	0.99567
50541-3	T47D	10444-101-1	Cediranib	VEGFR/cKIT	RTK	4.1027	-0.6403	0.1246	0.0754	2.9281	5.9706	0.99504
50541-3	T47D	10194-106-1	Cabozantinib	VEGFR2/MET	RTK	7.8808	0.3126	0.0578	0.0045	1.8911	14.0627	0.99417
50131-2	CAMA-1	10390-103-1	Abemaciclib	CDK4/6	Cell cycle	0.007859	0.2222	0.6130	-0.0040	1.3608	0.0046978	0.97968
50131-2	CAMA-1	10071-101-1	Palbociclib	CDK4/6	Cell cycle	0.074216	0.2816	0.3530	-0.0016	1.1861	0.038743	0.99185
50131-2	CAMA-1	10006-101-1	AZD7762	CHK1/2	Cell cycle	0.25282	-0.0865	0.4185	0.0673	1.0859	0.30852	0.99437
50131-2	CAMA-1	10387-101-1	Volasertib	PLK	Cell cycle	0.0078167	-0.2965	0.6740	0.2054	3.0791	0.009001	0.98295
50131-2	CAMA-1	10287-101-2	Dinaciclib	pan CDK	Cell cycle	0.014558	-0.4849	0.6062	0.1927	2.0283	0.019954	0.99839
50131-2	CAMA-1	10245-999-4	Cisplatin	Chemo	Chemotherapy	0.91281	-0.0042	0.3350	0.0351	0.4780	9.0889	0.95264
50131-2	CAMA-1	10248-102-3	Doxorubicin	Chemo	Chemotherapy	0.0074655	-0.6517	0.8426	0.2593	0.7583	0.020458	0.96039
50131-2	CAMA-1	10102-101-4	Taxol	Chemo	Chemotherapy	0.0022699	-0.4944	0.9525	0.3547	2.4920	0.0029769	0.99478
50131-2	CAMA-1	10278-102-2	Topotecan	Topo I	Chemotherapy	0.0032129	-0.4230	1.0539	0.2099	1.1100	0.0049245	0.96968
50131-2	CAMA-1	10250-101-3	Etoposide	Topo II	Chemotherapy	0.15466	-0.4476	0.5722	0.1479	1.3512	0.24426	0.99498
50131-2	CAMA-1	10020-101-1	Dasatinib	BCR/ABL	MAPK/nRTK	Inf	0.6790	0.1521	-0.0025	0.1987	999.7954	0.90943
50131-2	CAMA-1	10142-101-1	Trametinib	MEK	MAPK/nRTK	4.9546	0.5526	0.1688	0.0031	0.5322	0.09227	0.9741
50131-2	CAMA-1	10032-101-1	Saracatinib	SRC	MAPK/nRTK	Inf	0.7736	0.0306	-0.0005	1.1372	11.0154	0.85387
50131-2	CAMA-1	10179-101-1	ABT-737	Bcl2/XL	Misc	Inf	0.8643	0.0008	0.0221	5.0000	3.6752	0.74188
50131-2	CAMA-1	10282-101-2	Vorinostat	HDAC	Misc	0.88364	-0.4902	0.3827	0.1366	1.5106	1.4957	0.98509
50131-2	CAMA-1	10161-101-1	Luminespib	HSP90	Misc	0.0088457	-0.0698	0.5359	0.0808	5.0000	0.0090456	0.99836
50131-2	CAMA-1	10478-102-1	A-1210477	Mcl-1	Misc	Inf	0.8758	0.0026	0.0051	0.0000	Inf	0.45696
50131-2	CAMA-1	10144-101-3	Olaparib	PARP	Misc	14.8517	0.6788	0.0527	-0.0008	1.4312	31.9803	0.84248
50131-2	CAMA-1	10482-114-1	Bleomycin	Radiation	Misc	1.6866	-0.0365	0.2741	0.0341	0.6542	9.0438	0.951
50131-2	CAMA-1	10338-101-1	Ipatasertib	AKT	PI3K/mTOR	0.34089	-0.2361	0.4116	0.0837	0.7950	0.66403	0.98884
50131-2	CAMA-1	10233-101-1	Alpelisib	PI3Ka	PI3K/mTOR	Inf	0.9788	0.0106	0.0056	0.0000	Inf	-0.0228
50131-2	CAMA-1	10445-101-1	Taselisib	PI3Ka, g, d	PI3K/mTOR	1.7729	-0.1525	0.2454	0.0541	0.7933	7.0816	0.98719
50131-2	CAMA-1	10171-101-1	TGX221	PI3Kb	PI3K/mTOR	42.7345	0.8500	0.0067	0.0034	0.9968	118.889	0.79474
50131-2	CAMA-1	10080-101-1	Torin2	mTOR/ATM/ATR	PI3K/mTOR	0.0091746	-0.1470	0.5071	0.0717	1.1560	0.0098166	0.97482
50131-2	CAMA-1	10235-101-1	Everolimus	mTOR1	PI3K/mTOR	-Inf	0.1642	0.7666	0.0258	0.1000	1.9385e-07	0.61758
50131-2	CAMA-1	10205-101-1	INK-128	mTORC1/2	PI3K/mTOR	0.0096119	-0.0962	0.6396	0.0808	1.3963	0.0099563	0.98744
50131-2	CAMA-1	10404-101-1	PF-4708671	p70S6K	PI3K/mTOR	15.3455	0.6555	0.0582	0.0027	1.1133	41.0889	0.78738
50131-2	CAMA-1	10147-101-1	Buparlisib	pan PI3K	PI3K/mTOR	1.0052	-0.4226	0.3535	0.1148	2.4879	1.2949	0.98951
50131-2	CAMA-1	10047-101-1	Pictilisib	pan PI3K	PI3K/mTOR	1.5489	-0.2370	0.2620	0.0557	0.8407	5.7216	0.99225
50131-2	CAMA-1	10394-101-1	Ceritinib	ALK	RTK	1.797	-0.6988	0.2366	0.0972	1.5849	3.5941	0.99647
50131-2	CAMA-1	10018-101-1	Neratinib	EGFR/HER2	RTK	2.8315	0.4493	0.0703	0.0063	1.1466	7.3732	0.99027
50131-2	CAMA-1	10131-101-1	Tivantinib	MET	RTK	0.27573	-0.5655	0.5259	0.2061	2.2178	0.36921	0.99228
50131-2	CAMA-1	10444-101-1	Cediranib	VEGFR/cKIT	RTK	5.0236	-0.2923	0.1089	0.0448	2.4671	7.8416	0.99299
50131-2	CAMA-1	10194-106-1	Cabozantinib	VEGFR2/MET	RTK	8.7107	0.2436	0.0342	0.0090	4.9963	10.1282	0.97965
50208-2	HCC1428	10390-103-1	Abemaciclib	CDK4/6	Cell cycle	0.0097947	0.0492	0.6359	0.0146	0.9863	0.0062766	0.95101
50208-2	HCC1428	10071-101-1	Palbociclib	CDK4/6	Cell cycle	0.074657	0.2542	0.3272	0.0037	1.4145	0.043222	0.98733
50208-2	HCC1428	10006-101-1	AZD7762	CHK1/2	Cell cycle	0.39126	-0.2152	0.3761	0.0843	1.2225	0.55117	0.98948
50208-2	HCC1428	10387-101-1	Volasertib	PLK	Cell cycle	0.018634	-0.0388	0.4063	0.0917	2.1456	0.018507	0.99276
50208-2	HCC1428	10287-101-2	Dinaciclib	pan CDK	Cell cycle	0.017078	-0.6716	0.6610	0.2408	2.9825	0.02239	0.9979
50208-2	HCC1428	10245-999-4	Cisplatin	Chemo	Chemotherapy	0.91164	0.1223	0.2655	0.0096	1.2004	0.80529	0.9803
50208-2	HCC1428	10248-102-3	Doxorubicin	Chemo	Chemotherapy	0.0047408	-0.7396	0.8955	0.2242	0.5182	0.029971	0.95944
50208-2	HCC1428	10102-101-4	Taxol	Chemo	Chemotherapy	0.0086248	0.0645	0.5066	0.2045	0.7260	0.0074214	0.91451
50208-2	HCC1428	10278-102-2	Topotecan	Topo I	Chemotherapy	0.010613	-0.3764	0.8345	0.1405	0.6324	0.02202	0.8529
50208-2	HCC1428	10250-101-3	Etoposide	Topo II	Chemotherapy	0.21399	-0.0320	0.4009	0.0511	1.7833	0.20625	0.98346
50208-2	HCC1428	10020-101-1	Dasatinib	BCR/ABL	MAPK/nRTK	Inf	0.5784	0.2562	0.0192	0.6681	0.040103	0.94117
50208-2	HCC1428	10142-101-1	Trametinib	MEK	MAPK/nRTK	Inf	0.8152	0.0767	0.0025	5.0000	0.024413	0.9037
50208-2	HCC1428	10032-101-1	Saracatinib	SRC	MAPK/nRTK	Inf	0.6691	0.0697	0.0076	0.8735	1.6565	0.94133
50208-2	HCC1428	10179-101-1	ABT-737	Bcl2/XL	Misc	4.0616	0.2431	0.1194	0.0716	1.0222	5.0858	0.98165
50208-2	HCC1428	10282-101-2	Vorinostat	HDAC	Misc	0.83512	-0.4792	0.3399	0.1022	1.4868	1.371	0.99679
50208-2	HCC1428	10161-101-1	Luminespib	HSP90	Misc	0.0028629	-0.0043	0.6375	0.0972	5.0000	0.0028677	0.99886
50208-2	HCC1428	10478-102-1	A-1210477	Mcl-1	Misc	Inf	0.8155	-0.0207	0.0026	4.9615	5.2131	0.71606
50208-2	HCC1428	10144-101-3	Olaparib	PARP	Misc	0.55326	0.1185	0.3229	0.0089	0.8769	0.48774	0.98952
50208-2	HCC1428	10482-114-1	Bleomycin	Radiation	Misc	4.2581	0.2173	0.1780	0.0166	0.7393	18.8191	0.91689
50208-2	HCC1428	10338-101-1	Ipatasertib	AKT	PI3K/mTOR	Inf	0.9911	-0.0383	-0.0001	0.0000	Inf	-2.9826
50208-2	HCC1428	10233-101-1	Alpelisib	PI3Ka	PI3K/mTOR	Inf	0.8530	0.0202	0.0031	0.0000	Inf	0.41688
50208-2	HCC1428	10445-101-1	Taselisib	PI3Ka, g, d	PI3K/mTOR	4.2249	0.1734	0.1438	0.0192	0.8693	14.9521	0.96527
50208-2	HCC1428	10171-101-1	TGX221	PI3Kb	PI3K/mTOR	Inf	0.7695	0.0143	0.0033	4.9999	3.7973	0.75865
50208-2	HCC1428	10080-101-1	Torin2	mTOR/ATM/ATR	PI3K/mTOR	0.012745	-0.0145	0.4463	0.0566	1.2300	0.012006	0.9876
50208-2	HCC1428	10235-101-1	Everolimus	mTOR1	PI3K/mTOR	0.031039	0.3462	0.5186	0.0192	0.1000	0.0006981	0.70927
50208-2	HCC1428	10205-101-1	INK-128	mTORC1/2	PI3K/mTOR	0.0059301	-0.0001	0.6483	0.0519	1.1926	0.0053821	0.98873
50208-2	HCC1428	10404-101-1	PF-4708671	p70S6K	PI3K/mTOR	69.2764	0.8643	-0.0019	-0.0001	0.8694	128.134	0.60897
50208-2	HCC1428	10147-101-1	Buparlisib	pan PI3K	PI3K/mTOR	0.69074	-0.2646	0.3524	0.1087	1.9122	0.88637	0.99206
50208-2	HCC1428	10047-101-1	Pictilisib	pan PI3K	PI3K/mTOR	5.8689	0.1916	0.1171	0.0310	1.2411	14.2229	0.90007
50208-2	HCC1428	10394-101-1	Ceritinib	ALK	RTK	1.2414	-0.8673	0.3014	0.1288	1.6178	2.4481	0.99584
50208-2	HCC1428	10018-101-1	Neratinib	EGFR/HER2	RTK	1.4327	-0.0412	0.1042	0.0283	1.5482	2.7752	0.9933
50208-2	HCC1428	10131-101-1	Tivantinib	MET	RTK	0.2516	0.0341	0.3664	0.1106	2.2041	0.23715	0.99573
50208-2	HCC1428	10444-101-1	Cediranib	VEGFR/cKIT	RTK	3.1657	-0.5502	0.1943	0.0619	1.9637	5.5392	0.98192
50208-2	HCC1428	10194-106-1	Cabozantinib	VEGFR2/MET	RTK	Inf	0.6310	0.0204	-0.0008	2.9241	4.2982	0.94377
50056-1	HME1	10390-103-1	Abemaciclib	CDK4/6	Cell cycle	0.19935	0.0156	0.4285	0.0217	0.6437	0.22196	0.98583
50056-1	HME1	10071-101-1	Palbociclib	CDK4/6	Cell cycle	0.22285	0.2572	0.2611	0.0111	0.9777	0.10881	0.98803
50056-1	HME1	10006-101-1	AZD7762	CHK1/2	Cell cycle	0.2501	-0.4780	0.4638	0.2260	1.0093	0.48873	0.98439
50056-1	HME1	10387-101-1	Volasertib	PLK	Cell cycle	0.017242	-0.0817	0.4263	0.1273	3.6204	0.017483	0.99425
50056-1	HME1	10287-101-2	Dinaciclib	pan CDK	Cell cycle	0.012053	-0.2848	0.5701	0.2465	5.0000	0.013188	0.9972
50056-1	HME1	10245-999-4	Cisplatin	Chemo	Chemotherapy	1.1201	-0.2180	0.2969	0.0782	0.8418	3.0767	0.99525
50056-1	HME1	10248-102-3	Doxorubicin	Chemo	Chemotherapy	0.0047147	-0.3985	0.8359	0.2785	0.9521	0.0078037	0.96003
50056-1	HME1	10102-101-4	Taxol	Chemo	Chemotherapy	0.0031675	-0.2241	0.6794	0.2401	1.5314	0.0037399	0.98563
50056-1	HME1	10278-102-2	Topotecan	Topo I	Chemotherapy	0.0072669	-0.3399	0.8727	0.2534	1.2621	0.0091245	0.95352
50056-1	HME1	10250-101-3	Etoposide	Topo II	Chemotherapy	0.13797	-0.3838	0.5421	0.1754	1.3297	0.19469	0.98888
50056-1	HME1	10020-101-1	Dasatinib	BCR/ABL	MAPK/nRTK	0.18336	-0.0749	0.4174	0.0505	1.1864	0.19403	0.97949
50056-1	HME1	10142-101-1	Trametinib	MEK	MAPK/nRTK	0.0057339	0.2032	0.4387	0.0257	2.4280	0.0044228	0.99436
50056-1	HME1	10032-101-1	Saracatinib	SRC	MAPK/nRTK	7.2253	0.4596	0.0026	0.0041	5.0000	4.583	0.94329
50056-1	HME1	10179-101-1	ABT-737	Bcl2/XL	Misc	Inf	0.4949	0.0896	0.0303	5.0000	1.1036	0.96879
50056-1	HME1	10282-101-2	Vorinostat	HDAC	Misc	3.0223	0.0551	0.1529	0.0150	1.2382	4.3407	0.99434
50056-1	HME1	10161-101-1	Luminespib	HSP90	Misc	0.0085459	-0.3346	0.6544	0.3132	5.0000	0.0094546	0.99721
50056-1	HME1	10478-102-1	A-1210477	Mcl-1	Misc	0.89942	-0.4222	0.3385	0.1394	2.8064	1.1273	0.99868
50056-1	HME1	10144-101-3	Olaparib	PARP	Misc	25.4252	0.5911	0.0258	-0.0009	1.9303	5.1651	0.96396
50056-1	HME1	10482-114-1	Bleomycin	Radiation	Misc	0.20687	-0.1105	0.4801	0.1073	0.8989	0.29746	0.98718
50056-1	HME1	10338-101-1	Ipatasertib	AKT	PI3K/mTOR	Inf	0.6353	0.0365	0.0079	1.2722	3.6876	0.93611
50056-1	HME1	10233-101-1	Alpelisib	PI3Ka	PI3K/mTOR	6.0356	0.3071	0.1123	0.0079	0.9018	20.4027	0.98253
50056-1	HME1	10445-101-1	Taselisib	PI3Ka, g, d	PI3K/mTOR	0.14812	0.0336	0.4394	0.0340	0.8119	0.13524	0.98597
50056-1	HME1	10171-101-1	TGX221	PI3Kb	PI3K/mTOR	Inf	1.0265	-0.0318	-0.0005	0.0000	Inf	-0.12868
50056-1	HME1	10080-101-1	Torin2	mTOR/ATM/ATR	PI3K/mTOR	0.025621	0.0764	0.3468	0.0310	1.0824	0.018946	0.97645
50056-1	HME1	10235-101-1	Everolimus	mTOR1	PI3K/mTOR	Inf	0.4888	0.3716	0.0206	0.0000	Inf	0.05647
50056-1	HME1	10205-101-1	INK-128	mTORC1/2	PI3K/mTOR	0.033475	0.1969	0.4005	0.0164	1.3589	0.020278	0.99162
50056-1	HME1	10404-101-1	PF-4708671	p70S6K	PI3K/mTOR	5.3765	0.4546	0.1358	0.0746	1.1002	0.7834	0.96742
50056-1	HME1	10147-101-1	Buparlisib	pan PI3K	PI3K/mTOR	1.1504	-0.2416	0.2469	0.0826	1.9615	1.4311	0.99598
50056-1	HME1	10047-101-1	Pictilisib	pan PI3K	PI3K/mTOR	2.8093	0.1260	0.1418	0.0078	1.0287	3.8551	0.98326
50056-1	HME1	10394-101-1	Ceritinib	ALK	RTK	0.82116	-0.3557	0.3036	0.1273	1.8255	1.1186	0.99521
50056-1	HME1	10018-101-1	Neratinib	EGFR/HER2	RTK	0.15243	0.0983	0.2773	0.0166	1.3397	0.11637	0.9808
50056-1	HME1	10131-101-1	Tivantinib	MET	RTK	0.034438	-0.1612	0.6592	0.2212	2.3055	0.037958	0.99175
50056-1	HME1	10444-101-1	Cediranib	VEGFR/cKIT	RTK	7.6446	0.0275	0.0214	0.0244	4.8856	8.7954	0.98095
50056-1	HME1	10194-106-1	Cabozantinib	VEGFR2/MET	RTK	3.2402	-0.1052	0.1020	0.0260	2.6885	3.6278	0.98973
51081-2	SUM1315MO2	10390-103-1	Abemaciclib	CDK4/6	Cell cycle	0.049304	-0.1445	0.5815	0.0291	0.5067	0.075697	0.94514
51081-2	SUM1315MO2	10071-101-1	Palbociclib	CDK4/6	Cell cycle	0.093193	0.3001	0.3314	0.0115	0.9738	0.030153	0.98295
51081-2	SUM1315MO2	10006-101-1	AZD7762	CHK1/2	Cell cycle	0.050295	-0.6526	0.7008	0.2071	0.9510	0.10294	0.9607
51081-2	SUM1315MO2	10387-101-1	Volasertib	PLK	Cell cycle	0.0095	-0.3877	0.6658	0.2263	2.3240	0.012143	0.99552
51081-2	SUM1315MO2	10287-101-2	Dinaciclib	pan CDK	Cell cycle	0.010938	-0.6674	0.7696	0.2780	4.1442	0.013399	0.99826
51081-2	SUM1315MO2	10245-999-4	Cisplatin	Chemo	Chemotherapy	1.275	0.2028	0.2961	0.0592	0.4798	3.6243	0.95111
51081-2	SUM1315MO2	10248-102-3	Doxorubicin	Chemo	Chemotherapy	0.018222	-0.0635	0.5132	0.1324	2.0980	0.016338	0.96491
51081-2	SUM1315MO2	10102-101-4	Taxol	Chemo	Chemotherapy	0.0024623	-0.3258	0.7931	0.2940	2.0093	0.0030737	0.99498
51081-2	SUM1315MO2	10278-102-2	Topotecan	Topo I	Chemotherapy	0.011771	-0.3317	0.7690	0.2174	0.3263	0.11949	0.94357
51081-2	SUM1315MO2	10250-101-3	Etoposide	Topo II	Chemotherapy	0.29244	0.0416	0.3833	0.1087	0.7536	0.26458	0.97369
51081-2	SUM1315MO2	10020-101-1	Dasatinib	BCR/ABL	MAPK/nRTK	0.019122	-0.2366	0.7398	0.1323	0.4601	0.063919	0.98963
51081-2	SUM1315MO2	10142-101-1	Trametinib	MEK	MAPK/nRTK	0.021115	0.1329	0.3887	0.0532	1.0540	0.01638	0.99458
51081-2	SUM1315MO2	10032-101-1	Saracatinib	SRC	MAPK/nRTK	1.3921	0.0846	0.2439	0.0407	0.7066	2.4563	0.99551
51081-2	SUM1315MO2	10179-101-1	ABT-737	Bcl2/XL	Misc	5.9406	0.3056	0.0987	0.0360	0.8016	23.3924	0.93756
51081-2	SUM1315MO2	10282-101-2	Vorinostat	HDAC	Misc	1.7621	-0.0668	0.1742	0.0660	2.7811	1.8526	0.9927
51081-2	SUM1315MO2	10161-101-1	Luminespib	HSP90	Misc	0.0048627	-0.0810	0.6112	0.1374	5.0000	0.0050309	0.99738
51081-2	SUM1315MO2	10478-102-1	A-1210477	Mcl-1	Misc	Inf	0.7399	-0.0234	-0.0009	3.9393	9.1387	0.79269
51081-2	SUM1315MO2	10144-101-3	Olaparib	PARP	Misc	2.0295	0.0911	0.2452	0.0432	0.5075	17.6824	0.94995
51081-2	SUM1315MO2	10482-114-1	Bleomycin	Radiation	Misc	0.21351	0.1491	0.4103	0.1246	0.8125	0.15089	0.9779
51081-2	SUM1315MO2	10338-101-1	Ipatasertib	AKT	PI3K/mTOR	36.6304	0.6070	0.1242	0.0099	0.3263	999.2697	0.9146
51081-2	SUM1315MO2	10233-101-1	Alpelisib	PI3Ka	PI3K/mTOR	6.462	0.3829	0.1169	0.0203	0.5997	40.3568	0.94056
51081-2	SUM1315MO2	10445-101-1	Taselisib	PI3Ka, g, d	PI3K/mTOR	0.51622	0.0942	0.3970	0.0476	0.2926	22.0638	0.995
51081-2	SUM1315MO2	10171-101-1	TGX221	PI3Kb	PI3K/mTOR	Inf	0.7054	0.1362	0.0073	0.9367	0.077385	0.83645
51081-2	SUM1315MO2	10080-101-1	Torin2	mTOR/ATM/ATR	PI3K/mTOR	0.015037	-0.0903	0.4863	0.0621	0.7079	0.022637	0.99665
51081-2	SUM1315MO2	10235-101-1	Everolimus	mTOR1	PI3K/mTOR	Inf	0.4018	0.4539	0.0330	0.0000	Inf	0.42807
51081-2	SUM1315MO2	10205-101-1	INK-128	mTORC1/2	PI3K/mTOR	0.0065863	0.0256	0.6471	0.0662	0.8616	0.0061137	0.99691
51081-2	SUM1315MO2	10404-101-1	PF-4708671	p70S6K	PI3K/mTOR	Inf	0.5951	0.0977	0.0059	0.9518	1.3643	0.93531
51081-2	SUM1315MO2	10147-101-1	Buparlisib	pan PI3K	PI3K/mTOR	0.40124	-0.3686	0.4388	0.1149	0.9148	0.94031	0.98014
51081-2	SUM1315MO2	10047-101-1	Pictilisib	pan PI3K	PI3K/mTOR	0.51112	0.1300	0.3707	0.0433	0.4384	0.96851	0.98439
51081-2	SUM1315MO2	10394-101-1	Ceritinib	ALK	RTK	0.6688	-0.7650	0.4135	0.0975	1.0318	1.9396	0.99439
51081-2	SUM1315MO2	10018-101-1	Neratinib	EGFR/HER2	RTK	0.092366	0.1140	0.3661	0.0353	0.9382	0.073122	0.99266
51081-2	SUM1315MO2	10131-101-1	Tivantinib	MET	RTK	0.36967	-0.4300	0.4751	0.1718	2.1700	0.49553	0.9978
51081-2	SUM1315MO2	10444-101-1	Cediranib	VEGFR/cKIT	RTK	1.4839	-0.2276	0.2430	0.0500	0.7936	5.924	0.99038
51081-2	SUM1315MO2	10194-106-1	Cabozantinib	VEGFR2/MET	RTK	4.5316	0.1095	0.1089	0.0163	1.1058	12.2361	0.99069
51083-2	SUM159PT	10390-103-1	Abemaciclib	CDK4/6	Cell cycle	0.28398	-0.4677	0.4585	0.1015	0.4799	2.802	0.95259
51083-2	SUM159PT	10071-101-1	Palbociclib	CDK4/6	Cell cycle	1.1058	0.3876	0.1990	-0.0006	0.6326	0.40763	0.99661
51083-2	SUM159PT	10006-101-1	AZD7762	CHK1/2	Cell cycle	0.81589	-0.1124	0.2697	0.0926	1.5031	0.93462	0.99443
51083-2	SUM159PT	10387-101-1	Volasertib	PLK	Cell cycle	0.024832	0.0468	0.3873	0.1208	3.5660	0.024055	0.99966
51083-2	SUM159PT	10287-101-2	Dinaciclib	pan CDK	Cell cycle	0.016967	-0.0646	0.4536	0.1030	5.0000	0.017277	0.99948
51083-2	SUM159PT	10245-999-4	Cisplatin	Chemo	Chemotherapy	5.2539	0.1742	0.1149	0.0416	1.1412	13.758	0.99717
51083-2	SUM159PT	10248-102-3	Doxorubicin	Chemo	Chemotherapy	0.019121	-0.2740	0.6068	0.2965	1.5857	0.022541	0.98806
51083-2	SUM159PT	10102-101-4	Taxol	Chemo	Chemotherapy	0.0047473	-0.1485	0.6380	0.2976	2.2238	0.0052544	0.99906
51083-2	SUM159PT	10278-102-2	Topotecan	Topo I	Chemotherapy	0.019593	-0.3284	0.7927	0.3329	1.4860	0.025267	0.97848
51083-2	SUM159PT	10250-101-3	Etoposide	Topo II	Chemotherapy	0.41904	-0.1489	0.3736	0.1389	1.7468	0.47824	0.99862
51083-2	SUM159PT	10020-101-1	Dasatinib	BCR/ABL	MAPK/nRTK	Inf	0.5642	0.1850	0.0047	1.3689	0.14044	0.98104
51083-2	SUM159PT	10142-101-1	Trametinib	MEK	MAPK/nRTK	0.0055877	0.2792	0.4613	0.0039	0.9923	0.0023029	0.99862
51083-2	SUM159PT	10032-101-1	Saracatinib	SRC	MAPK/nRTK	13.9057	0.5624	0.0724	-0.0011	0.9804	8.3037	0.99931
51083-2	SUM159PT	10179-101-1	ABT-737	Bcl2/XL	Misc	14.892	0.6822	0.0239	0.0074	1.9362	14.743	0.99356
51083-2	SUM159PT	10282-101-2	Vorinostat	HDAC	Misc	1.9985	0.1195	0.1810	0.0216	1.3229	1.9352	0.99956
51083-2	SUM159PT	10161-101-1	Luminespib	HSP90	Misc	0.0063084	-0.0476	0.5743	0.2156	4.5596	0.0064127	0.9997
51083-2	SUM159PT	10478-102-1	A-1210477	Mcl-1	Misc	15.1726	0.7796	0.0000	0.0026	4.9964	11.2086	0.95671
51083-2	SUM159PT	10144-101-3	Olaparib	PARP	Misc	18.3192	0.7244	0.0350	0.0011	1.2272	44.7404	0.98618
51083-2	SUM159PT	10482-114-1	Bleomycin	Radiation	Misc	0.28119	-0.0577	0.4191	0.1680	0.7700	0.38984	0.99881
51083-2	SUM159PT	10338-101-1	Ipatasertib	AKT	PI3K/mTOR	9.2403	0.4884	0.1149	0.0020	0.9180	2.8242	0.99791
51083-2	SUM159PT	10233-101-1	Alpelisib	PI3Ka	PI3K/mTOR	4.3125	0.2818	0.1409	0.0003	0.7761	8.5413	0.99788
51083-2	SUM159PT	10445-101-1	Taselisib	PI3Ka, g, d	PI3K/mTOR	0.024971	0.0916	0.5859	0.0023	1.1458	0.019444	0.99527
51083-2	SUM159PT	10171-101-1	TGX221	PI3Kb	PI3K/mTOR	Inf	0.9906	-0.0088	-0.0001	0.0000	Inf	-0.54094
51083-2	SUM159PT	10080-101-1	Torin2	mTOR/ATM/ATR	PI3K/mTOR	0.014492	0.1057	0.4137	0.0050	1.4641	0.011782	0.9977
51083-2	SUM159PT	10235-101-1	Everolimus	mTOR1	PI3K/mTOR	Inf	0.6876	0.3173	-0.0017	0.0000	Inf	0.45421
51083-2	SUM159PT	10205-101-1	INK-128	mTORC1/2	PI3K/mTOR	0.018735	0.1504	0.4832	0.0004	1.5649	0.014424	0.99839
51083-2	SUM159PT	10404-101-1	PF-4708671	p70S6K	PI3K/mTOR	22.2837	0.7309	0.0337	0.0128	0.9688	68.5361	0.98758
51083-2	SUM159PT	10147-101-1	Buparlisib	pan PI3K	PI3K/mTOR	1.5871	-0.1942	0.2253	0.0613	1.5281	2.1811	0.99923
51083-2	SUM159PT	10047-101-1	Pictilisib	pan PI3K	PI3K/mTOR	1.2625	0.0942	0.2390	-0.0024	0.9852	1.2984	0.99746
51083-2	SUM159PT	10394-101-1	Ceritinib	ALK	RTK	1.5606	-0.3800	0.2590	0.1427	2.5153	1.9758	0.99862
51083-2	SUM159PT	10018-101-1	Neratinib	EGFR/HER2	RTK	1.0155	0.3337	0.1585	0.0028	0.9807	0.58582	0.99938
51083-2	SUM159PT	10131-101-1	Tivantinib	MET	RTK	0.37997	-0.1921	0.3954	0.1806	2.0717	0.4458	0.9982
51083-2	SUM159PT	10444-101-1	Cediranib	VEGFR/cKIT	RTK	8.1187	0.3173	0.0491	0.0085	2.1882	12.8042	0.99762
51083-2	SUM159PT	10194-106-1	Cabozantinib	VEGFR2/MET	RTK	5.7873	0.1744	0.0876	0.0357	1.3651	12.895	0.99886
